- Trials with a EudraCT protocol (1,296)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2,726)
Query did not match any clinical trials.
| These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006). | |
| Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records. | |
| Study title: multicentre study of the efficacy and tolerability of clotrimazole 10% vaginal cream in the treatment of vaginal candidosis |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0524_study_synopsis.pdf |
| View full study record |
| Document reference: 24447 |
| Study title: safety and efficacy of bay b 5097 2vaginal cream in 3-day treatment as compared with 7-day treatment with econazole cream (gyno-pevaryl cream). |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0583_study_synopsis.pdf |
| View full study record |
| Document reference: 24454 |
| Study title: Vergleichende Prüfung von vier Clotrimazol-Zubereitungen |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24464 |
| Study title: Essai randomisé, ouvert, en groupes parallèles, afin d'évaluer la non infériorité de la cloxacilline versus la pristinamycine en termes d'efficacité et de tolérance dans les infections cutanées à staphylocoque ou à streptocoque |
| Active substance: CLOTRIMAZOLE + SALICYLIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24467 |
| Study title: "Essai randomisé, ouvert, en groupes parallèles, afin d'évaluer la non infériorité de la cloxacilline versus la pristinamycine en termes d'efficacité et de tolérance dans les infections cutanées à staphylocoque ou à streptocoque" |
| Active substance: CLOXACILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24468 |
| Study title: "Evaluation de l'acceptabilité et de la tolérance de la cloxacilline poudre pédiatrique pour suspension buvable 250 mg, en sachets, dans les angines streptococciques et infections cutanées de l'enfant" |
| Active substance: CLOXACILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24469 |
| Study title: TO MAKE FLUCONAZOLE AVAILABLE IN PATIENTS WITH CRYPTOCOCCAL MENINGITIS WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. ALSO SAFETY AND EFFECTIVENESS OF THE DRUG. THIS PROTOCOL NUMBER WAS ORIGINALLY FCA-BRA-90-002A. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27746 |
| Study title: TO STUDY THE EFFICACY AND TOLERATION OF FCA WHEN GIVEN AT A SINGLE 400 MG DOSE IN THOSE PATIENTS WITH OP IN WHOM THE SINGLE 150 MG DOSE DID NOT INDUCE SYMPTOMS WITHIN 3-10 DAYS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27393 |
| Study title: TO STUDY THE EFFICACY AND TOLERATION OF FCA WHEN GIVEN AT A SINGLE 400 MG DOSE IN THOSE PATIENTS WITH OP IN WHOM THE SINGLE 150 MG DOSE DID NOT INDUCE SYMPTOMS WITHIN 3-10 DAYS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27758 |
| Study title: TO STUDY THE SAFETY AND EFFICACY OF ORAL IV FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH NON-CANDIDA MYCOSES. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27588 |
| Study title: TO STUDY THE SAFETY AND EFFICACY OF ORAL IV FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH NON-CANDIDA MYCOSES. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27951 |
| Study title: TOLERATION AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27376 |
| Study title: TOLERATION AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27741 |
| Study title: TOLERATION AND SAFETY OF ORAL FLUCONAZOLE IN THE PROPHYLAXIS OF FUNGAL COLONIZATION AND INFECTION IN PATIENTS UNDERGOING BONE MARROW TRANSPLANTATION. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27463 |
| Study title: TOLERATION AND SAFETY OF ORAL FLUCONAZOLE IN THE PROPHYLAXIS OF FUNGAL COLONIZATION AND INFECTION IN PATIENTS UNDERGOING BONE MARROW TRANSPLANTATION. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27827 |
| Study title: TREATMENT OF OROPHARYNGEAL CANDIDIASIS RESISTANT TO FLUCONAZOLE A DAILY DOSE OF 400 MG FOR 7 DAYS. A PILOT DOSE STUDY USING 800, 1200 AND 1600 MG DAILY TO 7 DAYS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27401 |
| Study title: Eur Spine J. 2001 Dec;10(6):534-9. Fluorine-18 fluorodeoxyglucose positron emission tomography findings in spondylodiscitis: preliminary results. Schmitz A, Risse JH, Grünwald F, Gassel F, Biersack HJ, Schmitt O. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28163 |
| Study title: Nucl Med Commun. 2002 Aug;23(8):773-7. Cerebral metabolic changes associated with Lyme disease. Newberg A, Hassan A, Alavi A. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28157 |
| Study title: Ensaio clinico e terapeutico com um novo antimicotico piridonico de emprego topico o HOE 296-Clinical and therapeutic trial with a new pyridonic anti-mycotic compound for topical use, the HOE 296 - Luiz Carlos Pereira et al. - 1974 (Rev Bras Clin Ter vol 3) - Publication in Part Clinical documentation Batrafen Losung-No author - 11/1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24151 |
| Study title: Estudo sobre o uso do ciclopirox (HOE 296) em Dermatologia : Resultados clinicos das micoses superficiais- Clinical effects of use of ciclopirox (HOE 296) in dermatology : therapeutic efficacy in superficial mycosis- Marcio lobo Jardim et al. - 1975 ( Rev Bras Clin Ter vol 4) - Publication in Part Clinical documentation Batrafen Losung - No author - 11/1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24152 |
| Study title: Estudo sobre o uso do ciclopirox (HOE 296) em Dermatologia : Resultados clinicos das micoses superficiais- Clinical effects of use of ciclopirox (HOE 296) in dermatology : therapeutic efficacy in superficial mycosis- Marcio lobo Jardim et al. - 1975 ( Rev Bras Clin Ter vol 4) - Publication in Part Clinical documentation Batrafen Losung -No author - 11/1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24153 |
| Study title: Evaluation of a new antifungal cream, ciclopirox alamine 1% in the treatment of cutaneous candidosis - Fillmore K. Bagatell et al. - 1985 (Clincals Therapeutics vol 8, N°1) -Publication in clinical studies (volume 5) - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24154 |
| Study title: Evaluation of a new antifungal cream, ciclopirox alamine 1% in the treatment of cutaneous candidosis - Fillmore K. Bagatell et al. - 1985 (Clincals Therapeutics vol 8, N°1) -Publication in clinical studies (volume 5) - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24155 |
| Study title: Evaluation of ciclopirox olamine for the treatment of tinea pedis : multicenter, double-blind comparatives studies - Albert M. Kligman et al.- 1985 (Clinical therapeutics vol 7, n°4) - Publication in clinical studies ( volume 4)- a double blind multicentre parallel study group comparing ciclopirox olamine 1% cream and vehicle, cream base in the subjects with Tinea corporis or Tinea cruris - No author - 08/1988 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24156 |
| Study title: Experiencia clinica com um novo antimicotico : HOE 296-Clinical experience with HOE 296, a new antimycotic agent- R.D Azulay et al. - 1973 (Rev bras. Clin Ter vol 2) - Publication in Part Clinical documentation Batrafen Losung - No author - 11/1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24157 |
| Study title: Fungal colonization in the very low birth weight infants - J.E Baley et al. - 1986 (Pedriatrics vol 78) - Publication in Part clinical documentation- Batrafen Losung Study CIOMS - No author -11/ 1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24158 |
| Study title: High prevalence of cervical dysplasia in female consorts of men with genital warts- T. Hockenstrom et al.- No date (Acta Derm Venereol vol 67) - Publication in clinical studies (volume 6) - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24159 |
| Study title: HOE 296 - Its safety evaluated by laboratory test and its clinical effect- Y. Watanabe - 1975 (Journal of new Remedies and Clinicals vol 24) - Publication in Part clinical documentation-Batrafen Losung Study CIOMS -No author - 11/1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24160 |
| Study title: HOE 296, um novo antimicotico piridonicode emprego topico,com atividade antibacteriana adicional - Ney Romiti - 1974 (Rev Bras Clin Ter vol 3, n°10, suppl 7) - Publication in Part clinical documentation Batrafen Losung - Study CIOMS - No author - 11/ 1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24161 |
| Study title: HOE 296, um novo antimicotico piridonicode emprego topico,com atividade antibacteriana adicional - Ney Romiti - 1974 (Rev Bras Clin Ter vol 3, n°10, suppl 7) - Publication in Part clinical documentation Batrafen Losung - Study CIOMS - No author - 11/ 1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24162 |
| Study title: Investigacion clinica sobre el HOE 296 en demafitosis de la piel lampina y en pitiriasis versicolor - Antonio Gonzalvez-Ochoa et al. - 1974 (Rev Int Salud publica vol 34) - Publication in Part clinical Documentation Batrafen Losung - No author - 11/ 1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24163 |
| Study title: La ciclopiroxolamina nel trattamento della pityriasis versicolor (Ciclopiroxolamine in the treatment of pityriasis versicolor) - G. Trevisan et al. - 1988 (Giornale Italiano Di Dermatologica e Venerologica vol 123) - Publication in Part clinical documenta |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24164 |
| Study title: Multicentre Double-blind clinical trials of ciclopirox olamine cream 1%in the treatment of tinea corporis or tinea cruris -Humberto Bogaert et al. - 1986 (J Int Med Res vol 14) - Publication in clinical studies ( volume 3) - a double bind multicentre parallel study group comparing ciclopirox olamine 1% cream and vehicle, cream base in the subjects with Tinea corporis or Tinea cruris - No author - 08/ 1988 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24165 |
| Study title: TREATMENT OF OROPHARYNGEAL CANDIDIASIS RESISTANT TO FLUCONAZOLE A DAILY DOSE OF 400 MG FOR 7 DAYS. A PILOT DOSE STUDY USING 800, 1200 AND 1600 MG DAILY TO 7 DAYS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27766 |
| Study title: TREATMENT OF SYSTEMIC MYCOSIS WITH FLUCONAZOLE AND ITS IN VITRO ANTIFUNGAL ACTIVITY |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27498 |
| Study title: TREATMENT OF SYSTEMIC MYCOSIS WITH FLUCONAZOLE AND ITS IN VITRO ANTIFUNGAL ACTIVITY |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27862 |
| Study title: TREATMENT OF VAGINAL CANDIDIASIS WITH A SINGLE ORAL DOSE OF FCA. MULTICENTER NON-COMPARATIVE OPEN STUDY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27407 |
| Study title: TREATMENT OF VAGINAL CANDIDIASIS WITH A SINGLE ORAL DOSE OF FCA. MULTICENTER NON-COMPARATIVE OPEN STUDY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27772 |
| Study title: USEFULNESS OF DIFLUCAN THERAPY FOR SYSTEMIC FUNGAL INFECTIONS ASSOCIATED WITH HEMATOLOGIC DISEASES |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27486 |
| Study title: USEFULNESS OF DIFLUCAN THERAPY FOR SYSTEMIC FUNGAL INFECTIONS ASSOCIATED WITH HEMATOLOGIC DISEASES |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27850 |
| Study title: TO DETERMINE FLUCONAZOLE EFFICACY AND SAFETY IN AIDS PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27405 |
| Study title: TO DETERMINE FLUCONAZOLE EFFICACY AND SAFETY IN AIDS PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27770 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF A SINGLE ORAL DOSE OF FLUCONAZOLE (150 MG) IN THE TREATMENT OF NON-SEVERE ORAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27590 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF A SINGLE ORAL DOSE OF FLUCONAZOLE (150 MG) IN THE TREATMENT OF NON-SEVERE ORAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27953 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL AND/OR IV FLUCONAZOLE 100-400 MG ONCE A DAY IN THE TREATMENT OF CRYPTOCOCCAL MENINGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27592 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL AND/OR IV FLUCONAZOLE 100-400 MG ONCE A DAY IN THE TREATMENT OF CRYPTOCOCCAL MENINGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27955 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL AND/OR IV FLUCONAZOLE 200-400 MG ONCE A DAY IN THE TREATMENT OF SYSTEMIC CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27591 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL AND/OR IV FLUCONAZOLE 200-400 MG ONCE A DAY IN THE TREATMENT OF SYSTEMIC CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27954 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL FLUCONAZOLE (CAPSULES AND SYRUP) ONCE DAILY IN THE TREATMENT OF PATIENTS SUFFERING FROM ORAL ATROPHIC CANDIDIASIS WITH DENTURES. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27439 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL FLUCONAZOLE (CAPSULES AND SYRUP) ONCE DAILY IN THE TREATMENT OF PATIENTS SUFFERING FROM ORAL ATROPHIC CANDIDIASIS WITH DENTURES. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27804 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FCA 50 TO 200 O.D. IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27418 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FCA 50 TO 200 O.D. IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27783 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 100-400 MG/DAY IN THE TREATMENT OF SYSTEMIC CANDIDIASIS/CRYPTOCOCCAL MENINGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27580 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 100-400 MG/DAY IN THE TREATMENT OF SYSTEMIC CANDIDIASIS/CRYPTOCOCCAL MENINGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27943 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 50/100 MG O.D. IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27420 |
| Study title: A DOUBLE-BLIND MULTICENTER COMPARATIVE STUDY OF TWO DOSE REGIMENS OF ORAL CLINDAMYCIN HYDROCHLORIDE IN THE TREATMENT OF ACUTE TONSILLITIS/PHARYNGITIS DUE TO GROUP A BETA-HEMOLYTIC STREPTOCOCCI. |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): 251F-INF-0496-001 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 24361 |
| Study title: A PROSPECTIVE, STRATIFIED, RANDOMIZED, THIRD-PARTY BLINDED COMPARISON OF THE SAFETY AND EFFICACY OF CEFOPERAZONE PLUS PIPERACILLIN VERSUS CEFOPERAZONE PLUS AMIKACIN IN THERAPY OF INFECTED SOLID TUMOR PATIENTS RECEIVING CISPLATIN |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24360 |
| Study title: bay b 5097 500 mg vaginal tablet: efficacy and tolerance of bay b 5097 500 mg vaginal tablet as single or one day therapy of vaginal yeast infections |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0420_study_synopsis.pdf |
| View full study record |
| Document reference: 24457 |
| Study title: BAY b 5097 Solution N Activity and Tolerability in Dermatomycoses. |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24441 |
| Study title: BAY b 5097 Solution N Activity and Tolerance in Otomycoses. |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24442 |
| Study title: BAY b 5097 Solution N Activity and Tolerance in Otomycoses. |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0220_study_synopsis.pdf |
| View full study record |
| Document reference: 24443 |
| Study title: Comparative study on the efficacy of clotrimazole vaginal cream 10 & econazole depot ovule 150 mg in the treatment of candida vaginitis. |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24445 |
| Study title: Comparative study on the efficacy of clotrimazole vaginal cream 10% and econazole depot ovule 150 mg in the treatment of Candida vaginitis |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0595_study_synopsis.pdf |
| View full study record |
| Document reference: 24448 |
| Study title: effectiveness and tolerance of bay b 5097 2 per cent vaginal cream on therapy for 3 days compared to therapy for 7 days with econazole 1 per cent vaginal cream (gyno-pevaryl cream) |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0396_study_synopsis.pdf |
| View full study record |
| Document reference: 24455 |
| Study title: Efficacy and tolerability of clotrimazole vaginal cream 10 in comparison with clotrimazole vaginal tablets 500 mg after a single application in patients with vaginal yeast infections |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0345_study_synopsis.pdf |
| View full study record |
| Document reference: 24444 |
| Study title: Efficacy and tolerability of clotrimazole vaginal cream 10 in comparison with clotrimazole vaginal tablets 500 mg after a single application in patients with vaginal yeast infections |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0473_study_synopsis.pdf |
| View full study record |
| Document reference: 24462 |
| Study title: efficacy and tolerability of clotrimazole vaginal tablets 100 mg (galenic formulation with lactic acid) in the 6-day-therapy in vaginal candida-infections |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0516_study_synopsis.pdf |
| View full study record |
| Document reference: 24451 |
| Study title: efficacy and tolerance of bay b 5097 vaginal cream 2% in the 3-day therapy compared to a 6-day therapy with Canesten vaginal cream 1% |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24453 |
| Study title: efficacy and tolerance of two galenical product formulations of canesten vaginal tablets containing 500 mg of the active ingredient clotrimazole after a single administration to patients with vaginal yeast infections |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0444_study_synopsis.pdf |
| View full study record |
| Document reference: 24458 |
| Study title: Gutachten über die klinische Prüfung von Mykichthol Paste |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0524_study_synopsis.pdf |
| View full study record |
| Document reference: 24465 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 50/100 MG O.D. IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27785 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 50/100 MG/DAY IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27589 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 50/100 MG/DAY IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27952 |
| Study title: TO EVALUATE THE EFFICACY AND SAFETY OF FLUCONAZOLE IN THE TREATMENT OF DISSEMINATED CANDIDIASIS AND CRYPTOCOCCAL MENINGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27623 |
| Study title: TO EVALUATE THE EFFICACY AND SAFETY OF FLUCONAZOLE IN THE TREATMENT OF DISSEMINATED CANDIDIASIS AND CRYPTOCOCCAL MENINGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27985 |
| Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF A SINGLE 400 MG ORAL/IV DOSE OF FLUCONAZOLE IN PATIENTS SUFFERING FROM CANDIDAL ESOPHAGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27394 |
| Study title: Investigation of the effectiveness and tolerance of a single administration of clotrimazole vaginal tablet of 500 mg in cases of vaginal candida infection in comparison with a 6-day theraphy with clotrimazole vaginal tablets of 100 mg |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0581_study_synopsis.pdf |
| View full study record |
| Document reference: 24450 |
| Study title: Investigation of the effectiveness and tolerance of a single administration of clotrImazole vaginal tablet of 500 mg in cases of vaginal candida infection in comparison with a 6-day theraphy with clotrimazole vaginal tablets of 100 mg |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0460_study_synopsis.pdf |
| View full study record |
| Document reference: 24461 |
| Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF A SINGLE 400 MG ORAL/IV DOSE OF FLUCONAZOLE IN PATIENTS SUFFERING FROM CANDIDAL ESOPHAGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27759 |
| Study title: TO EVALUATE THE PHARMACOKINETIC PARAMETERS AFTER IV FLUCONAZOLE IN PATIENTS WITH EITHER 1. AIDS WITHOUT LIVER DISEASE OR 2. LIVER CIRRHOSIS OR SEVERE HEPATIC DISEASE IN COMPARISON WITH HEALTHY SUBJECTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27427 |
| Study title: TO EVALUATE THE PHARMACOKINETIC PARAMETERS AFTER IV FLUCONAZOLE IN PATIENTS WITH EITHER 1. AIDS WITHOUT LIVER DISEASE OR 2. LIVER CIRRHOSIS OR SEVERE HEPATIC DISEASE IN COMPARISON WITH HEALTHY SUBJECTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27792 |
| Study title: TO EVALUATE THE SAFETY AND EFFICACY OF FLUCONAZOLE CAPSULES VS. NYSTATIN SUSPENSION IN THE PREVENTION OF CANDIDIASIS IN LEUKEMIC PATIENTS UNDERGOING CHEMOTHERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27593 |
| Study title: TO EVALUATE THE SAFETY AND EFFICACY OF FLUCONAZOLE CAPSULES VS. NYSTATIN SUSPENSION IN THE PREVENTION OF CANDIDIASIS IN LEUKEMIC PATIENTS UNDERGOING CHEMOTHERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27956 |
| Study title: TO GATHER ADDITIONAL DATA ON THE SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS CRYPTOCOCCAL MENINGITIS. TO MAKE FLUCONAZOLE AVAILABLE FOR USE IN PATIENTS WITH CRYPTOCOCCAL MENINGITIS WHO IN THE INVESTIGATOR JUDGEMENT WOULD BENEFIT FROM TREATMENT WITH THIS AGENT |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27594 |
| Study title: TO GATHER ADDITIONAL DATA ON THE SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS CRYPTOCOCCAL MENINGITIS. TO MAKE FLUCONAZOLE AVAILABLE FOR USE IN PATIENTS WITH CRYPTOCOCCAL MENINGITIS WHO IN THE INVESTIGATOR JUDGEMENT WOULD BENEFIT FROM TREATMENT WITH THIS AGENT |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27957 |
| Study title: TO INVESTIGATE THE SAFETY AND EFFICACY OF A SINGLE ORAL DOSE OF FCA 150 MG CAPS FOR THE TX OF WOMEN WITH VAGINAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27683 |
| Study title: Bronchial secretion and serum levels in children with cystic fibrosis treated with gentamicin. - Vogt E. - 1973 ( Praxis, 62 : 444-447) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28891 |
| Study title: |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28723 |
| Study title: |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28724 |
| Study title: |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28725 |
| Study title: 4A. A report of patients with superficial skin sepsis treated with fucidin cream. An open assessment of Fucidin Cream as a treatment for superficial sepsis (Newby) |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28669 |
| Study title: A clinical investigation of the pharmacokinetics of MULTIHANCE in healthy normal subjects from two to fifteen years of age. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28720 |
| Study title: A comparative study of Fucidin® ointment (sodium fusidate 2%) and Cicatrin cream (neomycin sulphate 0.5%, bacitracin zinc 250u/g |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28692 |
| Study title: A comparison of Fucidin tablets and Flucloxacillin in skin and soft-tissue infections |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28694 |
| Study title: A comparison of Fucithalmic® eye drops and Chloramphenicol® eye ointment as single treatment in brasion corneae, corpus alieni corneae |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28650 |
| Study title: A comparison of Fusidic acid 1% viscous eye drops (Fucithalmic LEO) and neosporin eye ointment (Wellcome) in patients with external eye infections; Yacinto U Dy, Llacco Int. J. of clinical practices, Vol 7., No. 3., 1991 82 pts (4-75) |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28708 |
| Study title: A comparison of fusidic acid gel 1% (Fucithalmic®) and chloramphenicol 0.5% in acute bacterial conjunctivits Carr WD, Journal Clin Research 1998;1:403-411 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28713 |
| Study title: A comparison of fusidic acid viscous eye drops and Chloramphenicol eye ointment in acute conjunctivitis |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28697 |
| Study title: A comparison of low dose and standard dose systemic Fucidin® in skin and soft tissue infections |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28716 |
| Study title: A comparison of sodium fusidate ointment and mupirocin ointment in superficial skin sepsis |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28693 |
| Study title: A comparison of the efficacy of Fucidin® H cream(2% fusidic acid/1%hydrocortisone acetate) with Fucidin® cream(2% fusidic acid) in the management of patients with mild to moderate atopic eczema |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28672 |
| Study title: Open clinical study to evaluate the reactogenicity of SmithKline Beecham Biologicals' Hib conjugate vaccine mixed with SmithKline Beecham Biologicals' DTPa vaccine when given as a booster dose to children at 15 to 18 months of age, previously primed with SB Bio's Hib tetanus conjugate and DTPa vaccines in study HIB-012. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41133 |
| Study title: Open label, randomised comparative assessment of the immunogenicity and reactogenicity of SmithKline Beecham's (SB's) diphteria/tetanus/acellular pertussis (DTPa) vaccine and SB's Hib with commercially available diphtheria/tetanus/whole cell pertussis (DTPw) and SB's Hib. Vaccines to be combined in the same syringe and administered to healthy infants as three consecutive doses at 2, 3 and 4 months of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41137 |
| Study title: Open randomised clinical study to evaluate the immunogenicity and reactogenicity of SB Biologicals' Hib tetanus conjugate vaccine, co-administered with SB Biologicals' DTPa vaccine either mixed in one syringe, or in two separate injections into opposite limbs, to healthy children around two years of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41141 |
| Study title: Open study to assess the immunogenicity and reactogenicity of a three-dose primary vaccination course against Haemophilus influenzae type b, diphtheria, tetanus, pertussis and hepatitis B in healthy infants at 6, 10 and 14 weeks of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41155 |
| Study title: Open, phase II clinical trial to assess long-term antibody persistence, before Td booster vaccination, in healthy children 5 to 6 years old, previously vaccinated with 4 doses of SB Biologicals¿ DTPa vaccine mixed with SB Biologicals¿ Hib conjugate vaccine in primary vaccination study Hib-006 (208108/005) and in booster vaccination study Hib-017 (208108/017). |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41156 |
| Study title: A Prospective Blinded Read to Explore the Efficacy of MULTIHANCE and MAGNEVIST (0.10 mmol/kg) in Magnetic Resonance Imaging (MRI) of Brain and Spine Tumors in Pediatric Population |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28722 |
| Study title: Fucidin® tablets in cutaneous infection in comparison with pristinamycin tablets |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28695 |
| Study title: Fucithalmic in external eye infections. Fucithalmic in The Baltic States (adults & children) |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28648 |
| Study title: Fucithalmic viscous eye drops in acute conjunctivitis Single-Blind, Ramdomized Comparison with Chloramphenicol Eye Drops ; J. Hvidberg Acta Ophthalmologica, vol 65, no 1. 1987 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28699 |
| Study title: Fucithalmic viscous eye drops in superficial eye infections Open non-comparative study |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28652 |
| Study title: Fucithalmic, chloramphenicol or no treatment after squint surgery in children: a single blind randomised study |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28719 |
| Study title: Fucithalmic® versus 1% rifamycin in acute conjunctivitis.Adenis J P, Arrata M, Gastaud P, Limon S, Massin M. J. Fr Ophtalmol 1989; 12(4): 317-322 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28653 |
| Study title: Fusidic Acid and the Treatment of Patients with Skin and Soft Tissue Infections |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28698 |
| Study title: Fusidic acid versus tobramycin in suspected bacterial conjunctivitis |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28680 |
| Study title: Garborg-O, Nyjordet-R. Pyogenic Cutaneous Infections In East African Children Treated With Fucidin Ointment. Journal of Tropical Pediatrics and Environmental Child Health, 1971, vol. 17, no. 4, p. 153-157. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28663 |
| Study title: Garborg-O. Cutaneous staphylococcal infections in children treated by 2 per cent sodium fusidate ointment. Bruxelles medical, {Brux-Med}, Jun 1968, vol. 48, no. 6, p. 377-82, ISSN: 0068-3027. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28664 |
| Study title: Koning-S, van-Suijlekom-Smit-LWA, Nouwen-JL, Verduin-CM, Bernsen-RMD, et-al. Erasmus University and University Hospital Rotterdam, Rotterdam, The Netherlands. Fusidic acid cream in the treatment of impetigo in general practice: double blind randomised placebo controlled trial. BMJ, {BMJ}, 26 Jan 2002, vol. 324, p. 203-206, ISSN: 0959-8138. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28656 |
| Study title: Koning-S, van-Suijlekom-Smit-LWA, Nouwen-JL, Op-t-Veld-Mulders-M, Snijders-S, et-al. Erasmus University Medical Center, Rotterdam, The Netherlands. Fusidic acid cream versus placebo in the treatment of impetigo: a double blind placebo controlled randomized trial. 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, {41st-ICAAC}, 22 Sep 2001, p. 269. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28657 |
| Study title: Liddy-N. Intravenous fusidic acid in the newborn. Lancet, {Lancet}, 17 Mar 1973, vol. 1, no. 7803, p. 621, ISSN: 0140-6736. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28662 |
| Study title: Gentamycin in the treatment of infections in the premature infant. - Forti G. - 1968 (Antibiotica, Dec, 4:255)- Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28925 |
| Study title: Is the primary suture indicated in infected wounds in pediatric surgery?Is the primary suture indicated in infected wounds in pediatric surgery? |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28887 |
| Study title: Occella-C, Schiazza-L, Nemelka-O, Persi-A, Rampini-E. Ist.Sci. "G.Gaslini", Div.Dermatologica, Genova, Italia. Garze medicate con acido fusidico nella terapia topica Rassegna di Dermatologia e Sifilografia, vol.XXXV, n.unico, genn-dic 1982. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28660 |
| Study title: Perianal streptococcal dermatitis treated with oral fusidic acid: report of two cases |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28718 |
| Study title: Pharmacokinetics of fusidic acid given as an oral suspension to children |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28687 |
| Study title: Pharmacokinetics of fusidic acid in children after single dose administration |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28689 |
| Study title: Pyogenic cutaneous infections in east African children treated with Fucidin® ointment; Garborg O and Nyjordet R. 1971 J Trop Pediatr. Child Health, 17: 153-157 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28677 |
| Study title: A phase IIb randomised, multi-site clinical study to assess the immunogenicity and reactogenicity of formulation B of SB Biologicals¿ Hib conjugate vaccine administered mixed as single injection with SB Biologicals¿ DTPa vaccine versus formulation A of SB Biologicals¿ Hib conjugate vaccine administered either mixed as single injection or separately into opposite thighs with SB Biologicals¿ DTPa vaccine as a three-dose primary vaccination course in healthy infants at 3, 4, and 5 months of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41147 |
| Study title: A post-marketing surveillance study of GlaxoSmithKline Biologicals¿ Haemophilus influenzae type b (Hib) tetanus conjugate vaccine in 3,000 Filipino subjects. Phase IV single-blind randomised study to assess the feasibility of syringe mixing of combined diphtheria, tetanus, whole cell Bordetella pertussis (DTPw) vaccine and Haemophilus influenzae type b (Hib) conjugate vaccine as a three dose primary vaccination course in healthy infants. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41151 |
| Study title: An open multicentric post marketing surveillance study of SmithKline Beecham haemophilus influenzae type B tetanus conjugate vaccine-Hiberix- administered according to local recommendations in infants and children up to the age of 5 years. Only Korean version-English title to be provided. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41157 |
| Study title: An open, parallel, randomised clinical study to assess the reactogenicity of SB Biologicals¿ Hib conjugate vaccine mixed with SB Biologicals¿ DTPa vaccine in comparison to the Pasteur-Mérieux´s Hib conjugate vaccine mixed with Pasteur-Mérieux´s DTPw vaccine as a booster vaccination to healthy children at 15 to 20 months, previously primed with three doses of commercially available DTPw and Hib conjugate vaccines. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41154 |
| Study title: An open, parallel, randomized clinical study to assess the reactogenicity of SmithKline Beecham (SB) Biologicals¿ Hib conjugate vaccine mixed with SB Biologicals¿ DTPa vaccine in comparison to Pasteur-Mérieux Connaught¿s (PMC) Hib conjugate vaccine mixed with PMCs¿ DTPw vaccine, as a three-dose primary vaccination course to healthy infants at 2, 4 and 6 months of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41153 |
| Study title: An open, randomised clinical study to assess the reactogenicity of SB Biologicals¿ Hib conjugate vaccine administered mixed as single injection with SB Biologicals¿ DTPa vaccine in comparison to commercially available Hib conjugate vaccine and DTPw vaccine administered separately into opposite limbs as a booster vaccination in healthy infants at 18 months of age, previously primed with three doses of DTPw and Hib conjugate vaccines. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41149 |
| Study title: Clinical study to assess the immunogenicity and reactogenicity of a booster dose of formulation B of SB Biologicals¿ Hib conjugate vaccine administered either mixed as a single injection or separate into opposite sites with SB Biologicals¿ DTPa vaccine, or formulation A of SB Biologicals¿ Hib conjugate vaccine separately into opposite sites with SB Biologicals¿ DTPa vaccine at 13 months of age in infants primed in study 208108/032 (Hib-032). |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41150 |
| Study title: Clinical study to assess the immunological memory induced by a primary course using different formulations of Hib conjugate vaccines in several combinations with acellular pertussis vaccines by giving one dose of unconjugated PRP co-administered with SB Biologicals¿ DTPa-HBV combined vaccine at 12-24 months of age in infants primed in study DTPa-HBV-037. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41146 |
| Study title: Report on clinical study with iv fucidin in the treatment of severe staphylococcal infection |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28686 |
| Study title: Sputum penetration of fusidic acid in patients with cystic fibrosis |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28717 |
| Study title: Staemmler-H-G, Rodeck-H, Linzenmeier-G. On the treatment of superficial staphylococcal diseases in childhood with Fucidin-gel. Deutsche medizinische Wochenschrift (1946), {Dtsch-Med-Wochenschr}, 6 Sep 1968, vol. 93, no. 36, p. 1714-6, ISSN: 0012-0472. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28665 |
| Study title: Staemmler-H-G, Rodeck-H, Loss-G. The Effect Of Fusidic-Acid Anti Infect On Staphylococcus Infections In Children Abstract From Deutsch-Med-Wschr 91-45 2013-2017 November 11 1996 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28666 |
| Study title: Study of fusidic acid administered intravenously for the treatment of severe staphylococcus infection |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28685 |
| Study title: Systemic or Local Treatment of Erythrasma. Thorn P Scand J Prim Health Care 1991 9 35-39 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28671 |
| Study title: Therapeutic assessment of application of calcipotriol ointment (Daivonex®) in children with psoriasis |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28704 |
| Study title: Treatment of skin infections with two dosages of fusidic acid (500 mg/day and 1 g/day) compared with pristinamycin 2 g/day : a multicentre randomised study; L. Machet, A. Puissant, L. Vaillant t le groupe d’étude des infections cutanéesNouvelles Dermatologiques 1994; 13: 512-9 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28683 |
| Study title: A comparative study of Fucidin H cream and Hydrocortisone cream in children (4-17 years) with a flare-up of atopic dermatitis. A study using non-invasive bioengineering techniques. |
| Active substance: FUSIDIC ACID AND HYDROCORTISONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28726 |
| Study title: Open, randomised, clinical study to evaluate the interference on the immunogenicity of vaccine antigens, when Haemophilus influenzae type b tetanus conjugate and combined diphtheria, tetanus, acellular pertussis vaccines are co-administered, either in one single or two separate injections as a primary vaccination course to healthy infants at 2, 4 and 6 months of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41136 |
| Study title: Open, randomized clinical study of the immunogenicity and reactogenicity of the SB Biologicals¿ DTPa and Hib conjugate vaccines, either mixed in one syringe or given in two separate injections, to healthy infants at the age of 2, 4, 6 and 18 months, or the administration of a dose of plain PRP at the age of 12 months in infants primed with Hib conjugate vaccine. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41135 |
| Study title: Phase II open randomized primary vaccination study to assess the immunogenicity and reactogenicity of GlaxoSmithKline Biologicals (GSK) Haemophilus influenzae type b (Hib) conjugate vaccine administered either mixed or in two separated injections with commercially available DTPw vaccine (Government Pharmaceutical Organization: GPO) as compared to GSK Biologicals¿ Hib administered mixed with GSK Biologicals¿ DTPw vaccine in healthy infants, aged 2, 4 and 6 months. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41158 |
| Study title: Phase IV primary vaccination study to assess the immunogenicity and reactogenicity of concomitant administration of Haemophilus influenzae type b (Hib) vaccine with either diphtheria-tetanus-whole cell pertussis vaccine and hepatitis B vaccine or with quadrivalent diphtheria-tetanus-whole cell pertussis-hepatitis B vaccine |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41152 |
| Study title: A PHASE IV RANDOMIZED STUDY OF THE USE OF FLUCONAZOLE AS CHRONIC SUPPRESSIVE THERAPY VERSUS EPISODIC THERAPY IN HIV POSITIVE SUBJECTS WITH RECURRENT OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FOSPHENYTOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28603 |
| Study title: A RANDOMIZED, DOUBLE-BLIND COMPARATIVE MULTICENTER STUDY OF FLUCONAZOLE PLUS AMPHOTERICIN B VERSUS FLUCONAZOLE PLUS PLACEBO IN THE TREATMENT OF CANDIDEMIA AND ITS CONSEQUENCES IN NON-NEUTROPENIC PATIENTS |
| Active substance: FOSPHENYTOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28602 |
| Study title: PILOT STUDY TO DETERMINE THE FEASIBILITY OF FLUCONAZOLE FOR INDUCTION TREATMENT AND SUPPRESSION OF RELAPSE OF HISTOPLASMOSIS IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME |
| Active substance: FOSPHENYTOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28601 |
| Study title: Safety and pharmacokinetic profile of the pasteurized purified antitetanus serum (pasteurized pats) associated with adsorbed Td vaccine |
| Active substance: Fragments F(ab')2 of Antitetanus Immunoglobulins (Pasteurized) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41392 |
| Study title: A randomized clinical trial of two topical preparations (framycitin/gramicidin and oxytetracycline/hydrocortisone with polymyxin B) in the treatment of external otitis. Wadsten CJ, Bertilsson CA, Sieradzki H, Edström S. Arch Otorhinolaryngol. 1985;242(2):135-9. |
| Active substance: FRAMYCETIN |
| Study summary document link (including results): A randomized clinical trial of two topical preparations.pdf |
| View full study record |
| Document reference: 28623 |
| Study title: Comparative clinical trial of anti-diarrhoeal drugs. - Gupta S. - 1977 (14:639-644) - Micromedex ref. in CES - Ohlrogge R. - 24 July 2004 - |
| Active substance: FRAMYCETIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28621 |
| Study title: Treatment of acute tonsillo−pharyngitis: a comparative study of spiramycin and erythromycin. Suprihati, Noersinggih, Hoedijono R. Current medical research and opinion, {Curr−Med−Res−Opin}, 1984, vol. 9, no. 3, p. 192−6. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26523 |
| Study title: Micromedex ref. in CES - Ohlrogge R. - 24 July 2004 : Comparative clinical trial of anti-diarrhoeal drugs. - Gupta S. - 1977 (14:639-644) |
| Active substance: FRAMYCETIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28617 |
| Study title: Double-blind, randomised clinical study to evaluate the consistency of the immunogenicity and reactogenicity of three consecutive production lots of SB Biologicals¿ Hib formulation B vaccine, co-administered with SB Biologicals¿ DTPa vaccine into opposite limbs, and in comparison to the SB Biologicals¿ Hib formulation A vaccine co-administered with SB Biologicals¿ DTPa vaccine into opposite limbs, as a primary vaccination course to healthy infants at 3, 4 and 5 months of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41140 |
| Study title: Double-blind, randomised clinical study to evaluate the immunogenicity and reactogenicity of four different lots of SB Biologicals' Hib vaccine co-administered with SB Biologicals¿ DTPa vaccine into opposite limbs, as a primary vaccination course to healthy infants at the age of 3, 4½ and 6 months. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41138 |
| Study title: Double-blind, randomised, comparative, multicentre, clinical study to assess the immunogenicity and reactogenicity of three lots of SmithKline Beecham Biologicals' Haemophilus influenzae type b (Hib) tetanus conjugate vaccine when administered simultaneously with SmithKline Beecham Biologicals' tricomponent DTPa vaccine, reconstituted in one single injection, as a primary vaccination course in healthy infants at the age of 3 and 5 months (referred to in this report as Hib-10). |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41131 |
| Study title: Open clinical study to assess the immunogenicity and reactogenicity of a booster dose of formulation B of SB Biologicals¿ Hib conjugate vaccine mixed with SB Biologicals¿ DTPa vaccine as a single injection at 12 or 15-18 months of age in healthy children primed with SB Biologicals¿ Hib conjugate vaccines co-administrated with DTPa-HBV vaccine in study DTPa-HBV-038 |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41144 |
| Study title: Open clinical study to assess the immunogenicity and reactogenicity of a dose of SB Biologicals¿ plain PRP vaccine at 12 months of age followed by SB Biologicals¿ DTPa-HBV vaccine at 15 to 18 months of age in children primed with a new formulation of SB Biologicals¿ Hib conjugate vaccine mixed with DTPa-HBV combined vaccine as a single injection (group 5 of study DTPa-HBV-023). |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41143 |
| Study title: Open clinical study to assess the safety of SmithKline Beecham Biologicals' Haemophilus influenzae type b conjugate vaccine mixed with SmithKline Beecham Biologicals' diphtheria, tetanus, tricomponent acellular pertussis vaccine and administered in one single injection, given as a primary vaccination course to healthy infants at 3, 4 and 5 months of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41132 |
| Study title: Open clinical study to evaluate persistence of antibodies induced by a primary vaccination course using SmithKline Beecham Biologicals¿ Hib vaccine mixed with SmithKline Beecham Biologicals' DTPa vaccine, and to assess immunogenicity and reactogenicity of a booster dose of the same vaccines at 15-20 months of age (referred to in this report as Hib-21). |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41134 |
| Study title: Open clinical study to evaluate the immunogenicity and reactogenicity of SB Biologicals' Hib vaccine, co-administered with routine DTPw vaccine into opposite limbs, as a primary vaccination course to healthy infants at the age of 2, 4 and 6 months. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41142 |
| Study title: Open clinical study to evaluate the priming, in terms of antibody persistence and immunological memory, induced by the administration of SB Biologicals¿ Hib conjugate vaccine administered with DTPa-HBV vaccine in study DTPa-HBV-039 and to evaluate the immunogenicity and reactogenicity of a booster dose of SB Biologicals¿ Hib conjugate vaccine when administered mixed with DTPa-HBV combined vaccine. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41145 |
| Study title: Open clinical study to evaluate the priming, in terms of antibody persistence and immunological memory, induced by the administration of SB Biologicals¿ Hib conjugate vaccine administered with DTPa-HBV vaccine in study DTPa-HBV-043 and to evaluate the immunogenicity and reactogenicity of a booster dose of SB Biologicals¿ Hib conjugate vaccine when administered either mixed or separately with DTPa-HBV combined vaccine. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41148 |
| Study title: Clinical experience with gentamicin in neonates. - Sila R. - 1973 (Acta Pat. Microbiol. Scand. 81? sUPPL; 241: 130-136) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28894 |
| Study title: Clinical Expert Statement - Renewal Application for Gentamicin sulfate (all strengths in EU) - T. Darragon - 13 Sept. 2004 Clinical Expert Statement - Renewal Application for Gentamicin sulfate (all strengths in EU) - T. Darragon - 13 Sept. 2004 |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28895 |
| Study title: Clinical Pharmacology evaluation of gentamicin in newborn infants. - McCracken - 1972 (J. of Infectious Dis. 124 : 884) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28896 |
| Study title: Comparative in-vitro studies of Knamycin and gentamicin : E-coli isolated from newborn infants -Backer CJ. - 1970 (Clin Res. Vol. 20 :1) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28897 |
| Study title: Consideration of Gentamicin for therapy of neonatal sepsis. - Klein JO. - 1969 (J. Infectious Dis. 119,4-5:361) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28898 |
| Study title: Diffusion dans le liquide céphalorachidien de gentamycine injectée par voie IM. Etude chez 5 enfants attents de méningite purulente. - Mariel C - 1971 (Therapie, 26:511-6) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28899 |
| Study title: Emploi de la Gentamicine dans les infections graves du nouveau-né - Raynaud EJ. & Al. - 1971 (Gazette Médicale de France) - Publication in Gentamicin Registration Dossier - No author - 1977 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28901 |
| Study title: Essai therapeutique en pédiatrie d'un nouvel antibiotique : la gentamicine. - Thieffry S. - 1968 (Medecine Infantile, 6 : 444-52) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28902 |
| Study title: Belkum-A, Snijders-S, van-leeuwen-W, Verbrugh-H, NouwenJ, Op--t-Veld- Koning-S, Van-M, van-Suijlekom-Smit-LW, van-der-Wouden-JC, Verduin-C. Severity of nonbullous Staphylococcus aureus impetigo in children is associated with strains harboring genetic markers for exfoliative toxin B, Panton-Valentine leukocidin, and the multidrug resistance plasmid pSK41. Journal of Clinical Microbiology, {J-Clin-Microbiol}, 1 Jul 2003, vol. 41, p. 3017-3021, ISSN: 0095-1137. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28667 |
| Study title: Bourget-P, Duhamel-J-F, Soerensen-H, Roiron-R. Clinical Pharmacy Department, Antoine Beclere Hospital, Clamart, France. Pharmacokinetics of fusidic acid after a single dose of a new paediatric suspension. Journal of clinical pharmacy and therapeutics, {J-Clin-Pharm-Ther}, Jun 1993, vol. 18, no. 3, p. 171-7, ISSN: 0269-4727. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28659 |
| Study title: Cannarozzo-C, Zagni-G-F. Osp.Gen.Reg. "Vittorio Emanuele II", Div.Dermatologica, Catania, Italia. Studio clinico sul fusidato di sodio in polvere per uso topico. Clin.Europea, anno xx, n.3, maggio-giugno 1981. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28661 |
| Study title: Chu-AC. Imperial College of Science, London, England. Incidence of resistance to fusidic acid in atopic eczema patients treated with topical fusidic acid, with or without topical steroid. 59th Annual Meeting American Academy of Dermatology, {59th-AAD}, 2 Mar 2001, p. abstr. 091. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28658 |
| Study title: Clinical study report Fucidin Creme Vol II (Efficacy and compatibility of Fucidin Crème)West German trial. 337 patients. 90 patients were under the age of 10, 63 patients aged 11-20. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28709 |
| Study title: Clinical trial of fusidic acid for lepromatous leprosy Franzblau S.G. et al ACC 1994; 38(7):1651-1654 LEO provided tablets |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28710 |
| Study title: Comparative effect of fusidic acid (Fucithalmic®) and ofloxacin (tarivid®) eye drops in acute conjunctivitis. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28649 |
| Study title: Comparative effect of fusidic acid gel 1% (Fucithalmic®) and norfloxacin 0.3% (Noroxin®) in acute bacterial conjunctivitis |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28681 |
| Study title: Comparative effects of fusidic acid (1%) viscous eye drops (Fucithalmic® Unit Dose) and Chloramphenicol (0.5% ) eye drops (Minims® Chloramphenicol) in acute neonatal bacterial conjunctivitis |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28679 |
| Study title: Comparison of Fusidic acid and Oxacillin in bacterial skin infections |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28711 |
| Study title: Comparison of Safety and Efficacy of Gadobenate Dimeglumine and Gadopentetate Dimeglumine in Magnetic Resonance Imaging of Central Nervous System Disorders in Pediatric Patients. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28721 |
| Study title: Data collection and treatment of children with Daivonex® ointment |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28706 |
| Study title: Efficacy and acceptability of Fusidic acid cream and mupirocin ointment in acute skin sepsis |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28700 |
| Study title: Efficacy and acceptability of fusidic acid cream and mupirocin ointment in facial impetigo |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28701 |
| Study title: Efficacy and acceptability of fusidic acid cream and mupirocin ointment in facial impetigo. Sutton J.B. Curr Ther Res 1992; 51(5): 673-678 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28670 |
| Study title: Efficacy and safety of calcipotriol ointment in treating children (2-14 years) with psoriasis vulgaris |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28705 |
| Study title: Gentamicin in childhood infections - Marsden HB. & Al - 1970 - Publication in Gentamicin Registration Dossier - No author - 1977 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28907 |
| Study title: Gentamicin in Pediatric Infections caused by Gram-Negative Organisms. - Del Valle - 1969 (J. of Infectious Dis. 119, 4-5 : 453) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28913 |
| Study title: Gentamicin in Pediatrics. II. Treatment of severe urinary-tract infections caused by Gram-negative Bacilli and of Staphylococcal infections - Holt RJ. Al. - 1971 (J. of Infectious Dis. 124 Suppl.: S257) - Publication in Gentamicin Registration Dossier - N |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28916 |
| Study title: Randomised, double-blind clinical study to evaluate and compare the immunogenicity and reactogenicity of a booster dose of two formulations of SB Biologicals' Hib conjugate vaccine, when administered mixed in one syringe with SB Biologicals' DTPa vaccine to healthy children in their 2nd year of life. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41139 |
| Study title: Clinical efficacy of dirithromycin in pharyngitis and tonsillitis. Müller O, Wettich K. The Journal of antimicrobial chemotherapy, { Mar 1993, vol. 31 Suppl C, p. 97−102. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26472 |
| Study title: Noncontrolled clinical trial of framycetin sulphate (sofrakay) bacterial diarrhoea and cholera in children. - Praharaj SC. - 1977 (Indian J. Pediatr. 44: 39-44) - Micromedex ref. in CES - Ohlrogge R. - 24 July 2004 - |
| Active substance: FRAMYCETIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28618 |
| Study title: Oral non-absorbed antibiotics prevent infection in acute non-lymphoblastic leukemia. - Storring RA -1977 (Lancet, 837-840) - Micromedex ref. in CES - Ohlrogge R. - 24 July 2004 - |
| Active substance: FRAMYCETIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28619 |
| Study title: Which dressing ? - Gough DCS - 1990 (Br. J. Urol. 65: 418-419) - Micromedex ref. in CES - Ohlrogge R. - 24 July 2004 - |
| Active substance: FRAMYCETIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28620 |
| Study title: Experience with Fucidin® Gel preparations in general practice |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28690 |
| Study title: Final report for a trial of Fucidin® cream using both photographic and clinical assessments (Fucidin® cream in the treatment of superficial skin sepsis) |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28673 |
| Study title: Fucidin eye drops in acute, bacterial eye infections; Thanpaichitra, Bangkok Thailland |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28654 |
| Study title: Fucidin H Gel in acne |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28691 |
| Study title: Fucidin in various eye infections Open evaluation with fucidin eye drops and fucithalmic viscous eye drops |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28651 |
| Study title: Fucidin Ointment and Fucidin tablets in various indications |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28696 |
| Study title: Fucidin treatment of soft tissue infections in children: comparison of two dosages |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28688 |
| Study title: Fucidin versus erythromycin in skin and soft tissue infection |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28714 |
| Study title: Fucidin versus flucloxacillin in skin and soft tissue infection |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28715 |
| Study title: Fucidin® cream in the treatment of impetigo |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28682 |
| Study title: Fucidin® cream versus its vehicle and Bactroban® in the treatment of impetigo |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28675 |
| Study title: Fucidin® cream versus its vehicle in the treatment of impetigo |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28668 |
| Study title: Fucidin® cream versus its vehicle in the treatment of impetigo |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28674 |
| Study title: Fucidin® cream versus its vehicle in the treatment of impetigo |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28702 |
| Study title: Fucidin® levels in osteomyelitis. E H Chater et al. J Ir. Med. Assoc. 1972; 65: 506 -508 Note this study is included for suspension, tablets and iv reports Study includes pts from 2-72. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28712 |
| Study title: Fucidin® levels in osteomyelitis.E H Chater et al. J Ir. Med. Assoc. 1972; 65: 506 -508 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28684 |
| Study title: Fucidin® ointment versus its vehicle and Bactroban® in the treatment of impetigo |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28703 |
| Study title: Effect on gingivitis of daily rinsing with 1.5 percent h2O2Boyd 1989 |
| Active substance: HYDROGEN PEROXIDE |
| Study summary document link (including results): Boyd_1989_effect on gingivitis of daily rinsing with 1.5 percent h2o2.pdf |
| View full study record |
| Document reference: 48175 |
| Study title: Topical oral antiseptics, mouthwashes and throat remediesDarlington 1973 |
| Active substance: HYDROGEN PEROXIDE |
| Study summary document link (including results): Darlington_1973_Topical oral antiseptics, mouthwashes and throat remedies.pdf |
| View full study record |
| Document reference: 48176 |
| Study title: PROPHYLAXIS OF FUNGAL INFECTION WITH DIFLUCAN IN PATIENTS WITH COLLAGEN DISEASE ON THE LONG TERM, AND LARGE-DOSAGE STEROID THERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27865 |
| Study title: Prophylaxis, costs and effectiveness of gram positive therapy in neatropenic children |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27454 |
| Study title: Prophylaxis, costs and effectiveness of gram positive therapy in neatropenic children |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27818 |
| Study title: PROSPECTIVE COMPARATIVE TRIAL OF AMPHOTERICIN B VS. FCA IN NEONATAL SYSTEMIC FUNGAL INFECTIONS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27643 |
| Study title: PROSPECTIVE COMPARATIVE TRIAL OF AMPHOTERICIN B VS. FCA IN NEONATAL SYSTEMIC FUNGAL INFECTIONS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28005 |
| Study title: PROSPECTIVE OPEN PILOT COMPARATIVE STUDY OF SAFETY & EFFICACY OF FCA PARENTERAL/ORAL VS STANDARD PROPHYLACTIC REGIMEN IN PREVENTION OF FUNGAL INFECTIONS IN PTS WITH PANCYTOPENIA CAUSED BY CHEMOTHERAPY OR IN PTS SUFFERING FROM APLASTIC ANEMIA |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27396 |
| Study title: PROSPECTIVE OPEN PILOT COMPARATIVE STUDY OF SAFETY & EFFICACY OF FCA PARENTERAL/ORAL VS STANDARD PROPHYLACTIC REGIMEN IN PREVENTION OF FUNGAL INFECTIONS IN PTS WITH PANCYTOPENIA CAUSED BY CHEMOTHERAPY OR IN PTS SUFFERING FROM APLASTIC ANEMIA |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27761 |
| Study title: RANDOMIZED CONTROLLED STUDY COMPARING ORAL FLUCONAZOLE TO TOPICAL CLOTRIMAZOLE IN THE TREATMENT OF VAGINAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27648 |
| Study title: RANDOMIZED CONTROLLED STUDY COMPARING ORAL FLUCONAZOLE TO TOPICAL CLOTRIMAZOLE IN THE TREATMENT OF VAGINAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28010 |
| Study title: RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY OF THE EFFICACY OF FLUCONAZOLE PARENTERAL/ORAL IN THE PREVENTION OF FUNGAL INFECTIONS IN PATIENTS WITH PANCYTOPENIA CAUSED BY CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML). |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27397 |
| Study title: RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY OF THE EFFICACY OF FLUCONAZOLE PARENTERAL/ORAL IN THE PREVENTION OF FUNGAL INFECTIONS IN PATIENTS WITH PANCYTOPENIA CAUSED BY CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML). |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27762 |
| Study title: RETROSPECTIVE CONTROLLED ANALYSIS OF FLUCONAZOLE PROPHYLAXIS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27619 |
| Study title: RETROSPECTIVE CONTROLLED ANALYSIS OF FLUCONAZOLE PROPHYLAXIS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27981 |
| Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN CRYPTOCOCCAL MENINGITIS IN PATIENTS WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27677 |
| Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN CRYPTOCOCCAL MENINGITIS IN PATIENTS WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28039 |
| Study title: Adame G Oral itraconazole in the treatment of tinea manus and tinea pedis. Clinical summary on R51211, August 1987. (14-54 years, LMD56451)Adame G Oral itraconazole in the treatment of tinea manus and tinea pedis. Clinical summary on R51211, August 1987. (14-54 years, LMD56451) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30793 |
| Study title: Alcantara R. Treatment of dermatomycosis with 100 mg itraconazole o.d. during fifteen or thirty days. Janssen Research Foundation Products Information service. Clinical research report, February 1988. (5-90 years, LMD59929)Alcantara R. Treatment of dermatomycosis with 100 mg itraconazole o.d. during fifteen or thirty days. Janssen Research Foundation Products Information service. Clinical research report, February 1988. (5-90 years, LMD59929) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30779 |
| Study title: An open evaluation of itraconazole oral solution in paediatric patients undergoing treatment for haematological malignancy or solid tumour. Safety findings. |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): LMD129189_Interventional_Itraconazole.xls |
| View full study record |
| Document reference: 45124 |
| Study title: An open study on the pharmacokinetics and safety of itraconazole oral solution in 24 cystic fibrosis subjects |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): LMD172168_Interventional_Itraconazole.xls |
| View full study record |
| Document reference: 47581 |
| Study title: Boogaerts MA, Verhoef GE, Zachee P, Demuynck H, Verbist L, De Beulke K. Antifungal prophylaxis with itraconazole in prolonged neutropenia: Correlation with plasma levels. Proceedings of the 2nd internationa symposium on itraconazole, Antwerp, Belgium, June 22-23, 1989. Mycoses 32 (suppl.1), p.103-108, 1989. (9-78 years, LMD69411)Boogaerts MA, Verhoef GE, Zachee P, Demuynck H, Verbist L, De Beulke K. Antifungal prophylaxis with itraconazole in prolonged neutropenia: Correlation with plasma levels. Proceedings of the 2nd internationa symposium on itraconazole, Antwerp, Belgium, June 22-23, 1989. Mycoses 32 (suppl.1), p.103-108, 1989. (9-78 years, LMD69411) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30811 |
| Study title: Coninx S, et al Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea Corporis and tinea cruris. Clinical research report on R051211 no-71, May 1987. (2-78 years, LMD56442)Coninx S, et al Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea Corporis and tinea cruris. Clinical research report on R051211 no-71, May 1987. (2-78 years, LMD56442) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30784 |
| Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN LIFE THREATENING DEEP MYCOSES |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27674 |
| Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN LIFE THREATENING DEEP MYCOSES |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28036 |
| Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS WITH NON-LIFE THREATENING MYCOSIS WHO CANNOT BE TREATED ADEQUATELY TREATED WITH AVAILABLE AGENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27676 |
| Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS WITH NON-LIFE THREATENING MYCOSIS WHO CANNOT BE TREATED ADEQUATELY TREATED WITH AVAILABLE AGENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28038 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN CANCER PATIENTS WITH OROPHARYNGEAL AND OESOPHAGEAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27651 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN CANCER PATIENTS WITH OROPHARYNGEAL AND OESOPHAGEAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28013 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH LIFE THREATENING DEEP MYCOSES. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27675 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH LIFE THREATENING DEEP MYCOSES. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28037 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH LIFE-THREATENING DEEP MYCOSES, WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27449 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH LIFE-THREATENING DEEP MYCOSES, WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27813 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27426 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27791 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE PO VS. AMPHOTERICIN B SUSPENSION IN PREVENTION OF CANDIDIASIS IN LEUKEMIC PATIENTS UNDERGOING CHEMOTHERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27961 |
| Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH GASTRO-INTESTINAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27419 |
| Study title: Prevention of nosocomial infection in a pediatric intensive care unit (PICU) through the use of selective digestive decontamination. Ruza F, Alvarado F, Herruzo R, Delgado MA, García S, Dorao P, Goded F. Eur J Epidemiol. 1998 Oct;14(7):719-27.Prevention of nosocomial infection in a pediatric intensive care unit (PICU) through the use of selective digestive decontamination. Ruza F, Alvarado F, Herruzo R, Delgado MA, García S, Dorao P, Goded F. Eur J Epidemiol. 1998 Oct;14(7):719-27. |
| Active substance: HEXETIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29121 |
| Study title: Thomas JG et al. Managing the complexity of a dynamic biofilm. J Am Dent Assoc 2006; 137: 10s-15sThomas JG et al. Managing the complexity of a dynamic biofilm. J Am Dent Assoc 2006; 137: 10s-15s |
| Active substance: HEXETIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29122 |
| Study title: AN OPEN STUDY OF CEFOPERAZONE PLUS SULBACTAM IN THE TREATMENT OF SEVERE SKIN AND SKIN STRUCTURE INFECTIONS OF BACTERIAL ETIOLOGY |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42638 |
| Study title: CLINICAL USEFULNESS OF SULTAMICILLIN FINE GRANULES FOR TONSILLITIS AND ACUTE BRONCHITIS OF CHILDREN |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43006 |
| Study title: Open Study to determine the concentration of telithromycin in middle ear fluid and plasma in infants/children with acute otitis media or otitis media with effusion after single oral administration of 20mg/kg or 30mg/kg of a telithromycin pediatric suspension |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41566 |
| Study title: A report on the method of treatment of chronic osteomyelitis at the Clinic of Infectious Diseases in Lund, which is both general and local in antibiotics administration. Comparisons are made with reports on the same general, but without the local treatment.Moilanen et al. |
| Active substance: testa triticum |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Testa triticum tricum_1.xlsx |
| View full study record |
| Document reference: 49079 |
| Study title: A report on the method of treatment of chronic osteomyelitis at the Clinic of Infectious Diseases in Lund, which is both general and local in antibiotics administration. Comparisons are made with reports on the same general, but without the local treatment.Moilanen et al. |
| Active substance: testa triticum |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Testa triticum tricum_1.xlsx |
| View full study record |
| Document reference: 49080 |
| Study title: A single-blind trial to investigate the ethiology of bacterial respiratory tract infections and the efficacy of penicillin V (Kåvepenin) and erythromycin (Ery-Max) in these infections.Hovelius et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_10.xlsx |
| View full study record |
| Document reference: 49041 |
| Study title: An open, randomized trila to evaluate if dose and frequency given bt American Heart Association coul be reduced (250 000 units x3 for 10 days)for streptococcal pharyngitis.Breese et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_3.xlsx |
| View full study record |
| Document reference: 49034 |
| Study title: Compare the effect of treatment with penicillin V in children with AOM for 5 and 10 days respectively and to investigate whether a higher dose of penicillin V is associated with a beneficial result.Ingvarsson et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_11.xlsx |
| View full study record |
| Document reference: 49042 |
| Study title: COMPARISON OF AMPICILLIN PLUS SULBACTAM VS CEFOXITIN/DOXYCYCLINE OR CLINDAMYCIN/GENTAMICIN IN THE TREATMENT OF GYNECOLOGICAL OR OBSTETRICAL INFECTIONS OF BACTERIAL ETIOLOGY |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42626 |
| Study title: Determine concentration of pcV in serum and in middle ear exudate and to isolate bacteria in the ear exsudate during the course of treatment with penicillin V in acute otitis media in children.Ingvarsson et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_15.xlsx |
| View full study record |
| Document reference: 49046 |
| Study title: determine concentration of pcV in serum and in middle ear exudate at various intervals of administration of different doses and to correlate the susceptibility in vitro of H Infl to pcVKamme et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_5.xlsx |
| View full study record |
| Document reference: 49036 |
| Study title: Double-blinded, Randomized parallel groups design trial, the primary objective of the study was to evaluate the taste of two formulations of phenoxymethylpenicillin suspension in children. The secondary objectives were to study age-related differences in taste perception, to evaluate the acceptability of the suspensions, and to determine patient compliance.Bagger-Sjöbäck et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_12.xlsx |
| View full study record |
| Document reference: 49043 |
| Study title: Evaluate in children the taste of two different phenoxymethylpenicillins, one containing aspartame.Norstedt |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_13.xlsx |
| View full study record |
| Document reference: 49044 |
| Study title: Investigate how absorption is influenced by volume, composition and food intake.Forsman et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_1.xlsx |
| View full study record |
| Document reference: 49031 |
| Study title: Investigate how absorption is influenced by volume, composition and food intake.Forsman et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_1.xlsx |
| View full study record |
| Document reference: 49032 |
| Study title: investigate serum concentrations achieved with potassium salt of penicillin V i n2 different galenic forms.Perlhagen et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_2.xlsx |
| View full study record |
| Document reference: 49033 |
| Study title: Investigate the minimum age limit in children accepting penicillin administered as tablets instead of mixture.Edvardsson et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_14.xlsx |
| View full study record |
| Document reference: 49045 |
| Study title: Investigate the possibility to administer penicillin V in a twice daily dosage regimen.Edlund et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_6.xlsx |
| View full study record |
| Document reference: 49037 |
| Study title: Use of the antiseptic Octenisept in children at the Fachklinik Hornheide.1996. |
| Active substance: OCTENIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32736 |
| Study title: Estimate plasma peak concentrations of ampicillin obtained after rectal administration of single doses of ampicillin suppositories given to children.Movin et al. (1987-06-15) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_25.xlsx |
| View full study record |
| Document reference: 49024 |
| Study title: Evaluate the safety of ampicillin suppositories with special emphasis on local intolerance reactions in pediatric patients. The secondary objective was to evaluate the short term efficiacy in the treatment of acute otitis media. The study was comparative against amoxycillin suspension.Bagger-Sjöbäck et al. (1986-11-28) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_19.xlsx |
| View full study record |
| Document reference: 49018 |
| Study title: Investigate the rapidity of change in excretion rate of Ampicillin and Methicillin in the days after birth and demonstrate the effect of premature birth upon the excretion rates.Boe et al. (Pediatrics, vol. 39, no. 2, Feb 1967) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_8.xlsx |
| View full study record |
| Document reference: 49001 |
| Study title: Double blind, controlled trial testing the immunogenicity and side effects of parenteral Vi polysaccharide typhoid vaccine in Indonesian children and adults |
| Active substance: Purified Vi capsular polysaccharide of Salmonella typhi (Ty2 strain) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21216 |
| Study title: Effectiveness of a Vi capsular polysaccharide vaccine |
| Active substance: Purified Vi capsular polysaccharide of Salmonella typhi (Ty2 strain) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41448 |
| Study title: Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi |
| Active substance: Purified Vi capsular polysaccharide of Salmonella typhi (Ty2 strain) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41447 |
| Study title: Safety and immunogenicity of Vi CPS vaccine in teenagers |
| Active substance: Purified Vi capsular polysaccharide of Salmonella typhi (Ty2 strain) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21215 |
| Study title: Open single centertrial to evaluate efficacy and safety of amoxicillin for treatment of UTIParsons et al |
| Active substance: AMOXICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Amoxillin_11.xlsx |
| View full study record |
| Document reference: 48995 |
| Study title: To determine the blood and tonsil levels of ampicillin after rectal and oral administration.Baba et al. (1983-05-04) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_9.xlsx |
| View full study record |
| Document reference: 49009 |
| Study title: To investigate the absorption and excretion of ampicillin from supporitories given to children.Iwai et al. (1983-05-04) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_12.xlsx |
| View full study record |
| Document reference: 49010 |
| Study title: To investigate the absorption and excretion of ampicillin from supporitories given to children.Nakazawa et al. (1983-05-16) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_16.xlsx |
| View full study record |
| Document reference: 49015 |
| Study title: To investigate the absorption of ampicillin from suppositories in children.Motohiro et al. (1983-05-09) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_15.xlsx |
| View full study record |
| Document reference: 49012 |
| Study title: Investigate the relationship between relapses in H. influenzae meningitis and the ability of ampicillin to penetrate to the CSF.Coleman et al. (The journal of pediatrics May 1969) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_7.xlsx |
| View full study record |
| Document reference: 49008 |
| Study title: Single-blind trial to evaluate the efficacy and safety of ampicillin suppositories in bacterial pneumonia in children using i.v. ampicillin as reference drug.Motohiro et al. (1983-05-09) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_21.xlsx |
| View full study record |
| Document reference: 49020 |
| Study title: Study plasma concentrations after rectal administration of ampicillin suppositories to children.Movin et al. (1987-06-15) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_23.xlsx |
| View full study record |
| Document reference: 49022 |
| Study title: A double blind trial to evaluate the incidence of diarrhea and C. difficile toxin (CDT) folloing therapy with ampicillin (AMP), amoxicillin (AMOX), or trimethoprim-sulfamethoxazole (TMP-SMX) for otitis media.Hyams et al. (Pediatr Infect Dis. 1984 Sep-Oct;3(5):433-6) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_30.xlsx |
| View full study record |
| Document reference: 49029 |
| Study title: To investigate the absorption of ampicillin from suppositories.Kida et al. (1983-05-04) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_13.xlsx |
| View full study record |
| Document reference: 49013 |
| Study title: To study changes in fecal bacterial flora, including its sensitivity to ampicillin, after rectal and oral administration of ampicillin. Fecal ampicillin concetrations were also studied.Motohiro et al. (1986-10-17) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_14.xlsx |
| View full study record |
| Document reference: 49014 |
| Study title: A Double-blind, Placebo-controlled trial: comparison of the clinical and bacteriological effectiveness of ampicillin and a placebo.Nelson et al. (Ann NY Acad Sci 145 1967) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_6.xlsx |
| View full study record |
| Document reference: 49006 |
| Study title: A prospective study of rash incidence in 532 patients treated with Amipicillin intravenously is reported.Scioli et al. (Boll 1st Sieroter Milan 1983;62;287-91) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_1.xlsx |
| View full study record |
| Document reference: 49000 |
| Study title: A Single-blind, randomized trial to Evaluate the efficacy and safety of ampicillin suppositories in the treatment of acute suppurative otitis media by a well controlled method using ampicillin dry syrup as control.Baba et al. (1985-09-27) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_20.xlsx |
| View full study record |
| Document reference: 49019 |
| Study title: To study the absorption and excretion of the 250 mg ampicillin supporitory in children.Nishimura et al. (1983-05-04) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_18.xlsx |
| View full study record |
| Document reference: 49017 |
| Study title: To study the pharmacokinetics of ampicillin suppositories in children.Toyonaga et al. (1983-05-06) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_17.xlsx |
| View full study record |
| Document reference: 49016 |
| Study title: A Single-blinded, Randomized trial to evaluate the efficacy and safety of 125 mg ampicillin suppositories in the treatment of acute respiratory tract infections in pediatric patients using ampicillin dry syrup as control.Nishimura et al. (1983-05-04) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_22.xlsx |
| View full study record |
| Document reference: 49021 |
| Study title: Clarify the effects of age, dosage, and route of administration on ampicillin-associated diarrhea in pediatric patients.Phillips et al. (PEDIATRICS Vol. 58 No. 6 Dec. 1976) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_5.xlsx |
| View full study record |
| Document reference: 49004 |
| Study title: Compare ampicillin and choramphenicol, both being given by the parenteral route in the therapyt of typhoid fever.Kaye et al. (Annals Ney York Academy of Sciences 145, 1967) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_3.xlsx |
| View full study record |
| Document reference: 49002 |
| Study title: Study the antibacterial and clinical efficacy of ampicillin as well as of its side-effects in comparison with penicillin V, our hitherto best peroral penicillin for scarlet fever therapy.Ström (Acta Paediatr Scand. 1968 Jul;57(4):285-8) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_31.xlsx |
| View full study record |
| Document reference: 49030 |
| Study title: The primary objective was to evaluate the safety of ampicillin suppositories with special emphasis on local intolerance reactions in pediatric patients. The secondary objective was to evaluate short term efficacy in the treatment of acute otitis media. The study was comparative against amoxIcillin suspension.Bagger-Sjöbäck et al. (1987-07-22) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_24.xlsx |
| View full study record |
| Document reference: 49023 |
| Study title: Aoyama R, Nagata K, Clinical results with ampicillin-cloxacillin for intravenous drip (author's transl.) The Japanese Journal of antibiotics, (Jpn-J_Antiot.), Nov.1978, vol. 31, no. 11, p. 681-4Aoyama R, Nagata K, Clinical results with ampicillin-cloxacillin for intravenous drip (author's transl.) The Japanese Journal of antibiotics, (Jpn-J_Antiot.), Nov.1978, vol. 31, no. 11, p. 681-4 |
| Active substance: AMPICILLIN AND CLOXACILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46646 |
| Study title: To study the absorption of ampicillin suppositories in children.Jozaki et al. (1983-03-10) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_11.xlsx |
| View full study record |
| Document reference: 49011 |
| Study title: The primary objective was to evaluate the safety of ampicillin suppositories with special emphasis on local intolerance reactions in pediatric patients. The secondary objective was to evaluate efficacy of a twice daily dosage regimen in the treatment of acute otitis media. The study was comparative against amoxIcillin suspension.Albertini et al. (1987-09-11) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_26.xlsx |
| View full study record |
| Document reference: 49025 |
| Study title: The primary objective was to evaluate the safety of ampicillin suppositories with special emphasis on local intolerance reactions. The study was comparative against amoxIcillin suspension.Albertini et al. (1987-09-11) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_27.xlsx |
| View full study record |
| Document reference: 49026 |
| Study title: Compare the achieved ampicillin concentrations in CSF following intravenous and intramuscular routes of administration, and to correlate the clinical and laboratory responses in patients treated by the two routes.Wilson et al. (AM J Dis Child/Vol 129, Feb 1975) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_4.xlsx |
| View full study record |
| Document reference: 49003 |
| Study title: Compare the tolerability of Ampicillin, Amoxicillin and Trimethoprim-Sulfamethoxazole in children with otitis media.Feder (Antimicrobial agents and chemotherapy, Mar. 1982. p. 426-427) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_29.xlsx |
| View full study record |
| Document reference: 49028 |
| Study title: Describing three children, two with meningitis and one with septicemia, from whom ampicillin-resistant Haemophilus influenzae type B were isolated from the CSF, blood or both. At least one case represents ampicillin failure in the treatment of H. influenzae meningitis because of resistence of the organism to the drug.Ousama et al. (JAMA, July 15 1974, Vol 229, No 3) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_7.xlsx |
| View full study record |
| Document reference: 49007 |
| Study title: Determine the plasma concentrations after rectal administration of ampicillin suppositories in children, and when possible to estimate the urine concentrations of ampicillin and the bioavailability of the suppository.Eriksson et al. (1991-08-12) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_28.xlsx |
| View full study record |
| Document reference: 49027 |
| Study title: |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41161 |
| Study title: A phase II, double-blind, randomized study to compare the immunogenicity, safety and reactogenicity of GlaxoSmithKline (GSK) Biologicals¿ Tritanrix¿-HepBlow thio/Hib2.5 Gödöllö to GSK Biologicals¿ Tritanrix¿-HepB/Hiberix¿Gödöllö when administered as a three-dose primary vaccination course to healthy infants at 6, 10 and 14 weeks of age. A dose of unconjugated Hib vaccine (plain PRP booster) will be administered at the age of 10 months to 50% of the subjects. Note: This report presents the results pertaining to the plain PRP challenge at 10 months of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41159 |
| Study title: Effect and tolerance of amoxicillin with and without probenecid.Alergant. |
| Active substance: AMOXICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48969 |
| Study title: Efficacy in General PracticeJorna J Lees |
| Active substance: AMOXICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48971 |
| Study title: Evaluate efficacy in spefic infections and to compare amoxicillin 250 mg qid and 500 mg bd.Andrews et al |
| Active substance: AMOXICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48972 |
| Study title: Evaluate the efficacy of amoxicillin i ndifferent dosages i nthe treatment of gonococcal urethritis in the male. Compare the results with stnadard treatment.Watt et al. |
| Active substance: AMOXICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48970 |
| Study title: A phase III, observer-blind, single-centre, randomized study to evaluate safety and immunogenicity of three lots of DTwPHib full liquid vaccine (Chiron Vaccines; now Novartis Vaccines) and of American Home Product (AHP-Wyeth) Tetramune (DTwPHib) vaccine administered to healthy infants at 2, 3 and 4 months of age.Please see report- sturdy report |
| Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
| Study summary document link (including results): V38P2.xlsx |
| View full study record |
| Document reference: 49184 |
| Study title: A randomized, stratified, double blind trial to compare safety and efficacy of the Fluvirin® Vaccine (a purified surface antigen vaccine) with Connaught Inactivated Influenza Vaccine Fluzone® (a split virion vaccine) in healthy children aged 6 to 47 months of age.Nicolay 1999, Vaccine 17 (1999) 2223-2228 |
| Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
| Study summary document link (including results): MPL-318-01.xlsx |
| View full study record |
| Document reference: 49190 |
| Study title: Diptheria booster vaccination one or two injections_1999Nicolay 1999, Vaccine 17 (1999) 2223-2228 |
| Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
| Study summary document link (including results): Nicolay_Diptheria booster vaccination one or two injections_1999.pdf |
| View full study record |
| Document reference: 49189 |
| Study title: Pilar 1983Please see report- sturdy report |
| Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
| Study summary document link (including results): Pilar 1983.pdf |
| View full study record |
| Document reference: 49188 |
| Study title: An open label, not randomized, age stratified trial to study safety and efficacy of the vaccine in subjects from 6 to 35 months of age.Please see report - study report |
| Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
| Study summary document link (including results): MEMUFL-95-001.xlsx |
| View full study record |
| Document reference: 49191 |
| Study title: Publication_8T-201RAPlease see report- sturdy report |
| Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
| Study summary document link (including results): Publication_8T-201RA.pdf |
| View full study record |
| Document reference: 49187 |
| Study title: Response to Diphtheria and Tetanus Booster Vaccination in pediatric renal transplantTransplantation, Issue: Volume 64(2),27 July 1997,pp 237-241, Enke |
| Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49193 |
| Study title: Safety and immunogenicity of anew fully liquid DTPw-HepB-Hib combination vaccine in infantsKanra_et_al_2006_Publication |
| Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
| Study summary document link (including results): Kanra_et_al_2006_Publication.pdf |
| View full study record |
| Document reference: 49192 |
| Study title: open uncontrolled study to evaluate the acceptance and tolerance of flucloxacillin suspension.Lidgren. Clinical trial on flucloxacillin suspension in children. |
| Active substance: FLUCLOXACILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Flukloxacillin_2.xlsx |
| View full study record |
| Document reference: 49075 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IV FCA IN THE TREATMENT OF CANDIDIASIS IN THE LEUKEMIC PATIENTS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27941 |
| Study title: EFFICACY AND SAFETY OF FLUCONAZOLE IN THE TREATMENT OF FUNGAL INFECTIONS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27663 |
| Study title: A report on the method of treatment of chronic osteomyelitis at the Clinic of Infectious Diseases in Lund, which is both general and local in antibiotics administration. Comparisons are made with reports on the same general, but without the local treatment.Hedström (Scand J Infec Dis 1: 175-180, 1969) |
| Active substance: CLOXACILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Cloxacillin_1.xlsx |
| View full study record |
| Document reference: 49082 |
| Study title: COMPARATIVE STUDY OF AMPICILLIN/SULBACTAM VS CEFOTAXIME PLUS AMPICILLIN IN PREVENTING INFECTIONS OF BACTERIAL ETIOLOGY IN PATIENTS UNDERGOING ELECTIVE LIVER TRANSPLANTS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42657 |
| Study title: AN OPEN, NON-COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF SULTAMICILLIN IN PATIENTS WITH RECURRENT TONSILLITIS DUE TO GABHS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43022 |
| Study title: Fucidin® ointment: survey of clinical trial. Fucidin® ointment was applied once daily to 10 children with impetigo, 2 patients with eczema and 20 adults with infected ulcers. Treatment was successful in all cases of impetigo and in patients with superficial leg ulcers whereas the treatment of 6 patients with 'deeper' ulcers was discontinued because of pain on application. Inflammation was also seen in another subject. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28678 |
| Study title: AN OPEN NONCOMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IM/IV SBT/CFP IN THE TREATMENT OF INTRAABDOMINAL INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42859 |
| Study title: Investigating the neurotoxicity of penicillin G at different serum- and CSF-concentrations.Holloway et al. (The American journal of clinical pathology, 1969 Jun;51(6):705-8) |
| Active substance: BENZATHINE BENZYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Benzylpenicillin sodium_1.xlsx |
| View full study record |
| Document reference: 49070 |
| Study title: Investigating the neurotoxicity of penicillin G at different serum- and CSF-concentrations.Lerner et al. (Ann NY Acad Sci 145, 310-8, no 2 1967) |
| Active substance: BENZATHINE BENZYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Benzylpenicillin sodium_2.xlsx |
| View full study record |
| Document reference: 49071 |
| Study title: The purpose uf this study was to determine what beneficiaI effect, if any, large doses of penicillin G procaine have on the treatment of hospitalized patients with pneumococcal pneumonia of varying severity, and to examine the effect of this treatment on the colonization and superinfection rates in these patients.Brewin et al. (JAMA 230:409-413, 1974) |
| Active substance: BENZATHINE BENZYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Benzylpenicillin sodium_3.xlsx |
| View full study record |
| Document reference: 49072 |
| Study title: Uchida Y. Clinical efficacy of topical lomefloxacin (NY-198) in bacterial infections of the external eye – A multicenter double-blind phase III study. No report dateUchida Y. Clinical efficacy of topical lomefloxacin (NY-198) in bacterial infections of the external eye – A multicenter double-blind phase III study. No report date |
| Active substance: LOMEFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31362 |
| Study title: Submission of result-related information on paediatric studies submitted under Article 45 of the Paediatric Regulation No 1901/2006. Product concerned by this submission: Cedax Suspension/Keimax and Associated Tradenames (Ceftibuten)Merck Sharp & Dohme (Europe), Inc. Clos du Lynx 5 Lynx Binnenhof B-1200 Brussels |
| Active substance: CEFTIBUTEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48847 |
| Study title: Submission of result-related information on paediatric studies submitted under Article 45 of the Paediatric Regulation No 1901/2006. Product concerned by this submission: Uroced/Cedax and Associated Tradenames (Ceftibuten)Merck Sharp & Dohme (Europe), Inc. Clos du Lynx 5 Lynx Binnenhof B-1200 Brussels |
| Active substance: CEFTIBUTEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48850 |
| Study title: An open randomised multicentre comparison of cefuroxime axetil suspension and amoxycillin syrup in the treatment of children with pharyngitis and tonsillitis. |
| Active substance: CEFUROXIME |
| Study summary document link (including results): Study CAET94 Cefuroxime Axetil (Suspension).xls |
| View full study record |
| Document reference: 47731 |
| Study title: Treatment of staphylococcal skin infections: a comparison of cephalexin and dicloxacillin. Dillon HC Jr. J Am Acad Dermatol. 1983 Feb;8(2):177-81. |
| Active substance: Cephalexin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48898 |
| Study title: Study defined factors in the pathogenesis for relapse (bacteriological and clinical) in 337 children with URT infections with cultured group A beta hemolytic streptococci.Rosenstein et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_4.xlsx |
| View full study record |
| Document reference: 49035 |
| Study title: Study the absorption of different salts of pc-V in syrup form and also to investigate whether gastrointestinal diseases, leading to malabsorption affects the absorption of pc in varying rates for different salts.Bolme et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_8.xlsx |
| View full study record |
| Document reference: 49039 |
| Study title: Study the effects of a twice a day dosage of penicillin V instead of three times a day.Nordbring et el |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_7.xlsx |
| View full study record |
| Document reference: 49038 |
| Study title: Study the effects of a twice a day dosage of potassium penicillin G, instead of three times a day.Vann et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_9.xlsx |
| View full study record |
| Document reference: 49040 |
| Study title: To evaluate the efficacy and safety of penicillin V in the treatment of acute tonsillitis in adults, when given as two or three daily doses.Mosbaek et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_16.xlsx |
| View full study record |
| Document reference: 49047 |
| Study title: To study the clinical efficacy of penicillin V given to children as a daily dosage of 50 mg/kg/day divided into two or three doses.Rundcrantz et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_17.xlsx |
| View full study record |
| Document reference: 49048 |
| Study title: Treatment of recurrent bacteriuria with mecillinam; Verrier Jones E:R: and Asscher A.W:. 1975, JAC, 1: 193-196 LEO sponsored Treatment of recurrent bacteriuria with mecillinam; Verrier Jones E:R: and Asscher A.W:. 1975, JAC, 1: 193-196 LEO sponsored |
| Active substance: PIVMECILLINAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34526 |
| Study title: Decroix J, et al Oral itraconazole in the treatment of dermatomycosis. A multicenter evaluation of different treatment schedules. Clinical summary on R51211, August 1987. (10-86 years, LMD56447)Decroix J, et al Oral itraconazole in the treatment of dermatomycosis. A multicenter evaluation of different treatment schedules. Clinical summary on R51211, August 1987. (10-86 years, LMD56447) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30789 |
| Study title: Evaluation of the efficacy and tolerance of RU51807 (cefpodoxime proxetil) in children with skin and soft tissue infections |
| Active substance: CEFPODOXIME |
| Study summary document link (including results): CEFPODOXIME STUDY FF8980740.xls |
| View full study record |
| Document reference: 47975 |
| Study title: Schmidt LM. Topical dermatologic therapy for the pediatrician. Pediatr Clin North Am. 1978 May;25(2):191-208. Schmidt LM. Topical dermatologic therapy for the pediatrician. Pediatr Clin North Am. 1978 May;25(2):191-208. |
| Active substance: TOLNAFTATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44831 |
| Study title: A double-blind, randomised trial to compare treatment results for trimethoprim treatment in a once a day-dosage regimen with conventional thrice a day pivmecillinam in female patients with cystitis.Örsten et al |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Trimetoprim_7.xlsx |
| View full study record |
| Document reference: 49065 |
| Study title: Compare the effectiveness of trimethoprim alone with both co-trimoxazole and sulphamethizole for the treatment of uncomplicated urinary tract infections in general practice.Keenan et al |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Trimetoprim_6.xlsx |
| View full study record |
| Document reference: 49064 |
| Study title: Evaluate the prophylactic efficacy of trimetoprim in urinary tract infections and its effect on the normal gastrointestinal and periurethral bacterial flora.Lidin-Janson et al |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Trimetoprim_3.xlsx |
| View full study record |
| Document reference: 49061 |
| Study title: Investigate the efficacy of trimethoprim administered once daily for three days.Ahlmén et al |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Trimetoprim_4.xlsx |
| View full study record |
| Document reference: 49062 |
| Study title: Investigate the efficacy of trimethoprim in the long-term treatment of urinary tract infections in children.Helle |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Trimetoprim_2.xlsx |
| View full study record |
| Document reference: 49060 |
| Study title: Pharmacokinetics of teicoplanin in children. - Tarral E, Jehl F, Tarral A et al. (1988) - Journal of Antimicrobial Chematherapy 21, Supplement A, 47-51. |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44306 |
| Study title: A double blinded trial to compare once a day dose regimen of trimethoprim with standard dose of two tablets twice daily of co-trimoxazole in the treatment of uncomplicated urinary tract infections in general practice.Cartwright et al |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Trimetoprim_5.xlsx |
| View full study record |
| Document reference: 49063 |
| Study title: Effect of bacterial antigen lysate on IgG and IgA levels in children with recurrent infections and hypogamma-globulinemia |
| Active substance: Bacterial lysate |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41840 |
| Study title: To show the effect of trimethoprim alone in patients with difficult urinary tract infections.Parkkulainen et al |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Trimetoprim_1.xlsx |
| View full study record |
| Document reference: 49059 |
| Study title: Safety and efficacy comparison of two dosing regimens of MetroGel-Vaginal(R) in the treatment of bacterial vaginosis: a multicenter, randomized, single-blind, parallel comparison.Soper DE1, Livengood C, Sheehan KL, Fenner DE, Martens MG, Nelson AL, Ismail M, Thorp JM, Lappin M, Fleury FJ, Long BJ, Blackwelder T, Sweet RL, Sagov S. Prim Care Update Ob Gyns. 1998 Jul 1;5(4):150. |
| Active substance: METRONIDAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48942 |
| Study title: Comparative Evaluation of Cefixime versus Amoxicillin-Clavulate Following Ceftriaxone Therapy of PneumoniaClin Pediatr 1996; 35: 629-633, Amir J., 1996 |
| Active substance: CEFIXIME |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48974 |
| Study title: Comparative Evaluation of Cefpodoxime Versus Cefixime in children with Lower Respiratory Tract InfectionsIndian J Pediatr 2004; 71: 517-521 Sengupta J. |
| Active substance: CEFIXIME |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48975 |
| Study title: A new bowel preparation for elective colon and rectal surgery. A prospective, randomized clinical trial.Wolff BG, Beart RW Jr, Dozois RR, Pemberton JH, Zinsmeister AR, Ready RL, Farnell MB, Washington JA 2nd, Heppell J. Archives of surgery (Chicago Ill. : 1960), Jul 1988, vol. 123, no. 7, p. 895−900 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26507 |
| Study title: Aspects of pharmacology of Gentamicin in Newborn Infants - Andersen JH. & Al - 1972 ( Acta Paediat. Scand. 61:343-9) - Publication in Gentamicin Registration Dossier - 1978 -Aspects of pharmacology of Gentamicin in Newborn Infants - Andersen JH. & Al - 1972 ( Acta Paediat. Scand. 61:343-9) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28890 |
| Study title: A randomized, double-blind trial to determine whether 1 g of erythromycin daily for a week is as a effective as the 2 g daily dose but without the adverse gastrointestinal effects associated with the larger dose.Linnemann et al. (Sexually transmitted diseases, Vol 14, No. 2) |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Erythomycin ethylsuccinate_4.xlsx |
| View full study record |
| Document reference: 49052 |
| Study title: A single-blind trial to investigate the ethiology of bacterial respiratory tract infections and the efficacy of penicillin V (Kåvepenin) and erythromycin (Ery-Max) in these infections.Hovelius et al. (Clinical practice and Therapy, suppl 1, 1982) |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Erythomycin ethylsuccinate_1.xlsx |
| View full study record |
| Document reference: 49049 |
| Study title: Compare the clinical efficacy and tolerance of a new erythromycin formulation, when administered twice or four times daily in acute bronchitis.Pekkanen (Rhinology, 21, 00-00, 1983) |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Erythomycin ethylsuccinate_2.xlsx |
| View full study record |
| Document reference: 49050 |
| Study title: Double-blinded, randomized trial to evaluate the efficacy of early erythromycin treatment on the duration of fecal excretion and diarrhea associated with Campylobacter jejuni.Salazar-Lindo et al. (The Journal Of Pediatrics, Aug, 1986) |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Erythomycin ethylsuccinate_6.xlsx |
| View full study record |
| Document reference: 49054 |
| Study title: Examine the variability in erythromycin pharmacokinetics after single dose intravenous administration, determine the linearity of pharmacokinetic parameters after administration of different doses, evaluate the usefulness of non-invasive sampling techniques in studying erythromycin pharmacokinetics.Klaustin et al. (Br. J. Am. Pharmac. 1980, 273-279) |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Erythomycin ethylsuccinate_7.xlsx |
| View full study record |
| Document reference: 49055 |
| Study title: Investigate how compliance among children may be related to form and dosage of the medicine.Norstedt |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Erythomycin ethylsuccinate_3.xlsx |
| View full study record |
| Document reference: 49051 |
| Study title: Investigate if Bordetella pertussis bacterias, that disappear after a couple of days of erythromycin treatment, returns after completed treatment.Quiding Boström Läkartidningen 1981 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Erythomycin ethylsuccinate_10.xlsx |
| View full study record |
| Document reference: 49058 |
| Study title: Fucithalmic, chloramphenicol or no treatment after squint surgery in children. A single blind randomised study.Kearns P.P. 1992, Acta Ophthalmol, 70:132-134 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48459 |
| Study title: A PROSPECTIVE SURVEY OF OPPORTUNISTIC INFECTIONS IN PATIENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIAS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27481 |
| Study title: CLINICAL EVALUATION OF FLUCONAZOLE (UK-49,858) IN IV DRIP ENJECTION FROM EFFICACY AND SAFETY IN PEDIATRIC SYSTEMIC MYCOSIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27933 |
| Study title: ONCE-WEEKLY ORAL FCA VS. PLACEBO IN THE PREVENTION OF MUCOCUTANEOUS FUNGAL INFECTIONS IN PATIENTS DISCHARGED FROM THE HOSPITAL AFTER BONE MARROW TRANSPLANTATION. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27611 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS IN HOSPITALIZED PATIENTS ON IVH |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27520 |
| Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH GASTRO-INTESTINAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27784 |
| Study title: An open uncontrolled study to evaluate the effect of treatment and tolerance of a flucloxacillin nsyrup.Price et al Flucloxacillin in the treatment of infectious conditions in children. |
| Active substance: FLUCLOXACILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Flukloxacillin_1.xlsx |
| View full study record |
| Document reference: 49076 |
| Study title: Investigate the bioavailability of 2 commercially available pediatric suspensions of erythromycin containing the stearate salt and the ethylsuccinate ester, respectively.Eriksson et al. (Scand J Infcect Dis 13: 211-215, 1981) |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Erythomycin ethylsuccinate_9.xlsx |
| View full study record |
| Document reference: 49057 |
| Study title: Lack of effect of erythromycin and ketoconazole on the pharmacokinetics and pharmacodynamics of steady state intranasal levocabastine. Tran J Q, Di Cicco R A, Sheth S B, Tucci M, Peng L, Jorkasky D K, Hursting M J, Benincosa L J. Journal of clinical pharmacology, {May 1999, vol. 39, no. 5, p. 513 9. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26441 |
| Study title: Study the effect of erythromycin on diarrheal illnesses in a clinical trial among children at an orphanage in Bangkok, Thailand.Taylor et al. (Antimicrobial agents and chemotherapy, March 1987, p. 438-442) |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Erythomycin ethylsuccinate_5.xlsx |
| View full study record |
| Document reference: 49053 |
| Study title: Study the epidemiology, natural history, treatment and prevention of perinatally aquired chlamydial infections.Grossman et al. (Elsevier biomedical press, 1982) |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Erythomycin ethylsuccinate_8.xlsx |
| View full study record |
| Document reference: 49056 |
| Study title: To determine the apparent bioavailability of Dicloxacillin in children of ages ranging from 6 days to 11,5 years.Smith et al. (Dev Pharmacol Ther 1990;14:35-44) |
| Active substance: dicloxacillin |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Dikloxacillin_1.xlsx |
| View full study record |
| Document reference: 49078 |
| Study title: A modified schedule for routine pertussis immunization |
| Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40996 |
| Study title: A phase II, double blind, randomized, double center, controlled study to evaluate the safety and immunogenicity of four formulations of DTwPHib combined vaccine containing different concentrations of Hib conjugate in healthy infants at 3, 4, 5 months of age.Please see report- sturdy report |
| Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
| Study summary document link (including results): V45P1.xlsx |
| View full study record |
| Document reference: 49183 |
| Study title: A phase II, open-label, randomized, single-center, comparative study evaluating safety, tolerability and immunogenicity of three vaccinations of the DTPHib combined vaccine (Chiron Vaccines; now Novartis Vaccines) in comparison to separate vaccinations of DTP (Chiron Behring; now Novartis Vaccines) and Hib/AlPO4 (Chiron Vaccines; now Novartis Vaccines) vaccines, when administered to 2, 3, 4 months old healthy infants.Please see report- sturdy report |
| Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
| Study summary document link (including results): V38P1.xlsx |
| View full study record |
| Document reference: 49186 |
| Study title: A phase II, open-label, single-centre, singal-arm, extension study to evaluate the safety and immunogenicity of a booster vaccination of the DTPHib combined vaccine (Chiron Vaccines; now Novartis Vaccines) administered to 18-20 months old healthy infants who had previously received either DTPHib combined vaccine or separate administrations of DTP (Chiron Behring; now Novartis Vaccines) and Hib/AlPO4 (Chiron Vaccines; now Novartis Vaccines) vaccines at 2, 3 and 4 months of age.Please see report- sturdy report |
| Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
| Study summary document link (including results): V38P1E1.xlsx |
| View full study record |
| Document reference: 49185 |
| Study title: EFFICACY AND SAFETY OF AN INTERMITTENT REGIMEN INCLUDING RIFABUTIN (AMSAMYCIN LM 427) IN THE TREATMENT OF OUT-PATIENTS WITH MYCOBACTERIAL PULMONARY INFECTIONS. FARMITALIA CARLO ERBA INTERNAL REPORT LM 427/713I, OCTOBER 1990 |
| Active substance: RIFABUTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35374 |
| Study title: EFFICACY AND SAFETY OF RIFABUTIN (AMSAMYCIN LM 427) IN PATIENTS WITH NEWLY DIAGNOSED PULMONARY TUBERCULOSIS. FCE REPORT LM 427/714I NOVEMBER 1990 AGE RANGE 14-79 YEARS |
| Active substance: RIFABUTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35369 |
| Study title: EFFICACY AND SAFETY OF RIFABUTIN (AMSAMYCIN LM 427) IN PATIENTS WITH NEWLY DIAGNOSED PULMONARY TUBERCULOSIS. FCE REPORT LM 427/715I NOVEMBER 1990 AGE RANGE 15 -65 YEARSPuri H C et al. Severe hypertension in children with renal |
| Active substance: RIFABUTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35370 |
| Study title: EFFICACY AND SAFETY OF RIFABUTIN (AMSAMYCIN LM 427) IN PATIENTS WITH NEWLY DIAGNOSED PULMONARY TUBERCULOSIS. FCE REPORT LM 427/706I OCTOBER 1990 D93 AGE RANGE 15- 62 YEARS |
| Active substance: RIFABUTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35372 |
| Study title: PARTIALLY RANDOMIZED DOSE COMPARSION TRAIL OF COMPASSIONATE USE RIFABUTIN (AMSAMYCIN LM 427) IN AIDS OATIENTS WITH MYCOBACTERIUM AVIUM COMPLEX INFECTION FCE REPORT LM 427/723I FEBRUARY 1991 AGE RANGE 1-62 |
| Active substance: RIFABUTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35376 |
| Study title: PARTIALLY RANDOMIZED, DOSE COMPARISON TRIAL OF COMPASSIONATE USE RIFABUTIN (AMSAMYCIN LM 427) IN NON-AIDS PATIENTS WITH MYCOBACTERIUM AVIUM COMPLEX INFECTION. FCE REPORT: LM 427/719I MARCH, 1991 AGE RANGE: 0-91 YRS |
| Active substance: RIFABUTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35377 |
| Study title: RIFABUTIN FOR THE TREATMENT OF NEWLY DIAGNOSIED PULMONARYTUBERCULOIS: A MULTINATIONAL, RANDOMIZED COMPARATIVE STUDY VERUS RIFAMPICIN LUIS JULIO GONZALES-MONTANER AGE RANGE 15-67 |
| Active substance: RIFABUTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35375 |
| Study title: SAFETY OF RIFABUTIN (AMSAMYCIN, LM 427) IN PATIENTS WITH NEWLY DIAGNOSED PULMONARY TUBERCULOSIS. FCE REPORT LM 427/708I OCTOBER 1990 AGE RANGE: 15-68 YRS |
| Active substance: RIFABUTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35371 |
| Study title: THE COMPASSIONATE USE OF RIFABUTIN FOR THE TREATMENT OF MYCOBACTERIU AVIUM COMPLEX DISEASE IN HIV POSITIVE PATIENTS. FCE REPORTS LM 427/720I JANUARY 1991 AGE RANGE 5 -61 |
| Active substance: RIFABUTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35373 |
| Study title: Clinical Expert Statement for MA Renewal in Slovenial - Djebbar F. & Verdoncq B. - 12 July 2007 |
| Active substance: RIFAMPICIN/ISONIAZID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35378 |
| Study title: Clinical Certificate for MA Renewal in Slovenia - Verdoncq B. - 10 July 2007 (0703-CC-RIF+ISO+PYR-SLOVENIA-BV-10.07.07) |
| Active substance: RIFAMPICIN/ISONIAZID/PYRAZINAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35379 |
| Study title: Referenced in Rifater Registration Dossier - Clinical Documentation - Update April 1998 : The use of fixed-dose combinations in antituberculosis chemotherapy. Rationale for their application in daily, intermittant and pediatric regimens. - Acoccella G. - 1990 (Bulletin of the Int. Union Against Tuberculosis and Lung Disease, 65, 2-3: 77-83) |
| Active substance: RIFAMPICIN/ISONIAZID/PYRAZINAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35380 |
| Study title: Compliance and tolerance of new antitubercular short-term chemopreventive regimens in childhood - a pilot project - Magdorf K, Arizzi-Rusche AF, Geiter LJ, O'Brien RJ et al - 1994 (Pneumologie, 48(10): 761 - 4)Compliance and tolerance of new antitubercular short-term chemopreventive regimens in childhood - a pilot project - Magdorf K, Arizzi-Rusche AF, Geiter LJ, O'Brien RJ et al - 1994 (Pneumologie, 48(10): 761 - 4) |
| Active substance: RIFAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35381 |
| Study title: Hepatic enzyme abnormalities in children on triple therapy for tuberbulosis - Corrigan D, Paton J. - 1999 (Pediatr Pulmonol. 27(1): 37 - 42) Hepatic enzyme abnormalities in children on triple therapy for tuberbulosis - Corrigan D, Paton J. - 1999 (Pediatr Pulmonol. 27(1): 37 - 42) |
| Active substance: RIFAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35382 |
| Study title: Intraventricular chemotherapy in neonatal meningitis - E. L. Lee et al - 1977 (J. Pediat., 91. 991 - 995) Intraventricular chemotherapy in neonatal meningitis - E. L. Lee et al - 1977 (J. Pediat., 91. 991 - 995) |
| Active substance: RIFAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35383 |
| Study title: La Rifamycine SV dans les infections pulmonaires aigüe en pédiatrie - M. De Vriendt - 1967 (Brux. Méd., 47. 169 - 181) La Rifamycine SV dans les infections pulmonaires aigüe en pédiatrie - M. De Vriendt - 1967 (Brux. Méd., 47. 169 - 181) |
| Active substance: RIFAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35384 |
| Study title: Valoracion de la Rifamicina SV en la practica pediatrica - O. Turro et al - 1965 (Sem. Med., 127. 239 - 241.) Valoracion de la Rifamicina SV en la practica pediatrica - O. Turro et al - 1965 (Sem. Med., 127. 239 - 241.) |
| Active substance: RIFAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35385 |
| Study title: Beseghi; Comparison of two non-absorbable antibiotics for treatment of bacterial enteritis in children; European Review for Medical and Pharmacological SciencesBeseghi; Comparison of two non-absorbable antibiotics for treatment of bacterial enteritis in children; European Review for Medical and Pharmacological Sciences |
| Active substance: RIFAXIMIN |
| Study summary document link (including results): rifaximin-article-Beseghi.pdf |
| View full study record |
| Document reference: 47563 |
| Study title: Curr Med Res Opin. 1997;14(1):39-45. An open, controlled study of two non-absorbable antibiotics for the oral treatment of paediatric infectious diarrhoea. Frisari L, Viggiano V, Pelagalli M. Curr Med Res Opin. 1997;14(1):39-45. An open, controlled study of two non-absorbable antibiotics for the oral treatment of paediatric infectious diarrhoea. Frisari L, Viggiano V, Pelagalli M. |
| Active substance: RIFAXIMIN |
| Study summary document link (including results): 2011-05-20-Clin Dat Results-Alfa Wassermann.xls |
| View full study record |
| Document reference: 47566 |
| Study title: De Castro; RIFAXIMIN TREATMENT FOR ACUTE RECURRENT DIARRHEA IN CHILDREN WITH GENITOURINARY DISORDERSDe Castro; RIFAXIMIN TREATMENT FOR ACUTE RECURRENT DIARRHEA IN CHILDREN WITH GENITOURINARY DISORDERS |
| Active substance: RIFAXIMIN |
| Study summary document link (including results): rifaximin-article-De Castro.pdf |
| View full study record |
| Document reference: 47564 |
| Study title: Muniyappa; Use of Rifaximin in Pediatric Patients with Inflammatory Bowel DiseaseMuniyappa; Use of Rifaximin in Pediatric Patients with Inflammatory Bowel Disease |
| Active substance: RIFAXIMIN |
| Study summary document link (including results): rifaximin-article-Muniyappa.pdf |
| View full study record |
| Document reference: 47565 |
| Study title: A therapeutic trial of the use of penicillin V or erythromycin with or without rifampin in the treatment of psoriasis. Vincent F, Ross JB, Dalton M, Wort AJ. Journal of the American Academy of Dermatology, Mar 1992, vol. 26, no. 3 Pt 2, p. 458−61. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26479 |
| Study title: Liberal use of antibiotics and its effect in neonatal staphylococcal infection, with particular reference to erythromycin.Forfar J O, Keay A J, Maccabe A F, Gould J C, Bain A D. Lancet, {Lancet}, 6 Aug 1966, vol. 2, no. 7458, p. 295−300, ISSN: 0140−6736. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26564 |
| Study title: Report in Clinical documentation for Marketing Authorisation Application (June 1987): Clinical study of the efficacy and safety of teicoplanin in the treatment of Gram-positive infections - Schiraldi O., Terragna A., De Rosa F., Olivero S. - 4 March 1987Report in Clinical documentation for Marketing Authorisation Application (June 1987): Clinical study of the efficacy and safety of teicoplanin in the treatment of Gram-positive infections - Schiraldi O., Terragna A., De Rosa F., Olivero S. - 4 March 1987 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44316 |
| Study title: Report in Clinical documentation for Marketing Authorisation Application (June 1987): Drug experience reports on 2 children receiving overdosage of teicoplaninReport in Clinical documentation for Marketing Authorisation Application (June 1987): Drug experience reports on 2 children receiving overdosage of teicoplanin |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44317 |
| Study title: Report in Clinical documentation for Marketing Authorisation Application (June 1987): Efficacy and tolerability of teicoplanin in infections caused by Gram-positive organisms - Del Favero A. - 28 November 1985Report in Clinical documentation for Marketing Authorisation Application (June 1987): Efficacy and tolerability of teicoplanin in infections caused by Gram-positive organisms - Del Favero A. - 28 November 1985 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY Gram positive - Del Favero.xls |
| View full study record |
| Document reference: 44318 |
| Study title: Report in Clinical documentation for Marketing Authorisation Application (June 1987): Evaluation of therapeutic efficacy and tolerability of teicoplanin in serious infections caused by Gram-positive micro-organisms - Martino - 28 November 1985Report in Clinical documentation for Marketing Authorisation Application (June 1987): Evaluation of therapeutic efficacy and tolerability of teicoplanin in serious infections caused by Gram-positive micro-organisms - Martino - 28 November 1985 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY Serious infections - Martino.xls |
| View full study record |
| Document reference: 44320 |
| Study title: Report in Clinical documentation for Marketing Authorisation Application (March 1987): European Multicentre open study of teicoplanin in Gram-positive infection ; 1987 sponsor summary - P.J. Lewis - 6 April 1987 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY EG-87-42.xls |
| View full study record |
| Document reference: 44310 |
| Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Clinical Pharmacology of teicoplanin in children - Milner R.D.G., Whincup G. - 1985Report in Clinical documentation for Marketing Autorisation Application (June 1987): Clinical Pharmacology of teicoplanin in children - Milner R.D.G., Whincup G. - 1985 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY pharmacological.xls |
| View full study record |
| Document reference: 44315 |
| Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Clinical study of the efficacy and safety of teicoplanin in the treatment of Gram-positive infections - Concia E., Andreoni M., Suter F. - 4 March 1987 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY DRC 357.DLI.1075.xls |
| View full study record |
| Document reference: 44296 |
| Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Clinical study of the efficacy and safety of teicoplanin in the treatment of Gram-positive infections - Dietrich H.A., Fell J.J., Pugnetti P. - 6 February 1987 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY LP-SM-0025.xls |
| View full study record |
| Document reference: 44297 |
| Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Clinical study of the efficacy and safety of teicoplanin in the treatment of Gram-positive infections - Schiraldi O., Terragna A., De Rosa F., Olivero S. - 4 March 1987 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY DRC 356.DLI.1074.xls |
| View full study record |
| Document reference: 44298 |
| Study title: AN OPEN, NON-COMPARATIVE STUDY OF SULBACTAM/AMPICILLIN (UNASYN) ADMINISTERED INTRAVENOUSLY FOR THE TREATMENT OF PEDIATRIC INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42753 |
| Study title: AN OPEN, NON-COMPARATIVE STUDY OF SULBACTAM/AMPICILLIN (UNASYN) IN THE TREATMENT OF PEDIATRIC INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42754 |
| Study title: AN OPEN, NON-COMPARATIVE STUDY OF SULPERAZONE IN THE TREATMENT OF INFECTIONS IN LEUKEMIC CHILDREN. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42759 |
| Study title: AN OPEN, NON-COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF CEFOPERAZONE/SULBACTAM (1:1) IN THE EMPIRICAL TREATMENT OF SYSTEMIC INFECTIONS IN ADULT PATIENTS IN HOSPITAL KUALA LUMPUR |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42847 |
| Study title: AN OPEN, NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IM/IV SBT/CFP IN THE TREATMENT OF URINARY TRACT INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42851 |
| Study title: AN OPEN, NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IMIV SBT/CPZ IN THE TREATMENT OF LOWER RESPIRATORY TRACT INFECTION. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42854 |
| Study title: AN OPEN, NONCOMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IM/IV SBT/CFP IN THE TREATMENT OF BONE/JOINT INFECTIONS AND OSTEOMYELITIS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42857 |
| Study title: AN OPEN, NONCOMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IM/IV SBT/CFP IN THE TREATMENT OF SURGICAL INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42849 |
| Study title: AN OPEN, NONCOMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IM/IV SBT/CFP IN THE TREATMENT OF URINARY TRACT INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42852 |
| Study title: AN OPEN, PROSPECTIVE STUDY OF SBT/CFP (1:1) IN THE TREATMENT OF NEUTROPENIC PATIENTS WITH FEVER |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42861 |
| Study title: AN OPEN, PROSPECTIVE, STUDY OF THE EFFICACY AND SAFETY OF SBT/CFP (1:1) IN THE TREATMENT OF NOSOCOMIAL PNEUMONIA, IN ADULT PATIENTS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42869 |
| Study title: CLINICAL EVALUATION IF SULPERAZON (SP) FOR INFECTIONS WITH UNDERLYING DISEASES IN THE FIELD OF UROLOGY |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42769 |
| Study title: CLINICAL EVALUATION OF SBT/CFP FOR RESPIRATORY TRACT INFECTIONS IN PREMATURE BORN BABIES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42760 |
| Study title: CLINICAL EVALUATION OF SULPERAZON (SP) FOR HBTI COMPLICATED WITH HEPATO-BILIARY TRACT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42791 |
| Study title: CLINICAL EVALUATION OF SULPERAZON (SP) FOR INFECTIONS COMPLICATED WITH DIGESTIVE MALIGNANT DISEASE |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42797 |
| Study title: CLINICAL EVALUATION OF SULPERAZON (SP) FOR INFECTIONS COMPLICATED WITH HEPATO-BILIARY TRACT DISEASE |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42798 |
| Study title: CLINICAL EVALUATION OF SULPERAZON (SP) FOR INFECTIONS COMPLICATED WITH CEREBROVASCULAR DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42786 |
| Study title: CLINICAL EVALUATION OF SULPERAZON (SP) FOR INFECTIONS COMPLICATED WITH DIGESTIVE MALIGNANT DISEASE |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42783 |
| Study title: CLINICAL EVALUATION OF SULPERAZON (SP) FOR INFECTIONS COMPLICATED WITH GYNECOLOGICAL MALIGNANT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42814 |
| Study title: CLINICAL EVALUATION OF SULPERAZON (SP) FOR INFECTIONS COMPLICATED WITH HEPATO-BILIARY TRACT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42781 |
| Study title: CLINICAL EVALUATION OF SULPERAZON (SP) FOR INFECTIONS COMPLICATED WITH HEPATO-BILIARY TRACT DISEASE |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42820 |
| Study title: CLINICAL EVALUATION OF SULPERAZON (SP) FOR INFECTIONS COMPLICATED WITH HEPATO-BILIARY TRACT MALIGNANT DISEASES |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42782 |
| Study title: British-Scandinavian co-operative headinjury study (HIT-I) |
| Active substance: NIMODIPINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32649 |
| Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Efficacy and safety of teicoplanin in the treatment of infections caused by Gram-positive cocci. A summary report of over 298 cases treated in France - Garaud J.J., Tarra -17/02/1987 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY EG-87.03.xls |
| View full study record |
| Document reference: 44299 |
| Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Efficacy and tolerability of teicoplanin in infections caused by Gram-positive organisms - Martinetto P. - 22 November 1985Report in Clinical documentation for Marketing Autorisation Application (June 1987): Efficacy and tolerability of teicoplanin in infections caused by Gram-positive organisms - Martinetto P. - 22 November 1985 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY Gram positive - Martinetto.xls |
| View full study record |
| Document reference: 44319 |
| Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): European Multicentre open study of teicoplanin in Gram-positive infection ; 1987 sponsor summary - P.J. Lewis - 6 April 1987 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY EG-87-42.xls |
| View full study record |
| Document reference: 44300 |
| Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Evaluation of therapeutic efficacy and tolerability of teicoplanin in serious infections caused by Gram-positive micro-organisms - Terragna A. - 28 November 1985Report in Clinical documentation for Marketing Autorisation Application (June 1987): Evaluation of therapeutic efficacy and tolerability of teicoplanin in serious infections caused by Gram-positive micro-organisms - Terragna A. - 28 November 1985 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY Serious infections - Terragna.xls |
| View full study record |
| Document reference: 44321 |
| Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Pharmacokinetics of teicoplanin in paediatric patients - Rosina R., Bernareggi A., Danese A., Cavenaghi L - 14 November 1986 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY DRC 348.DLI 1039.xls |
| View full study record |
| Document reference: 44301 |
| Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients - Garaud J.J. - 9 March 1987 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY EG-87-16.xls |
| View full study record |
| Document reference: 44302 |
| Study title: Summary - Clinical documentation for Marketing Autorisation Application - June 1987Summary - Clinical documentation for Marketing Autorisation Application - June 1987 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44322 |
| Study title: Summary of clinical studies of the efficacy and safety of teicoplanin in the treatment of Gram-positive infections in the UK and Eire- Concia E., Andreoni M., Suter F. - 4 March 1987 ; Report in Clinical documentation for Marketing Autorisation Application - June 1987 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44303 |
| Study title: Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients. - Lemerle S, De la Roque F, Lamy R, et al. - J Antimicrob Chemother 1988; 21, S.A.: 112-116.Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients. - Lemerle S, De la Roque F, Lamy R, et al. - J Antimicrob Chemother 1988; 21, S.A.: 112-116. |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44324 |
| Study title: Teicoplanin in gram-positive paediatric infections. (Abstract) In: Abstracts of the 8th mediterranean congress of chemotherapy. - Careddi P, Boccazzi A, Mosconi G. - Athens, 24-29 May 1992: 236.Teicoplanin in gram-positive paediatric infections. (Abstract) In: Abstracts of the 8th mediterranean congress of chemotherapy. - Careddi P, Boccazzi A, Mosconi G. - Athens, 24-29 May 1992: 236. |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44325 |
| Study title: CLINICAL EVALUATION OF SULPERAZON (SP) FOR INFLAMMATION OF PELVIC DEAD SPACE POST-OPERATION OF GYNECOLOGICAL MALIGNANT DISEASE. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42823 |
| Study title: CLINICAL EVALUATION OF SULPERAZON (SP) FOR RESPIRATORY TRACT INFECTION (RTI) OR SEPSIS COMPLICATED WITH LUNG CANCER |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42793 |
| Study title: CLINICAL EVALUATION OF SULPERAZON (SP) FOR URINARY TRACT INFECTIONS (UTI) WITH UNDERLYING DISEASES IN THE FIELD OF UROLOGY. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42803 |
| Study title: CLINICAL EVALUATION OF SULPERAZON AND PIPERACILLIN FOR RESPIRATORY TRACT INFECTIONS (RTI) COMPLICATED WITH LUNG CANCER. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42838 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR HBTI COMPLICATED WITH HEPATO-BILIARY TRACT MALIGNANT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42822 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR HBTI COMPLICATED WITH HEPATO- BILIARY TRACT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42830 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR HBTI COMPLICATED WITH HEPATO- BILIARY TRACT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42831 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR HBTI COMPLICATED WITH HEPATO- BILIARY TRACT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42832 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR HBTI COMPLICATED WITH HEPATO- BILIARY TRACT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42836 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR HBTI COMPLICATED WITH HEPATO- BILIARY TRACT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42841 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR HBTI COMPLICATED WITH HEPATO- BILIARY TRACT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42842 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR HBTI COMPLICATED WITH HEPATO- BILIARY TRACT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42844 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR HBTI COMPLICATED WITH HEPATO- BILIARY TRACT MALIGNANT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42827 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR HBTI COMPLICATED WITH HEPATO- BILIARY TRACT MALIGNANT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42845 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR INFECTIONS COMPLICATED WITH HEPATO-BILIARY TRACT DISEASE |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42819 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR INFECTIONS COMPLICATED WITH HEPATO-BILIARY TRACT DISEASES |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42818 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR INFECTIONS COMPLICATED WITH HEPATO-BILIARY TRACT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42808 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR INFECTIONS COMPLICATED WITH HEPATO-BILIARY TRACT MALIGNANT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42816 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR INFECTIONS COMPLICATED WITH HEPATO-BILIARY TRACT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42811 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR INFECTIONS WITH TOTAL PARENTAL NUTRITION (T.P.N.) PATIENTS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42776 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR POST-OPERATIVE INFECTIONS IN THE FIELD OF PLASTIC SURGERY. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42771 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY INFECTIONS (RTI) IN PATIENTS WITH UNDERLYING DISEASES (CHRONIC OBSTRUCTIVE PULMONARY DISEASE ETC.) |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42772 |
| Study title: Teicoplanin in the treatment of gram positive infections in paediatric patients. (Abstract) In: Abstracts of the 7th mediterranean congress of chemotherapy. - Becker L, Fell JJ, Dieterich HA. -Barcelona, 20-25 May 1990: 183.Teicoplanin in the treatment of gram positive infections in paediatric patients. (Abstract) In: Abstracts of the 7th mediterranean congress of chemotherapy. - Becker L, Fell JJ, Dieterich HA. -Barcelona, 20-25 May 1990: 183. |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44326 |
| Study title: A 4-week repeated dose toxicity study of HMR3647 administered orally to young Beagle dogs followed by a 4-weeek recovery period |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41545 |
| Study title: A 4-week repeated dose toxicity study of HMR3647 administered to young rats |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41544 |
| Study title: Activity of telithromycin against erythromycin susceptible and resistant Streptococcus pyogenes and Streptococcus pneumoniae isolates from paediatric origin |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41554 |
| Study title: Activity of telithromycin and comparators against paediatric respiratory tract infection (RTI) isolates collected across Canada over the past 3 years (1997-1998, 1998-1999, and 1999-2000) |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41558 |
| Study title: Activity of telithromycin on clinical isolates of Streptococcus pyogenes and Streptococcus pneumoniae from paediatric patients in different regions of Italy |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41553 |
| Study title: Determination of the susceptibility of isolates of Streptococcus pneumoniae and Streptococcus pyogenes, from paediatric patients, to telithromycin and comparator compounds and identification of the mechanism of resistance in erythromycin A-resistant strains |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41551 |
| Study title: Evaluation of pharmacokinetics, safety, efficacy and acceptability of HMR3647 (20mg/kg and 30mg/kg q.d.) in pediatric patients with infection (a non-blind, randomised, parallel-group comparative study) |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41572 |
| Study title: Evaluation of telithromycin on acute otitis media in an experimental animal model (chinchilla) |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41563 |
| Study title: Evaluation of the Safety, Efficacy, Pharmacokinetics and Acceptability of HMR 3647 20 mg/kg QD for 5 Days with Acute Otitis Media in Children(Multicenter, open label, non comparative study) |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41574 |
| Study title: Evaluation of the Safety, Pharmacokinetics, Efficacy and Acceptability of HMR 3647 20mg/kg QD for 5-7 Days with Community Acquired Pneumonia (CAP) in children. (Multicenter, open label, non comparative study) |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41573 |
| Study title: Experimental studies of otitis media due to Streptococcus pneumoniae treated with HMR3647 |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41562 |
| Study title: HMR3647: Exploratory 7-day oral toxicity study in Sprague Dawley juvenile rats (from postnatal day 5) |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41546 |
| Study title: HMR3647: Single-dose toxicokinetic study in neonatal Sprague Dawley rats |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41543 |
| Study title: In vitro actibity of telithromycin (HMR3647) against Streptococcus pyogenes and Streptococcus pneumoniae clinical isolates from paediatric patients in Greece |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41552 |
| Study title: In vitro activity of antimicrobial agents against Streptococcus pyogenes in paediatrics : a Belgian multicenter study |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41560 |
| Study title: In vitro activity of telithromycin (HMR3647) against strains of S.pneumoniae and S. pyogenes isolated in Iceland and comparison with other antimicrobials |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41556 |
| Study title: In vitro activity of telithromycin and multiple comparison antibiotics against recent clinical isolates from children |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41559 |
| Study title: In vitro activity of telithromycin, including well characterized erythromycin. A - resistant clinical isolates of S. pneumoniae and S.pyogenes in paediatrics |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41549 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTION (RTI) WITH UNDERLYING DISEASES (CHRONIC OBSTRUCTIVE PULMONARY DISEASES, ETC.) |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42768 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS (RTI) COMPLICATED WITH LUNG CANCER. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42792 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS (RTI) IN PATIENTS WITH UNDERLYING DISEASES (COPD). |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42809 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS (RTI) IN PATIENTS WITH UNDERLYING DISEASES (COPD ETC.). |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42817 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS COMPLICATED WITH STOMACH CANCER OR COLON CANCER |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42824 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS (RTI) COMPLICATED WITH CEREBROVASCULAR DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42834 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS (RTI) COMPLICATED WITH LUNG CANCER |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42778 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS (RTI) COMPLICATED WITH LUNG CANCER |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42801 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS (RTI) COMPLICATED WITH LUNG CANCER. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42840 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS (RTI) COMPLICATED WITH LUNG CANCER. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42843 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS (RTI) IN PATIENTS WITH UNDERLYING DISEASES (COPD ETC.) |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42837 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS (RTI) OR SEPSIS COMPLICATED WITH LUNG CANCER. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42828 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS (RTI) WITH UNDERLYING DISEASE (COPD ETC.) |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42821 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS (RTI) IN PATIENTS WITH UNDERLYING DISEASES (CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ETC.) |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42835 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS IN PATIENTS WITH UNDERLYING DISEASES (CHRONIC OBSTRUCTIVE PULMONARY DISEASES, ETC.). |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42765 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR THE INFECTIONS COMPLICATED WITH GYNECOLOGICAL MALIGNANT DISEASE, ETC. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42775 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR THE INFECTIONS COMPLICATED WITH THE MALIGNANT DISEASES IN THE FIELD OF E.N.T. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42800 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR THE INFECTIONS IN THE FIELD OF INTENSIVE CARE UNIT. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42810 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR THE POST-OPERATIVE INFECTIONS COMPLICATED WITH DIGESTIVE SYSTEM MALIGNANT DISEASE |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42767 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR THE POST-OPERATIVE INFECTIONS IN THE FIELD OF ENT. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42780 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR THE POST-OPERATIVE INFECTIONS IN THE FIELD OF ENT. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42784 |
| Study title: Investigation of the efficacy, safety and acceptability of HMR 3647 (1-g divided 20% fine granule packets) in paediatric patients with infections ( a multi-center collaborative single-group non blinded study) |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41575 |
| Study title: macrolide-resistant streptococci among pediatric patients in Denmark, Luxemburg, The Netherlands and Turkey |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41548 |
| Study title: Minimal inhibittory concentrations of telithromycin (Ketek) against Streptococcus pneumoniae, Heamophilus influenzae and Moraxella catarrhalis strains isolated from specimen of young patients (17 years old or less) and from specimen of adults (18 years old and older) |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41557 |
| Study title: Multicenter, Phase II, open-label study of the efficacy, safety, acceptability, and pharmacokinetics of telithromycin, after repeated oral administration of either of two doses, once daily, for 5 days or 7 to 10 days, in the treatment of respiratory tracts infections in children of 6 months to 12 years |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41569 |
| Study title: Multicenter, Phase II, open-label study of the efficacy, safety, acceptability, and pharmacokinetics of telithromycin, following administration of 20mg/kg once daily, for 5 days in the treatment of acute otitis media in children |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41570 |
| Study title: Multicenter, Phase II, open-label study of the efficacy, safety, acceptability, and pharmacokinetics of telithromycin, following administration of 15mg/kg twice daily, for 5 days in the treatment of acute otitis media in children |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41571 |
| Study title: Open Study to determine the concentration of telithromycin in middle ear fluid and plasma in infants/children with otitis media with effusion after multiple oral administration of 20mg/kg, once daily for 5 days or 15mg/kg twice daily for 4.5/5 days of telithromycin pediatric suspension |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41568 |
| Study title: Open Study to determine the concentration of telithromycin in the extracellular and intracellular compartments of middle ear fluid in children with acute otitis media or otitis media with spontaneous effusion after single oral administration of a telithromycin pediatric suspension |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41567 |
| Study title: Pattern of killing of telithromycin and azithromycin against various strains of Streptococcus pneumoniae |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41561 |
| Study title: Pharmacokinetics of Telithromycin (HMR3647) in infants and children suffering from bacterial lower respiratory tract infections after single oral administration of 30mg/kg of a telithromyucin suspension (50mg/ml) |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41565 |
| Study title: Susceptibility of 1034 Streptococcus pneumoniae and 1039 Streptococcus pyogenes strains from paediatric patients in ten central and eastern European contries to telithromycin, erythromycin A, azithromycin, clarithromycin, clindamycin, levofloxacin, quinupristin/dalfopristin, and penicillin G |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41555 |
| Study title: Telithromycin : epidemiological multicenter study on macrolide resistance of S.pneumoniae and S.pyogenes in the pediatric population in Germany, 2000- 2001 |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41550 |
| Study title: Telithromycin epidemiological survey in Austria isolates from paediatric patients |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41547 |
| Study title: U.S Survey of Telithromycin Activity against Streptococcus pyogenes |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41564 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR THE POST-OPERATIVE INFECTIONS IN THE FIELD OF PLASTIC SURGERY. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42802 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR THE POST-OPERATIVE INFECTIONS IN THE FIELD OR UROLOGY. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42787 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR THE POST-OPERATIVE INFECTIONS IN THE FIELD OF UROLOGY. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42789 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR THE POST-OPERATIVE INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42785 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR THE POST-OPERATIVE PERITONITIS THE FIELD OF GYNECOLOGIA |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42770 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR UTI WITH UNDERLYING DISEASES IN THE FIELD OF UROLOGY |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42764 |
| Study title: CLINICAL EVALUATION OF SULPERAZONE FOR HBTI COMPLICATED WITH HEPATO- BILIARY TRACT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42833 |
| Study title: CLINICAL EVALUATION OF SULPERAZONE FOR INFECTIONS COMPLICATED WITH HEPATO-BILIARY TRACT DISEASE |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42812 |
| Study title: CLINICAL EVALUATION OF SULPERAZONE FOR INFECTIONS COMPLICATED WITH HEPATO-BILIARY TRACT DISEASES |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42807 |
| Study title: CLINICAL EVALUATION OF SULPERAZONE FOR INFECTIONS COMPLICATED WITH HEPATO-BILIARY TRACT MALIGNANCY DISEASES |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42804 |
| Study title: CLINICAL EVALUATION OF UNASYN-SIV IN THE TREATMENT OF PERFORATIVE PERITONITIS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42713 |
| Study title: CLINICAL EVALUATION SULPERAZON (SP) FOR INFECTIONS COMPLICATED WITH CNS DISEASES SUCH AS CEREBROVASCULAR DISORDERS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42774 |
| Study title: CLINICAL STUDY OF SULBACTAM/CEFOPERAZONE IN CHILDREN WITH HEMATOLOGICAL DISORDERS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42761 |
| Study title: CLINICAL TRIAL OF SULPERAZON (SP) PLUS FOSFOMYCIN/ARBEKACIN FOR RESPIRATORY TRACT INFECTIONS IN PATIENTS WITH UNDERLYING DISEASE |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42763 |
| Study title: CLINICAL TRIAL OF SULPERAZON (SP) PLUS FOSFOMYCIN/ARBEKACIN/VANCOMYCIN FOR MRSA AND GRAM NEG RODS INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42766 |
| Study title: CLINICAL TRIAL OF SULPERAZON ALONE OR SULPERAZON PLUS DALACIN-S FOR INFECTIONS IN PATIENTS WITH LUNG CANCER. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42826 |
| Study title: CLINICAL TRIAL OF SULPERAZON PLUS FOSFOMYCIN FOR SEVERE INFECTIONS ASSOCIATED WITH HEMATOLOGICAL DISORDERS. STUDY COMPARATIVE TO WHETHER PATIENTS RECEIVES SBT/CFP OR FOSFOMYCIN. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42825 |
| Study title: COMBINED THERAPY OF SBT/CFP AND CLINDAMYCIN (CLDM) FOR SEVERE INFECTIONS ASSOCIATED WITH HEMATOLOGICAL DISORDERS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42773 |
| Study title: COMBINED THERAPY OF SULBACTAM/CEFOPERAZONE AND DOXYCYCLINE FOR MRSA RESPIRATORY TRACT INFECTIONS (RTI) |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42762 |
| Study title: COMBINED THERAPY OF SULPERAZON AND AMIKACIN (AMK) FOR SEVERE INFECTIONS ASSOCIATED WITH HEMATOLOGICAL DISORDERS OF CHILDREN |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42779 |
| Study title: COMBINED THERAPY OF SULPERAZON AND FOSFOMYCIN FOR RESPIRATORY TRACT INFECTIONS (RTI) WITH UNDERLYING DISEASES (COPD ETC.). |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42806 |
| Study title: COMBINED THERAPY OF SULPERAZON AND PIPERACILLIN (OR AMIKACIN) FOR SEVERE INFECTIONS ASSOCIATED WITH HEMATOLOGICAL DISORDERS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42777 |
| Study title: A randomized, doble-blind, parallel group study to determine the effective duration (1,2 or 4 weeks) and safety of Lamisil (tablets) given once daily to patients with tinea capitis due to Trichophyton species (mainly T. tonsurans) |
| Active substance: TERBINAFINE |
| Study summary document link (including results): SFO327 T201MR.xls |
| View full study record |
| Document reference: 44355 |
| Study title: A randomized, double-blind, parallel group study to determine the effective duration (6, 8, 10 or 12 weeks) and safety of LamisilÒ (tablets) given once daily to patients with tinea capitis due to Microsporum species (mainly M. canis). |
| Active substance: TERBINAFINE |
| Study summary document link (including results): SFO327 T202MR.xls |
| View full study record |
| Document reference: 44356 |
| Study title: EVALUATIONS OF TOLERABILITY AND EFFICACY OF ORAL SF 86-327 IN CHILDREN TREATED FOR FUNGAL INFECTIONS. A SUMMARY OF DATA FROM EXPERIENCE OTHER THAN SPECIAL CLINICAL TRIALS IN CHILDREN |
| Active substance: TERBINAFINE |
| Study summary document link (including results): SFE700MR.xls |
| View full study record |
| Document reference: 44357 |
| Study title: Gupta et al, 2003 (overview article of studies) |
| Active substance: TERBINAFINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44341 |
| Study title: Jones, 1995: overview of six clinical studies, 152 children were evaluated for efficacy, 196 for tolerability. |
| Active substance: TERBINAFINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44342 |
| Study title: MULTICENTRIC, RANDOMIZED SINGLE-BLIND STUDY OF EFFICACY, SAFETY AND TOLERABILITY OF TERBINAFINE [LAMISIL(R)] TABLETS, ONCE DAILY, FOR 1, 2 OR 4 WEEKS IN THE TREATMENT OF TINEA CAPITIS IN CHILDREN |
| Active substance: TERBINAFINE |
| Study summary document link (including results): LASBR 06-22493MR.xls |
| View full study record |
| Document reference: 44349 |
| Study title: Nejjam et al, 1996: 12 children 5-11 years old |
| Active substance: TERBINAFINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44343 |
| Study title: OPEN STUDY TO DETERMINE THE EFFICACY OF 62.5 MG/D TERBINAFINE IN THE TREATMENT OF CHILDREN WITH TINEA CAPITIS. |
| Active substance: TERBINAFINE |
| Study summary document link (including results): SFE302 E-00 001MR.xls |
| View full study record |
| Document reference: 44352 |
| Study title: PILOT STUDY OF TERBINAFINE IN CHILDREN SUFFERING FROM TINEA CAPITIS: EVALUATION OF THE EFFICACY, SAFETY AND PHARMACOKINETICS SHORT TITLE: LAMISIL(R) _ EFFICACY, SAFETY, PHARMACOKINETICS IN CHILDREN |
| Active substance: TERBINAFINE |
| Study summary document link (including results): SFE 306MR.xls |
| View full study record |
| Document reference: 44353 |
| Study title: Study 1 - Gupta et al, 2003 (overview aricle of studies). |
| Active substance: TERBINAFINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44344 |
| Study title: Study 2 - Jones, 1995: overview of six clinical studies, 152 children were evaluated for efficacy, 196 for tolerability. |
| Active substance: TERBINAFINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44345 |
| Study title: Study 3 - Nejjam et al, 1996: 12 children 5-11 years old. |
| Active substance: TERBINAFINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44346 |
| Study title: TO DETERMINE THE SAFETY AND EFFICACY OF ORAL SULTAMICILLIN VS. CLAVULANIC ACID/AMOXICILLIN IN PEDIATRIC PATIENTS WITH ACUTE OTITIS MEDIA. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43024 |
| Study title: TO DETERMINE THE SAFETY AND EFFICACY OF PARENTERAL SBT/AMP FOLLOWED BY ORAL STM IN THE TREATMENT OF BACTERIAL INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42955 |
| Study title: TO DETERMINE THE SAFETY AND EFFICACY OF PARENTERAL SBT/AMP, FOLLOWED BY ORAL SULTAMICILLIN IN THE TREATMENT OF PATIENTS WITH THE ENTERIC FEVER SYNDROME. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42954 |
| Study title: TO DETERMINE THE SAFETY AND EFFICACY OF STM BID VS AUGMENTIN TID FOR THE TREATMENT OF RESPIRATORY TRACT OR UNCOMPLICATED URINARY TRACT INFECTIONS |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43018 |
| Study title: TO DETERMINE THE SAFETY AND EFFICACY OF SULTAMICILLIN FOR THE TREATMENT OF UPPER AND LOWER RESPIRATORY TRACT INFECTION AND UNCOMPLICATED URINARY TRACT INFECTION. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43048 |
| Study title: TO EVALUATE THE EFFICACY AND SAFETY OF A SINGLE ORAL DOSE OF 2.25 GM OF STM & PRABENECID 1 GM WITH AND WITHOUT PROBENECIDE IN THE TREATMENT OF GONORRHEA. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43062 |
| Study title: TO EVALUATE THE EFFICACY AND SAFETY OF SBT/AMP/STM IN THE TREATMENT OF (RTI) RESPIRATORY TRACT INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42951 |
| Study title: TO EVALUATE THE EFFICACY AND SAFETY OF SULTAMICILLIN IN THE TREATMENT OF PATIENTS WITH LOWER RESPIRATORY TRACT INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43012 |
| Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF STM (SBT/AMP) GIVEN ORALLY BID IN PEDIATRIC INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42982 |
| Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF STM GIVEN ORALLY BID IN PEDIATRIC INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42981 |
| Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF STM IN THE TREATMENT OF PATIENTS WITH DIAGNOSED CASES OF UTI. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43060 |
| Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF SULTAMICILLIN GIVEN ORALLY TWICE A DAY IN PEDIATRIC INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42983 |
| Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF SULTAMICILLIN IN THE TREATMENT OF A VARIETY OF CHILDHOOD INFECTIONS, E.G., OTITIS MEDIA. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43061 |
| Study title: TO EVALUATE THE EFFICACY OF STM IN THE TREATMENT OF PATIENTS WITH DIAGNOSED CASES OF BRONCHO-PNEUMONIA. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43059 |
| Study title: TO STUDY THE EFFICACY AND SAFETY OF ORAL STM FOR THE TREATMENT OF ACUTE PNEUMOPATHY AND LOWER RESPIRATORY TRACT INFECTION |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42991 |
| Study title: COMBINED THERAPY OF SULPERAZON AND PIPERACILLIN FOR SEVERE INFECTIONS ASSOCIATED WITH HEMATOLOGICAL DISORDERS OF CHILDREN |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42788 |
| Study title: COMPARATIVE STUDY OF SULBACTAM/AMPICILLIN VS METRONIDAZOLE/GENTAMICIN IN COLORECTAL SURGERY PROPHYLAXIS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42676 |
| Study title: COMPARATIVE STUDY ON THE PROPHYLAXIS OF ABDOMINAL SURGERIES WITH INJECTABLE SULBACTAM - AMPICILLIN (UNASYN) VERSUS CEPHALOSPORINS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42679 |
| Study title: COMPARISON OF AMPICILLIN PLUS SULBACTAM VS CEFUROXIME IN THE TREATMENT OF PERIORBITAL CELLULITIS AND/OR OTHER FACIAL CELLULITIS AND/OR EPIGLOTTIS OF BACTERIAL ETIOLOGY IN HOSPITALIZED PEDIATRIC PATIENTS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42642 |
| Study title: COMPARISON OF AMPICILLIN PLUS SULBACTAM VS CEFUROXIME IN THE TREATMENT OF SKIN AND/OR SKIN STRUCTURE INFECTIONS (E.G., PERIORBI-TAL CELLULITIS) AND/OR OSTEOMYELITIS/SUPPURATIVE ARTHRITIS OF BACTERIAL ETIOLOGY IN HOSPITALIZED PEDIATRIC PATIENTS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42643 |
| Study title: CONTROLLED, BLINDED, RANDOMIZED CLINICAL TRIAL OF THE EFFICACY AND TOXICITY OF AMPICILLIN/SULBACTAM VS AMPICILLIN/GENTAMYCIN/CLINDAMYCIN IN POSTPARTUM ENDOMETRIOSIS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42658 |
| Study title: DETERMINATION OF AMPICILLIN/SULBACTAM IN HUMAN MILK |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42633 |
| Study title: DRUG TREATMENT VERSUS EXPECTANT MANAGEMENT OF PRETERM PREMATURE RUPTURE OF MEMBRANES |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42652 |
| Study title: EFFICACY AND SAFETY OF BID DOSAGE OF PARENTERAL SULBACTAM/AMPICILLIN IN MILD-MODERATE SURGICAL INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42733 |
| Study title: EFFICACY AND SAFETY OF SBT/AMP FOLLOWED BY ORAL SULTAMICILLIN IN THE TREATMENT OF OSTEOMYELITIS AND BONE/JOINT INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42749 |
| Study title: EFFICACY AND SAFETY OF SBT/AMP IN PATIENTS WITH SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42685 |
| Study title: EFFICACY AND SAFETY OF SBT/AMP IN PATIENTS WITH SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42695 |
| Study title: EFFICACY AND SAFETY OF SBT/AMP IN THE PERIOPERATIVE PROPHYLAXIS IN MAXILLOFACIAL SURGERY. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42704 |
| Study title: EFFICACY AND SAFETY OF SBT/AMP IN THE TREATMENT OF DOCUMENTED COMMUNITY OR NOSOCOMIAL INFECTIONS IN GENERAL SURGERY. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42706 |
| Study title: EFFICACY AND SAFETY OF SBT/CFP IN MODERATE TO SEVERE BACTERIAL INFECTIONS IN SURGICAL PATIENTS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42848 |
| Study title: EFFICACY AND SAFETY OF SULBACTAM/AMPICILLIN (UNASYN) VS. PIPERCILLIN IN PATIENTS WITH EXACERBATION OF CHRONIC AND ACUTE LOWER RESPIRATORY INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42703 |
| Study title: EFFICACY AND SAFETY OF SULBACTAM/AMPICILLIN IN ACUTE ENT INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42692 |
| Study title: EFFICACY AND SAFETY OF SULBACTAM/AMPICILLIN IN NEWBORN PATIENTS WITH SEVERE INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42701 |
| Study title: EFFICACY AND SAFETY OF SULBACTAM/AMPICILLIN IN PATIENTS WITH SEVERE ORL INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42702 |
| Study title: EFFICACY AND SAFETY OF SULBACTAM/AMPICILLIN IN VARIOUS INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42742 |
| Study title: EFFICACY AND SAFETY OF SULBACTAM/AMPICILLIN IN VARIOUS INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42743 |
| Study title: EFFICACY AND SAFETY OF SULBACTAM/AMPICILLIN PARENTERAL IN THE TREATMENT OF GENERAL PEDIATRIC INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42739 |
| Study title: EFFICACY AND SAFETY OF SULBACTAM/AMPICILLIN VS. CEFTAZIDIME IN CHILDREN WITH BACTERIAL INFECTIONS OF LOWER RESPIRATORY TRACT. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42705 |
| Study title: EFFICACY AND TOLERANCE OF SULBACTAM/AMPICILLIN FOLLOWED BY ORAL SULTAMICILLIN IN PATIENTS WITH HEAD AND NECK ABSCESSES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42670 |
| Study title: EFFICACY AND TOLERATION OF SBT/AMP IN MILD SEVERE GYN-OB INFECTIONS (PID, ENDOMETRITIS, ETC.). |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42681 |
| Study title: EFFICACY AND TOLERATION OF SULBACTAM/AMPICILLIN IN PATIENTS WITH NON-SEVERE INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42729 |
| Study title: EFFICACY AND TOLERATION OF SULBACTAM/AMPICILLIN VS. NETILMICIN PLUS METRONIDAZOLE USED IN SHORT TERM PERIOPERATIVE PROPHYLAXIS IN PATIENTS WHO UNDERGO ABDOMINAL SURGERY. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42709 |
| Study title: EFFICACY AND TOLERATION OF UNASYN IN TREATMENT OF INFECTIONS OF THE RESPIRATORY TRACT, GASTROINTESTINAL TRACT, SKIN AND SAFE TISSUES AND UROGENITAL TRACT |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42675 |
| Study title: EFFICACY OF SBT.AMP IN VARIOUS INFECTIONS IN CHILDREN. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42741 |
| Study title: EFFICACY OF UNASYN IN PATIENTS WITH ACUTE DISEASE OF THE LUNGS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42691 |
| Study title: MULTICENTER CLINICAL STUDY OF SBT/AMP IN PEDIATRIC PATIENTS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42673 |
| Study title: MULTICENTER OPEN NON-COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF SBT/AMP IN BACTERIAL LOWER RESPIRATORY TRACT INFECTIONS IN ADULT PATIENTS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42735 |
| Study title: MULTICENTER OPEN NON-COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF SULBACTAM/AMPICILLIN IN GYNECOLOGICAL AND OBSTETRIC INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42669 |
| Study title: MULTICENTRIC OPEN NONCOMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF SBT/AMP IN INTRA-ABDOMINAL SURGICAL INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42736 |
| Study title: MULTICENTRIC, OPEN NONCOMPARATIVE STUDY OF EFFICACY AND SAFETY OF SBT/AMP IN BACTERIAL LOWER RESPIRATORY TRACT INFECTIONS IN PEDIATRIC PATIENTS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42734 |
| Study title: NONCOMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF PARENTERAL SBT/AMP IN THE TREATMENT OF PATIENTS WITH SKIN AND SOFT TISSUE INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42730 |
| Study title: OPEN COMPARATIVE STUDY OF SBT/AMP VS. AMPICILLIN IN THE TREATMENT OF LOWER RESPIRATORY TRACT INFECTIONS IN ADULT PATIENTS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42699 |
| Study title: OPEN COMPARATIVE STUDY OF SULBACTAM/CEFOPERAZONE (1:2) VS. CEFTAZIDIME PLUS AMIKACIN IN THE TREATMENT OF NEUTROPENIC PATIENTS WITH FEVER |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42865 |
| Study title: OPEN MULTICENTRIC STUDY OF THE EFFICACY AND SAFETY OF THE COMBINATION SBT/CFP (1:2) IN THE TREATMENT OF PATIENTS (ADULTS AND CHILDREN) WITH SEVERE INFECTIONS (VTI) |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42864 |
| Study title: OPEN NON-COMPARATIVE EVALUATION IN THE PROPHYLAXIS OF SURGICAL WOUND INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42684 |
| Study title: OPEN NON-COMPARATIVE SAFETY/EFFICACY STUDY SULBACTAM/AMPICILLIN IM/IV IN THE TREATMENT OF BACTERIOLOGICAL ENT INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42745 |
| Study title: Norfloxacin interferes with cyclosporine disposition in pediatric patients undergoing renal transplantation; Clin. Pharmacol. Ther. 1995 Sep. 58(3): 322-327 |
| Active substance: NORFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32721 |
| Study title: Alban J.Current therapeutic research 1972; 14(4):158-161 Efficacy of nystatin topical cream in the management of cutaneous candidiasis in infants PMID: 4623594 http://www.ncbi.nlm.nih.gov/pubmed?term=4623594 Alban J.Current therapeutic research 1972; 14(4):158-161 Efficacy of nystatin topical cream in the management of cutaneous candidiasis in infants PMID: 4623594 http://www.ncbi.nlm.nih.gov/pubmed?term=4623594 |
| Active substance: Nystatin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45239 |
| Study title: De Wet PM, Rode H, van Dyk A, Millar AJ W: Perianal Canidosis-a comparative study with mupirocin and nystatin. Int J Dermatol 1999;38(8):618-22.De Wet PM, Rode H, van Dyk A, Millar AJ W: Perianal Canidosis-a comparative study with mupirocin and nystatin. Int J Dermatol 1999;38(8):618-22. |
| Active substance: NYSTATIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32728 |
| Study title: Freitag V.; Schumacher G.; Sternowsky H-J. Der Kinderarzt 1983; 14(2):177-178 Soor im Mund- und Windelbereich (Thrush in the mouth and nappy area) Freitag V.; Schumacher G.; Sternowsky H-J. Der Kinderarzt 1983; 14(2):177-178 Soor im Mund- und Windelbereich (Thrush in the mouth and nappy area) |
| Active substance: NYSTATIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45240 |
| Study title: Kozinn PJ. et al.: Treatment of cutaneous candidiasis in infancy and childhood with nystatin and amphotericin B. Antibiotics Annual 1956/57:128-13Kozinn PJ. et al.: Treatment of cutaneous candidiasis in infancy and childhood with nystatin and amphotericin B. Antibiotics Annual 1956/57:128-13 |
| Active substance: NYSTATIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32727 |
| Study title: Munz D, Powell KR, Pai CH: Treatment of candidal diaper dermatitis: double blind placebo controlled com¬parison of topical nystatin with topical plus oral nystatin. J Pediatr 101 1022 – 1025 (1982)Munz D, Powell KR, Pai CH: Treatment of candidal diaper dermatitis: double blind placebo controlled com¬parison of topical nystatin with topical plus oral nystatin. J Pediatr 101 1022 – 1025 (1982) |
| Active substance: NYSTATIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32729 |
| Study title: Treatment of Pneumocystis carinii pneumonitis. Siegel, S.E., Wolff, L.J., Baehner, R.L. and Hammond D. (1984) American Journal of Disease of Children 138:1051-1054Treatment of Pneumocystis carinii pneumonitis. Siegel, S.E., Wolff, L.J., Baehner, R.L. and Hammond D. (1984) American Journal of Disease of Children 138:1051-1054 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45837 |
| Study title: Unusual complications of pentamidine in the treatment of Pneumocystis cariniii pneumonia. Wang, J.J., Freeman, A.I., Gaeta , J.F., and Sinks, L.F. (1970) Journal of Pediatrics 77:311-314Unusual complications of pentamidine in the treatment of Pneumocystis cariniii pneumonia. Wang, J.J., Freeman, A.I., Gaeta , J.F., and Sinks, L.F. (1970) Journal of Pediatrics 77:311-314 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45838 |
| Study title: THE TREATMENT OF ACUTE PELVIC INFECTIONS WITH PARENTERAL SBT/AMP. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42744 |
| Study title: OPEN, NON-COMPARATIVE STUDY OF THE EFFICACY, SAFETY AND TOLERABILITY OF SBT/AMP IMIV IN THE TREATMENT OF PEDIATRICS WITH VARIOUS BACTERIAL INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42689 |
| Study title: PROCEDURE FOR THE STUDY OF UNASYN USED IN PROPHYLAXIS IN TREATMENT OF ABDOMINAL WOUND SURGERY |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42720 |
| Study title: RANDOMIZED CONTROLLED CLINICAL TRIAL COMPARING CEFAZOLIN + METRONIDAZOLE TO AMPICILLIN/SULBACTAM IN MAJOR HEAD & NECK SURGERY. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42664 |
| Study title: SAFETY AND EFFICACY OF SBT/AMP IN ADULTS WITH LOWER RESPIRATORY TRACT INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42718 |
| Study title: SBT/AMP - OPEN TRIAL. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42671 |
| Study title: SBT/AMP NON-COMPARATIVE OPEN TRIAL. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42672 |
| Study title: THE COMPARISON OF SULBACTAM/AMPICILLIN (UNASYN) AND AMPICILLIN/GENTAMICIN IN THE TREATMENT OF CHORIOAMNIONITIS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42665 |
| Study title: THE EVALUATION OF CLINICAL EFFICACY AND SAFETY OF SULBACTAM/AMPICILLIN (UNASYN) IN THE TREATMENT OF COMMUNITY-ACQUIRED INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42750 |
| Study title: THE NECESSITY FOR GRAM NEGATIVE ANTIMICROBIAL COVERAGE IN THE PREVENTION OF INFECTION FOLLOWING HEAD AND NECK SURGERY |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42628 |
| Study title: Observational use study of the tolerability of Octenisept in premature infants with a gestational age of less than 27 weeks, at the Department of Neonatology of the Charite Campus Virchow Clinic.(Director: Prof. Dr. med. Michael Obladen.2002. |
| Active substance: OCTENIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32734 |
| Study title: Use of Octenisept for pre-operative skin and mucous membrane antisepsis and for supportive wound and suture treatment in small children and babies. UNIV-KLINIK FUR CHIRURGIE.1998. |
| Active substance: OCTENIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32737 |
| Study title: OPEN NON-COMPARATIVE STUDY TO DETERMINE THE CONCENTRATION OF SBT/AMP IN JUVENILE CARTILAGE. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42688 |
| Study title: Oral nystatin profilaxis to prevent invasive candidiasis in neonatal intensive care unit 2006 |
| Active substance: NYSTATIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41622 |
| Study title: "Addendum to the clinical expert report, Local and systemic tolerability in babies and premature infants. Author: Priv. Doz. Dr. med. E. Sebastian Debus.2003. " |
| Active substance: OCTENIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32735 |
| Study title: "Experience report of the use of Octenisept in children prior to urological procedures. UNIVERSITY TEACHING HOSPITAL OF THE JOHANNES GUTENBERG UNIVERSITY, MAINZ. 1996. "Experience report of the use of Octenisept in children prior to urological procedures. UNIVERSITY TEACHING HOSPITAL OF THE JOHANNES GUTENBERG UNIVERSITY, MAINZ. 1996. |
| Active substance: OCTENIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32740 |
| Study title: Bereston ES: Nystatin in the treatment of Candida albicans infections South Med J 50 547-550. (1957)Bereston ES: Nystatin in the treatment of Candida albicans infections South Med J 50 547-550. (1957) |
| Active substance: NYSTATIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29021 |
| Study title: Observational study of the use of Octenisept on babies and neonates at the Pediatric Clinic of Gera Hospital.1996. |
| Active substance: OCTENIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32738 |
| Study title: Zethionate injection 200 mg and 300 mg abridged application for a product licence. Part IV Clinical documentation - Volume 1.Zethionate injection 200 mg and 300 mg abridged application for a product licence. Part IV Clinical documentation - Volume 1. |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45839 |
| Study title: TIME-LAG COMBINED THERAPY OF SULPERAZON (SP) AND FOSFOMYCIN (FOM) FOR INFECTIONS COMPLICATED WITH CNS DISEASES SUCH AS CEREBROVASCULAR DISORDER |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42794 |
| Study title: TIME-LAG COMBINED THERAPY OF SULPERAZON (SP) AND FOSFOMYCIN (FOM) FOR P. AERUGINOSA RESPIRATORY TRACT INFECTIONS (RTI). |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42839 |
| Study title: TIME-LAG COMBINED THERAPY OF SULPERAZON (SP) AND FOSFOMYCIN (FOM) FOR RESPIRATORY TRACT INFECTIONS (RTI) COMPLICATED WITH UNDERLYING DISEASES (CHRONIC OBSTRUCTIVE PULMONARY DISEASES, ETC.). |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42790 |
| Study title: TIME-LAG COMBINED THERAPY OF SULPERAZON (SP) AND FOSFOMYCIN (FOM) FOR RESPIRATORY TRACT INFECTIONS (RIP) COMPLICATED WITH MALIGNANT DISEASE. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42813 |
| Study title: TIME-LAG COMBINED THERAPY OF SULPERAZON (SP) AND FOSFOMYCIN (FOM) FOR RESPIRATORY TRACT INFECTIONS (RTI) COMPLICATED WITH LUNG CANCER |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42815 |
| Study title: TIME-LAG COMBINED THERAPY OF SULPERAZON (SP) AND FOSFOMYCIN (FOM) FOR RESPIRATORY TRACT INFECTIONS (RTI) IN COMPLICATED LUNG CANCER |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42805 |
| Study title: TIME-LAG COMBINED THERAPY OF SULPERAZON (SP) AND FOSFOMYCIN (FOM) TO RESPIRATORY TRACT INFECTIONS (RTI) COMPLICATED WITH LUNG CANCER |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42799 |
| Study title: TIME-LAG COMBINED THERAPY OF SULPERAZON AND FOSFOMYCIN FOR FOR RESPIRATORY TRACT INFECTIONS COMPLICATED WITH LUNG CANCER. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42829 |
| Study title: TIME-LAG COMBINED THERAPY OF SULPERAZON AND FOSFOMYCIN FOR SEVERE INFECTIONS ASSOCIATED WITH HEMATOLOGICAL DISORDERS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42795 |
| Study title: TIME-LAG COMBINED THERAPY OF SULPERAZON AND FOSFOMYCIN FOR SEVERE INFECTIONS ASSOCIATED WITH HEMATOLOGICAL DISORDERS OF CHILDREN |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42796 |
| Study title: TO ASSESS THE EFFICACY AND SAFETY OF A SINGLE DOSE OF STUDY MEDICATION IN TREATMENT OF URINARY TRACT INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42728 |
| Study title: TO ASSESS THE SAFETY AND EFFICACY OF SULBACTAM/AMPICILLIN IN THE TREATMENT OF DOCUMENTED INFECTIONS AFTER SURGICAL OPERATION IN THE ABDOMINAL REGION. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42700 |
| Study title: TO COMPARE AND ASSESS THE EFFICACY OF SBT/AMP VS CEFOXITIN IN THE PREVENTION OF INFECTIVE COMPLICATIONS FOLLOWING RECTAL SURGERY. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42698 |
| Study title: THE USE OF CEFOPERAZONE PLUS SULBACTAM IN THE TREATMENT OF OSTEOMYELITIS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42631 |
| Study title: TO COMPARE THE EFFICACY AND SAFETY OF A SINGLE DOSE IM S/A PLUS PROBENECID AND SINGLE DOSES OF S/A WITHOUT PROBENECID IN TREATMENT OF |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42756 |
| Study title: TO COMPARE THE EFFICACY AND SAFETY OF A SINGLE DOSE OF SULBACTAM/ AMPICILLIN IM PLUS ORAL PROBENECID IN THE TREATMENT OF GONORRHEA. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42721 |
| Study title: TO COMPARE THE EFFICACY AND SAFETY OF SBT/AMP VS GENTAMYCIN/ORNIDAZOLE BY PARENTERAL ROUTE FOR TREATMENT OF ABDOMINAL INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42693 |
| Study title: TO CONTINUE TO COMPARE THE EFFICACY AND SAFETY OF SULBACTAM AND AMPICILLIN CO-ADMINISTERED INTRAVENOUSLY WITH THAT OF CONVENTIONAL THERAPY CHLORAMPHENICOL & AMPICILLIN IN THE TREATMENT OF INFANTS & CHILDREN BACTERIAL MENINGITIS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42644 |
| Study title: TO DETERMINE THE EFFICACY AND SAFETY OF SBT/AMP FOR THE TREATMENT OF PEDIATRIC PATIENTS WITH SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42726 |
| Study title: TO DETERMINE THE EFFICACY AND SAFETY OF SBT/AMP FOR THE TREATMENT OF PEDIATRIC PATIENTS WITH URTI. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42727 |
| Study title: A multi-centre, randomised, double masked, parallel-group study completed in the USA, Mexico and Brazil comparing the safety and efficacy of topical Ofloxacin 0.3% ophthalmix solution against that of topical Trimethoprim sulphate/Polymyxin B sulphate combination ophthalmic solution as a positive control, in infants, from birth to 31 days of age, with bacterial conjunctivitis. |
| Active substance: OFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41625 |
| Study title: John W.Warren et al., Guidelines fro Antimicrobial Treatment of Uncomplicated Acute Bacterial Cystitis and Acute Pyelonephritis in Women, Clinical Infectious Diseases, 1999; 29:745-58 |
| Active substance: OFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32757 |
| Study title: John W.Warren et al., Guidelines fro Antimicrobial Treatment of Uncomplicated Acute Bacterial Cystitis and Acute Pyelonephritis in Women, Clinical Infectious Diseases, 1999; 29:745-58 |
| Active substance: Ofloxacin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32767 |
| Study title: TO DETERMINE THE SAFETY AND EFFICACY OF SBT/AMP FOR THE TREATMENT OF PATIENTS WITH METHICILLIN-RESISTANT STAPH INFECTIONS OF THE SKIN AND SOFT TISSUE. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42725 |
| Study title: TO DOCUMENT THE EFFICACY AND SAFETY OF SBT/AMP IN MODERATE TO SEVERE PEDIATRIC INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42680 |
| Study title: TO EVALUATE THE CLINICAL AND BACTERIOLOGICAL EFFICACY, SAFETY AND TOLERABILITY OF SULBACTAM/AMPICILLIN IN THE TREATMENT OF SKIN/SOFT TISSUE INFECTIONS OF BACTERIAL ETIOLOGY. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42746 |
| Study title: TO EVALUATE THE CLINICAL AND BACTERIOLOGICAL EFFICACY, SAFETY AND TOLERATION OF UNASYN IM/IV IN VARIOUS INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42687 |
| Study title: TO EVALUATE THE CLINICAL EFFICACY OF S/S IN HOSPITALIZED PATIENT WITH URINARY TRACT INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42682 |
| Study title: TO EVALUATE THE EFFICACY AND SAFETY OF SULBACTAM/AMPICILLIN IN THE TREATMENT OF GYNECOLOGICAL INFECTIONS OF BACTERIAL ETIOLOGY, INCLUDING, BUT NOT NECESSARILY LIMITED TO: PELVIC INFLAMMATORY DISEASE, ENDOMETRITIS, SALPINGITIS, BARTHELINITIS, ETC. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42716 |
| Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF SBT/AMP GIVEN IM TWICE A DAY IN NON-SEVERE INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42724 |
| Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF SULBACTAM/AMPICILLIN GIVEN INTRAMUSCULARLY THREE/FOUR TIMES PER DAY TO PATIENTS WITH VARIOUS INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42715 |
| Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF SULBACTAM/AMPICILLIN GIVEN INTRAVENOUSLY EVERY 8 HOURS COMPARED TO NETILMYCIN 100 MG, PLUS METRONIDAZOLE TWO TIMES A DAY IN THE TREATMENT OF PATIENTS WITH INTRA ABDOMINAL INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42708 |
| Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF SULBACTAM/AMPICILLIN IM/IV IN THE TREATMENT OF SURGICAL INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42714 |
| Study title: TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF SBT/AMP IN THE TREATMENT OF MODERATE TO SEVERE SKIN/SOFT TISSUE OR BACTERIAL |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42748 |
| Study title: TO EVALUATE THE EFFICACY, SAFETY AND TOLERATION OF SBT/AMP IN THE TREATMENT OF BACTERIAL INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42747 |
| Study title: TO EVALUATE THE SAFETY AND EFFICACY OF SULBACTAM/AMPICILLIN COMPARED TO CEFOTETAN IN THE TREATMENT OF BACTERIAL ETIOLOGY INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42697 |
| Study title: TO STUDY THE EFFICACY AND SAFETY OF SBT/AMP IN THE TREATMENT OF INFECTIONS IN NEONATES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42694 |
| Study title: UNASYN IM/IV, OPEN, NON COMPARATIVE EVALUATION IN THE TREATMENT OF ACUTE AND CHRONIC INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42683 |
| Study title: TO DETERMINE THE SAFETY AND EFFICACY OF PARENTERAL SULBACTAM/AMPICILLIN FOLLOWED BY ORAL SULTAMICILLIN IN TREATING SEVERE LOWER RESPIRATORY TRACT INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42677 |
| Study title: "Prophylaxis of Bacterial Infections after Bone Msrrow Transplantation - E. Gluckman, C. Roudet, I. Hirsch, A. Devergie, H. Bourdeau, C. Arlet - Chemotherapy 1991; 33 (suppl 1): 33-38" |
| Active substance: OFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32756 |
| Study title: Immuntherapie bei kindern mit hilfe eines multibakteriellen ribosomenpräparates |
| Active substance: Tetanus Vaccine (Adsorbed) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41393 |
| Study title: A prospective study of a one-week nonbismuth quadruple therapy for childhood Helicobacter pylori infection. |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32784 |
| Study title: Braunsteiner A*,Habermacher B: Clinical acceptability, tolerability and efficacy of BACTRIM syrup (Ro 06-2580/103) in children. An open uncontrolled study. Final study report. Dr. Eggenberger, Yverdon, Switzerland. 16.04.1985 |
| Active substance: Sulfamethoxazole trimethoprim |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45243 |
| Study title: Braunsteiner A*,Habermacher B: Clinical acceptability, tolerability and efficacy of BACTRIM syrup (Ro 06-2580/103) in children. An open uncontrolled study. Final study report. Dr. Herz, Basel/Switzerland. 01.05.1985 |
| Active substance: Sulfamethoxazole trimethoprim |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45245 |
| Study title: Braunsteiner A*,Habermacher B: Clinical acceptability, tolerability and efficacy of BACTRIM syrup (Ro 06-2580/103) in children. An open uncontrolled study. Final study report. Dr. Vich, Winterthur/ Switzerland. 01.05.1985 |
| Active substance: Sulfamethoxazole trimethoprim |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45246 |
| Study title: Braunsteiner A*,Habermacher B: Clinical acceptability, tolerability and efficacy of BACTRIM syrup (Ro 06-2580/103) in children. An open uncontrolled study. Final study report by Dr. D'Aruzzo, Mendrisio/Switzerland. 10.05.1985 |
| Active substance: Sulfamethoxazole trimethoprim |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45247 |
| Study title: Cunningham M*,Barsanti F,Merrell R,Lentz E: Final Study Report: A Comparative Study of Single-Dose Intramuscular (IM) Ceftriaxone Versus Single-Dose IM Bicillin CR plus Oral Trimethoprim-Sulfamethoxazole for the Treatment of Uncomplicated Acute Otitis Media in Infants and Children (Howie Protocol) |
| Active substance: Sulfamethoxazole trimethoprim |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45248 |
| Study title: Cunningham M*,Barsanti F,Merrell R,Lentz E: Final Study Report: A Comparative Study of Single-Dose Intramuscular (IM) Ceftriaxone and a 10-Day Oral (PO) Course of Trimethorprim-sulfamethoxazole for the Treatment of Acute Otitis Media in Infants and Children (Klein Protocol) |
| Active substance: Sulfamethoxazole trimethoprim |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45249 |
| Study title: Havas L: DOSAGE OF PHARMACEUTICALS IN CHILDREN B-0054340 |
| Active substance: Sulfamethoxazole trimethoprim |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45251 |
| Study title: M. Sieniawska ,,Clinical evaluation of the prep. Biseptol 480 for i.v. use in children with bacterial infections" |
| Active substance: Sulfamethoxazole trimethoprim |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45242 |
| Study title: Reggiani G: PHARMACOKINETIC STUDIES OF TRIMETHOPRIM-SULFAMETHOXAZOLE IN CHILDREN WITH GASTROENTERITIS (MANUSCRIPT BY M.I. MARKS, M. KAZEMI, B. HALES AND A.H. NEIMS, ROCHE DEVELOPMENTAL PHARMACOLOGY UNIT, MCGILL UNIVERSITY, MONTREAL) |
| Active substance: Sulfamethoxazole trimethoprim |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45250 |
| Study title: A COMPARATIVE STUDY OF PARENTERAL AMPICILLIN/SULBACTAM VERSUS CEFTRIAXONE IN THE TREATMENT OF ACUTE BACTERIAL MENINGITIS IN INFANTS AND CHILDREN. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42629 |
| Study title: A COMPARATIVE STUDY OF PARENTERAL AMPICILLIN/SULBACTAM VERSUS CEFOTAXIME IN THE TREATMENT OF ACUTE BACTERIAL MENINGITIS IN INFANTS AND CHILDREN |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42649 |
| Study title: A COMPARATIVE STUDY OF PARENTERAL AMPICILLIN/SULBACTAM VERSUS CEFUROXIME IN THE TREATMENT OF ACUTE BACTERIAL MENINGITIS IN INFANTS AND CHILDREN |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42645 |
| Study title: A COMPARATIVE STUDY OF PARENTERAL AMPICILLIN/SULBACTAM VS AMPICILLIN AND CHLORAMPHENICOL IN THE TREATMENT OF ACUTE BACTERIAL MENINGITIS IN INFANTS AND CHILDREN |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42640 |
| Study title: A COMPARATIVE STUDY OF SBT/AMP IN COMPLICATED URINARY TRACT INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42674 |
| Study title: A COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF PARENTERAL SBT/AMP VS CEFUROXIME IN THE TREATMENT OF GENERAL PEDIATRIC INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42717 |
| Study title: A COMPARISON OF AMPICILLIN PLUS SULBACTAM VERSUS METRONIDAZOLE/GENTAMYCIN IN THE TREATMENT OF GYNECOLOGICAL OR OBSTETRICAL INFECTIONS OF BACTERIAL ETIOLOGY |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42635 |
| Study title: A COMPARISON OF AMPICILLIN PLUS SULBACTAM VERSUS CEFOXITIN IN THE TREATMENT OF GYNECOLOGICAL OR OBSTETRICAL INFECTIONS OF BACTERIAL |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42632 |
| Study title: A COMPARISON OF AMPICILLIN PLUS SULBACTAM VERSUS CEFOXITIN/DOXYCYCLINE OR CLINDAMYCIN/GENTAMICIN IN THE TREATMENT OF GYNECOLOGICAL OR OBSTETRICAL INFECTIONS OF BACTERIAL ETIOLOGY |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42630 |
| Study title: A COMPARISON OF AMPICILLIN PLUS SULBACTAM VERSUS CEFTRIAXONE IN`THE TREATMENT OF SKIN AND/OR SKIN STRUCTURE INFECTIONS (E.G. PERIORBITAL CELLULITIS) AND/OR OSTEOMYELITIS/SUPPURATIVE ARTHRITIS OF BACTERIAL ETIOLOGY IN HOSPITALIZED PEDIATRIC PATS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42641 |
| Study title: A COMPARISON OF AMPICILLIN PLUS SULBACTAM VERSUS CLINDAMYCIN PLUS GENTAMICIN VERSUS CEFOXITIN IN THE TREATMENT OF POST PARTUM ENDOMETRITIS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42651 |
| Study title: A COMPARISON OF AMPICILLIN PLUS SULBACTAM VERSUS CLINDAMYCIN/GENTAMICIN IN THE TREATMENT OF POST CESAREAN SECTION ENDOMETRITIS INFECTIONS OF BACTERIAL ETIOLOGY |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42636 |
| Study title: A COMPARISON OF AMPICILLIN/SULBACTAM PLUS DOXYCYCLINE VERSUS CEFOXITIN/DOXYCYCLINE IN THE TREATMENT OF PELVIC INFLAMMATORY DISEASE OF BACTERIAL ETIOLOGY |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42660 |
| Study title: A COMPARISON OF AMPICILLIN/SULBACTAM VERSUS CEFOTETAN FOR THE PREVENTION OF INFECTION FOLLOWING CESAREAN SECTION IN HIGH RISK PATIENTS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42656 |
| Study title: A COMPARISON OF AMPICILLIN/SULBACTAM VERSUS CEFOXITIN AS EARLY EMPIRIC THERAPY FOLLOWING PENETRATING AND BLUNT TRAUMA TO THE ABDOMEN |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42662 |
| Study title: A COMPARISON OF AMPICILLIN/SULBACTAM VERSUS CEFOXITIN FOR THE PREVENTION OF INFECTION FOLLOWING CESAREAN SECTION IN HIGH RISK PATIENTS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42634 |
| Study title: A COMPARISON OF AMPICILLIN/SULBACTAM VERSUS CEFOXITIN IN THE TREATMENT OF PELVIC INFLAMMATORY DISEASE |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42653 |
| Study title: A COMPARISON OF AMPICILLIN/SULBACTAM VERSUS CLINDAMYCIN/GENTAMICIN IN THE TREATMENT OF POST-CAESAREAN SECTION ENDOMETRITIS INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42667 |
| Study title: A COMPARISON OF AMPICILLIN/SULBACTAM VS CEFAZOLIN OR CEFOTETAN FOR THE PREVENTION OF INFECTION FOLLOWING CESAREAN SECTION IN HIGH RISK PATIENTS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42659 |
| Study title: A COMPARISON OF CEFOBID (CEFOPERAZONE) PLUS SULBACTAM VERSUS PRIMAXIN (IMIPENEN-CILASTATIN) IN THE THERAPY OF FEBRILE NEUTROPENIC PATIENTS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42661 |
| Study title: A COMPARISON OF CEFOPERAZONE PLUS SULBACTAM VERSUS AMIKACIN OR GENTAMICIN PLUS AMPICILLIN AND METRONIDAZOLE IN THE TREATMENT OFPATIENTS WITH AN INTRA-ABDOMINAL INFECTION |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42637 |
| Study title: A COMPARISON OF CEFOPERAZONE PLUS SULBACTAM VERSUS AMPICILLIN PLUS TOBRAMYCIN IN THE TREATMENT OF PATIENTS WITH BILIARY TRACT INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42655 |
| Study title: A COMPARISON OF AMPICILLIN PLUS SULBACTAM VS CLINDAMYCIN PLUS GENTAMICIN VS CEFOXITIN IN THE TREATMENT OF POSTPARTUM ENDOMETRITIS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42627 |
| Study title: A COMPARISON OF CEFOPERAZONE PLUS SULBACTAM VERSUS CEFOTAXIME IN THE TREATMENT OF RECURRENT OR COMPLICATED URINARY TRACT INFECTIONS OF BACTERIAL ETIOLOGY |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42639 |
| Study title: A COMPARISON OF CEFOPERAZONE PLUS SULBACTAM VERSUS PRIMAXIN (IMIPENEM-CILASTATIN) IN THE THERAPY OF FEBRILE NEUTROPENIC PATIENTS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42666 |
| Study title: A COMPARISON OF SULPERAZONE (SULBACTAM/CEFOPERAZONE) VERSUS CEFOBID (CEFOPERAZONE) IN THE TREATMENT OF INTRA ABDOMINAL INFECTIONS OF BACTERIAL ETIOLOGY. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42846 |
| Study title: A DOUBLE-BLIND COMPARATIVE STUDY OF ONCE VS TWICE ADMINISTRATION OF SBT/AMP IV IN THE PROPHYLAXIS OF POST-HYSTERECTOMY GYNECOLOGICAL |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42712 |
| Study title: A MULTICENTER COMPARISON OF 2:1 AMPICILLIN/SULBACTAM (UNASYN) VSCEFUROXIME IN THE TREATMENT OF SKIN AND/OR SKIN STRUCTURE INFEC-TIONS OF BACTERIAL ETIOLOGY IN HOSPITALIZED PEDIATRIC PATIENTS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42646 |
| Study title: A MULTICENTER COMPARISON OF 2:1 AMPICILLIN/SULBACTAM (UNASYN) + OPTIONAL AMINOGLYCOSIDE VS AMPICILLIN AMINOGLYCOSIDE IN THE TREATMENT OF INTRA-ABDOMINAL INFECTIONS OF BACTERIAL ETIOLOGY IN OSPITALIZED PEDIATRIC PATIENTS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42647 |
| Study title: A MULTICENTER STUDY OF 2:1 AMPICILLIN/SULBACTAM (UNASYN) IN THE TREATMENT OF PERIORBITAL/PRESEPTAL AND FACIAL CELLULITIS OF BACTERIAL ETIOLOGY IN HOSPITALIZED PEDIATRIC PATIENTS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42648 |
| Study title: A NON-COMPARATIVE STUDY OF UNASYN IM/IV (SULBACTAM/AMPICILLIN) ADMINISTERED INTRAVENOUSLY FOR THE TREATMENT OF COMMUNITY ACQUIRED INFECTIONS. A MULTICENTER TRIAL. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42737 |
| Study title: A NON-COMPARATIVE STUDY TO ASSESS THE EFFICACY AND SAFETY OF SULBACTAM/ AMPICILLIN IN PEDIATRIC PATIENTS IN BACTERIAL INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42723 |
| Study title: A once a day antimicrobial therapy. Teicoplanin and ceftriaxone in the treatment of febrile neutropenic children with acute leukaemia. - Schaison, G ., Leverger, G ., Artel, G ., Pecking, D. -28th Interscience Conference on Antimicrobial Agents and Chemotherapy, Los Angeles 1988 ; 23-26 October : 33.A once a day antimicrobial therapy. Teicoplanin and ceftriaxone in the treatment of febrile neutropenic children with acute leukaemia. - Schaison, G ., Leverger, G ., Artel, G ., Pecking, D. -28th Interscience Conference on Antimicrobial Agents and Chemotherapy, Los Angeles 1988 ; 23-26 October : 33. |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44323 |
| Study title: CES for MA renewal in Austria - Bruno Verdoncq - 28 February 2007 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44290 |
| Study title: Clinical and pharmacokinetic study of teicoplanin in children. - Kafetsis DA, Tspra H, Gianacopoulou C, Karamitsos S. -(Abstract) In: Abstract book of the 15th international congress of chemotherapy. Istanbul, 19-24 July 1987:322. |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44304 |
| Study title: Dagan R, Einhorm M, Howard CB, Williams AH. Outpatient and inpatient teicoplanin treatment for serious grm-positive infections in children. Pediatr Infedt Dis J 1993; 12 (6/2): S 17-S 20. |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44311 |
| Study title: A NONCOMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF PARENTERAL SBT/AMP IN THE TREATMENT OF PATIENTS WITH SKIN AND SOFT TISSUE INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42686 |
| Study title: A PLACEBO-CONTROLLED DOUBLE-BLIND PROSPECTIVE STUDY OF THE EFFICACY OF UNASYN IN MANAGING PRETERM PREMATURE RUPTURE OF THE MEMBRANES |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42663 |
| Study title: A PROSPECTIVE, RANDOMIZED, EVALUATION OF AMPICILLIN/SULBACTAM VS CLINDAMYCIN/GENTAMICIN FOR TREATMENT OF CHORIOAMNIONITIS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42668 |
| Study title: A RANDOMIZED, COMPARATIVE TRIAL OF CEFOPERAZONE/SULBACTAM VS. CEFTAZIDIME VS. PRIMAXIN FOR THE TREATMENT OF INSTITUTIONALLY ACQUIRED DISEASES |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42654 |
| Study title: AMPICILLIN/SULBACTAM VERSUS PLACEBO FOR THE INHIBITION OF PREMATURE LABOR OF PATIENTS ON TOCOLYSIS AND IN THE PROLONGATION OF THE LATENT PERIOD AFTER PREMATURE RUPTURE OF THE FETAL MEMBRANES |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42650 |
| Study title: AN OPEN COMPARATIVE PERIOPERATIVE PROPHYLAXIS STUDY OF SULBACTAM/ AMPICILLIN IN SINGLE DOSE VS. PROCAINE PENICILLIN PLUS CHLORAMPHENICOL IN PATIENTS WHO UNDERGO CAESAREAN SECTION |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42711 |
| Study title: AN OPEN COMPARATIVE STUDY OF SBT/CFP VS. CEFTAZIDIME PLUS AMIKACIN IN THE TREATMENT OF NEUTROPENIC PATIENTS WITH FEVER. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42867 |
| Study title: AN OPEN COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF PARENTERAL SBT/AMP VS CEFOTAXIME IN THE TREATMENT OF GENERAL PEDIATRIC INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42690 |
| Study title: AN OPEN EVALUATION OF SULBACTAM/AMPICILLIN IN THE MANAGEMENT OF CEREBRO-SPINAL MENINGITIS EMPIDERMICA. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42757 |
| Study title: AN OPEN MULTICENTER STUDY OF SBT/CFP (1:2) IN THE TREATMENT OF PATIENTS WITH MODERATE TO SEVERE ABDOMINAL INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42871 |
| Study title: AN OPEN MULTICENTER STUDY OF SULBACTAM/CEFOPERAZONE (1:2) IN THE TREATMENT OF PEDIATRIC PATIENTS WITH MODERATE OR SEVERE BACTERIAL INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42870 |
| Study title: AN OPEN MULTICENTRIC STUDY OF SULBACTAM/CEFOPERAZONE (1:2) IN THE TREATMENT OF PATIENTS WITH INTRAHOSPITALARY PNEUMONIA. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42862 |
| Study title: AN OPEN MULTICENTRIC STUDY OF SULPERAZONE (SULBACTAM/CEFOPERAZONE 1:2) IN THE TREATMENT OF PATIENTS WITH INTRAHOSPITALARY PNEUMONIA. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42872 |
| Study title: AN OPEN NON COMPARATIVE STUDY OF PARENTERAL SULBACTAM/AMPICILLIN IN THE TREATMENT OF MIXED AEROBIC/ANAEROBIC INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42722 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF EFFICACY AND SAFETY OF SBT/AMP PARENTERAL IN THE TREATMENT OF GENERAL PEDIATRIC INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42731 |
| Study title: An open non-comparative study of Sulbactam plus Ampicillin in Serious Infections in Paediatric Patients |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42874 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF SULBACTAM/AMPICILLIN I.V. IN THE TREATMENT OF HOSPITALIZED INFECTION PATIENTS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42707 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF SULBACTAM/AMPICILLIN I.V. IN THE TREATMENT OF INTRA ABDOMINAL INFECTION |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42710 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF SULBACTAM/CEFOPERAZONE (1:1) IN THE EMPIRICAL TREATMENT OF MODERATE TO SEVERE SYSTEMIC INFECTION IN ADULT PATIENTS IN HOSPITAL |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42866 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IM/IV SBT/CFP IN THE TREATMENT OF URINARY TRACT INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42850 |
| Study title: Bacopoulou, 2009;Netilmicin in the neonate: pharmacokinetic analysis and influence of parenteral nutrition Pharm World Sci (2009) 31:365–368 DOI 10.1007/s11096-009-9278-z |
| Active substance: NETILMICIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32622 |
| Study title: Bouissou, 2008; PEDIATRICS (ISSN Numbers: Print, 0031-4005; Online, 1098-4275).Prospective, Randomized Trial Comparing Short and Long Intravenous Antibiotic Treatment of Acute Pyelonephritis in Children: Dimercaptosuccinic Acid Scintigraphic Evaluation at 9 Months |
| Active substance: NETILMICIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32619 |
| Study title: Comparison of 5 milligrams of netilmicin per kilogram of body weight once daily versus 2 milligrams per kilogram thrice daily for treatment of gram-negative pyelonephritis in children; publication from american society for microbiology "antimicrobial agents and chemotherapy, july 1992, p 1499-1503, vol 36, No 7. |
| Active substance: NETILMICIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32618 |
| Study title: Contopoulos-Ioannidis et. Al ; PEDIATRICS Vol. 114 No. 1 July 2004 Extended-Interval Aminoglycoside Administration for Children: A Meta-analysis |
| Active substance: NETILMICIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32623 |
| Study title: Optimalisation of Netilmicin dosage based on therapeutic drug monitoring during the first days of life in very pre-term neonates (gestational age 23-32 weeks); MED.WIEKU ROZWOJ.,2009, XIII,4,252-259 |
| Active substance: NETILMICIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32621 |
| Study title: Sherwin, 2008;Individualising netilmicin dosing in neonates. Eur J Clin Pharmacol (2008) 64:1201–1208 DOI 10.1007/s00228-008-0536-0 |
| Active substance: NETILMICIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32620 |
| Study title: Efficacy and tolerability of teicoplanin in treatment of Gram-positive infections in children - Kafetzis D.A., Romeo B. - 20 February 1987 ; Report in Clinical documentation for Marketing Autorisation Application (June 1987) |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY DRC 359.DLI.1077.xls |
| View full study record |
| Document reference: 44291 |
| Study title: Expert Report in Clinical documentation for Marketing Autorisation Application (June 1987): Pharmacokinetic study of teicoplanin in paediatrics after a single dose of 6 mg/kg - Tarral A., Thomson G., Geisert J., Willard D., Monteil H. - 9 February 1987 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44292 |
| Study title: Expert Report on the Clinical documentation for Marketing Authorisation Application - Peter J Lewis - 18 March 1986 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44293 |
| Study title: Expert Report on the Clinical documentation for Marketing Authorisation Application - Peter J Lewis - 9 March 1987 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44309 |
| Study title: Expert Report on the Clinical documentation for Marketing Autorisation Application - Peter J Lewis - 20 November 1989 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44308 |
| Study title: Expert Report on the Clinical documentation for Marketing Autorisation Application - Peter J Lewis - 20 November 1989Expert Report on the Clinical documentation for Marketing Autorisation Application - Peter J Lewis - 20 November 1989 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44314 |
| Study title: Expert Report to amend therapeutic indications: Treatment of neonates - Haydn Clifford Cash - April 1992 amended July 1992 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44294 |
| Study title: Expert Report to amend therapeutic indications: Treatment of paediatric patients - Roscigno G. - 28 June 1991 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44295 |
| Study title: Open Study on teicoplanin efficacy and tolerability for the treatment of gram-positive infection in children. (Abstract) In: Abstracts of the 17th international congress of chemotherapy.- Careddu P, Boccazzi A, Mosconi G. - Berlin, 23-28 June 1991; Abstract: No. 1259.Open Study on teicoplanin efficacy and tolerability for the treatment of gram-positive infection in children. (Abstract) In: Abstracts of the 17th international congress of chemotherapy.- Careddu P, Boccazzi A, Mosconi G. - Berlin, 23-28 June 1991; Abstract: No. 1259. |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44327 |
| Study title: Efficacy and safety of teicoplanin in the treatment of infections caused by gram-positive cocci. A summary of over 298 cases in France.Efficacy and safety of teicoplanin in the treatment of infections caused by gram-positive cocci. A summary of over 298 cases in France. |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44312 |
| Study title: Open study on the efficacy and tolerability of teicoplanin in the treatment of Gram positive infection in children.Open study on the efficacy and tolerability of teicoplanin in the treatment of Gram positive infection in children. |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44313 |
| Study title: Outpatient and inpatient teicoplanin treatment for serious grm-positive infections in children. - Dagan R, Einhorm M, Howard CB, Williams AH. -Pediatr Infedt Dis J 1993; 12 (6/2): S 17-S 20. |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44305 |
| Study title: Pharmacokinetics of teicoplanin in pediatric patients. - Terragna A, Ferrea G, Loy A et al. (1988). - Antimicrobial Agents and Chemotherapy 32, 1223-1226. |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44307 |
| Study title: Clinical Expertise - Study N° ERI 175 - Pr. Bouletreau - Nov 83 |
| Active substance: PERFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45862 |
| Study title: Clinical Expertise - Study N° ERI 177 - Pefloxacin for infections intensive care - Pr Lhoste - Nov 84 |
| Active substance: PERFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45863 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IMIV SBT/CPZ IN THE TREATMENT OF LOWER RESPIRATORY TRACT INFECTION. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42853 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IMIV SBT/CPZ IN THE TREATMENT OF LOWER RESPIRATORY TRACT INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42855 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IMIV SBT/CPZ IN THE TREATMENT OF LOWER RESPIRATORY TRACT INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42856 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN IMIV IN VARIOUS INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42696 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN IMIV IN VARIOUS INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42738 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN IMIV IN VARIOUS INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42740 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN IMIV IN VARIOUS INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42758 |
| Study title: An Open Non-Comparative Study using a combination of Sulbactam plus Ampicillin or Penicillin G in serious but not life threatening infections in Paediatric Patients |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42873 |
| Study title: AN OPEN NON-COMPARATIVE STUDY, Q COMBINATION OF SULBACTAM SODIUM WITH AMPICILLIN IN SERIOUS INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42625 |
| Study title: AN OPEN NONCOMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IM/IV SULBACTAM/CFP IN THE TREATMENT OF INTRAABDOMINAL INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42860 |
| Study title: AN OPEN NONCOMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF SBT/AMP PARENTERAL FOLLOWED OF ORAL STM FOR THE TREATMENT OF PATIENTS WITH LOWER RESPIRATORY TRACT INFECTIONS INCLUDING BRONCHO-PNEUMONIA AND ASPIRATION PNEUMONIA |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42755 |
| Study title: AN OPEN PLACEBO COMPARATIVE STUDY OF SBT/AMP-IV IN THE PROPHYLAXIS OF POST SURGICAL OBSTETRIC AND GYNECOLOGICAL INFECTIONS. A MULTICENTRIC TRIAL DURATION OF STUDY APP. ONE POST-SURGERY WEEK. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42719 |
| Study title: AN OPEN STUDY OF PARENTERAL SULBACTAM SODIUM/AMPICILLIN. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42624 |
| Study title: AN OPEN, COMPARATIVE STUDY OF SBT/CFP VS. PIPERACILLIN PLUS AMIKACIN IN THE TREATMENT OF NEUTROPENIC PATIENTS WITH FEVER. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42868 |
| Study title: AN OPEN, COMPARATIVE STUDY OF SULBACTAM/CEFOPERAZONE PLUS AMIKACIN VS. CEFTAZIDIME PLUS AMIKACIN (1:2) IN THE TREATMENT OF NEUTROPENIC PATIENTS WITH FEVER. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42863 |
| Study title: AN OPEN, COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF SBT/CPZ (1:1) PLUS AMIKACIN VS CEFTAZIDIME PLUS AMIKACIN IN THE EMPIRIC TREATMENT OF NEUTROPENIC PATIENTS WITH FEVER |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42858 |
| Study title: AN OPEN, NON-COMPARATIVE MULTICENTER STUDY OF SULBACTAM/AMPICILLIN (UNASYN) ADMINISTERED INTRAVENOUSLY FOR THE TREATMENT OF PEDIATRIC INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42751 |
| Study title: AN OPEN, NON-COMPARATIVE MULTICENTER STUDY ON THE EFFICACY AND TOLERABILITY OF SULTAMICILLIN (SULBACTAM/AMPICILLIN) IN THE TREATMENT OF CHILDREN PATIENTS WITH SKIN AND SUBCUTANEOUS TISSUE INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42678 |
| Study title: AN OPEN, NON-COMPARATIVE STUDY IN PARENTERAL SULBACTAM/AMPICILLIN IN CASES OF MIXED AEROBIC/ANAEROB INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42732 |
| Study title: AN OPEN, NON-COMPARATIVE STUDY OF SULBACTAM/AMPICILLIN (UNASYN) ADMINISTERED INTRAVENOUSLY FOR THE TREATMENT OF PEDIATRIC INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42752 |
| Study title: 3. Numbers LC. Clinical experiences with tolnaftate. J Am Podiatry Assoc. 1967 . 3. Numbers LC. Clinical experiences with tolnaftate. J Am Podiatry Assoc. 1967 . |
| Active substance: TOLNAFTATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44826 |
| Study title: 4. Robinson HM, Jr., Raskin J. Tolnaftate, a potent topical antifungal agent. Arch Dermatol. 1965 Apr;91(4):372-6. 4. Robinson HM, Jr., Raskin J. Tolnaftate, a potent topical antifungal agent. Arch Dermatol. 1965 Apr;91(4):372-6. |
| Active substance: TOLNAFTATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44827 |
| Study title: Carpenter WE. Tolnaftate, its effectiveness in pedal mycosis. A preliminary report. J Am Podiatry Assoc. 1966 Dec;56(12):541-6.Jun;57(6):275 Carpenter WE. Tolnaftate, its effectiveness in pedal mycosis. A preliminary report. J Am Podiatry Assoc. 1966 Dec;56(12):541-6.Jun;57(6):275 |
| Active substance: TOLNAFTATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44824 |
| Study title: Jacobs PH. Fungal infections in childhood. Pediatr Clin North Am. 1978 May;25(2):357-70. Jacobs PH. Fungal infections in childhood. Pediatr Clin North Am. 1978 May;25(2):357-70. |
| Active substance: TOLNAFTATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44829 |
| Study title: Canadian experience with Pneumodine ( Pentamidine isethionate) in the treatment of Pneumocystis carinii Pneumonia : A retrospective analysis of the results of patients receiving Pneumodine as emergency treatment during 1986, 1987 and the first half of 1988.Canadian experience with Pneumodine ( Pentamidine isethionate) in the treatment of Pneumocystis carinii Pneumonia : A retrospective analysis of the results of patients receiving Pneumodine as emergency treatment during 1986, 1987 and the first half of 1988. |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45821 |
| Study title: Cardiac arrest after intravenous pentamidine in an infant. Miller H.C. The pediatric infectious disease journal 1993 Aug, Vol :12 (8), p:694-6; ISSN : 0891-3668Cardiac arrest after intravenous pentamidine in an infant. Miller H.C. The pediatric infectious disease journal 1993 Aug, Vol :12 (8), p:694-6; ISSN : 0891-3668 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45822 |
| Study title: Comparison of pentamdine isethionate abd trimethoprim-sulfametoxazole in the treatment of Pneumocystis carinii pneumonia. Walter T. Hughes M.D., Sandor Feldman M.D, Subhash C. Chaudary M.D., Michael J. Ossi M.D., Frederick Cox M.D. and S.K. Sanyal MBBS, Memphis-Tenn. The Journal of Pediatrics Vol 92 N° 2 p. 285-291Comparison of pentamdine isethionate abd trimethoprim-sulfametoxazole in the treatment of Pneumocystis carinii pneumonia. Walter T. Hughes M.D., Sandor Feldman M.D, Subhash C. Chaudary M.D., Michael J. Ossi M.D., Frederick Cox M.D. and S.K. Sanyal MBBS, Memphis-Tenn. The Journal of Pediatrics Vol 92 N° 2 p. 285-291 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45823 |
| Study title: Isethionate de pentamidine Poudre pour usage parentéral dosée à 200 et 300 mg - Documentation clinique - Synthèse bibliographique - Aout 1987.Isethionate de pentamidine Poudre pour usage parentéral dosée à 200 et 300 mg - Documentation clinique - Synthèse bibliographique - Aout 1987. |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45824 |
| Study title: Iséthionate de pentamidine Poudre pour usage parentéral dosée à 200 et 300 mg - Rapport d'expert concernant la documentation clinique - R. Woehrle - 20 Mai 1988Iséthionate de pentamidine Poudre pour usage parentéral dosée à 200 et 300 mg - Rapport d'expert concernant la documentation clinique - R. Woehrle - 20 Mai 1988 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45825 |
| Study title: Pentamidine isethionate in the treatment of Pneumocystis carinii pneumonia. Karl A. Western, M.D., David R., Perera, M.D. and Myrong G. Schultz, D.V.M, M.D. Annals of Internal Medicine 73 : 695-702, 1970Pentamidine isethionate in the treatment of Pneumocystis carinii pneumonia. Karl A. Western, M.D., David R., Perera, M.D. and Myrong G. Schultz, D.V.M, M.D. Annals of Internal Medicine 73 : 695-702, 1970 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45826 |
| Study title: Weisse−M−E et al. Fever response to acetaminophen in viral vs. bacterial infections. {Pediatr−Infect−Dis−J}, Dec 1987, vol. 6, no. 12, p. 1091−4Weisse−M−E et al. Fever response to acetaminophen in viral vs. bacterial infections. {Pediatr−Infect−Dis−J}, Dec 1987, vol. 6, no. 12, p. 1091−4 |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45765 |
| Study title: Pentamidine-induced hypoglycemia in patients with the acquired immune deficiency syndrome. Celijne M. Stahl-Baylis, M.D. Concetta M.Kalman, R.N., and Oscar L. Laskin, M.D. NY. Clin. Pharmacol. Ther. March 1986Pentamidine-induced hypoglycemia in patients with the acquired immune deficiency syndrome. Celijne M. Stahl-Baylis, M.D. Concetta M.Kalman, R.N., and Oscar L. Laskin, M.D. NY. Clin. Pharmacol. Ther. March 1986 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45827 |
| Study title: Pneumocystis carinii pneumonia and altered host resistance : treatement of one patient with pentamidine isethionate. Patterson, J.H. , Lindsey, I.L., Edwards, E.S. and Logan Jr., W.D. (1966) Pediatrics 38:388-397Pneumocystis carinii pneumonia and altered host resistance : treatement of one patient with pentamidine isethionate. Patterson, J.H. , Lindsey, I.L., Edwards, E.S. and Logan Jr., W.D. (1966) Pediatrics 38:388-397 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45828 |
| Study title: Pneumocystis carinii pneumonia and congenital hypogammaglobulinaemia. W.C. Marshall, H.J. Weston and Martin Bodian. Archives of Disease in Childhood, 1964, 39, 18.Pneumocystis carinii pneumonia and congenital hypogammaglobulinaemia. W.C. Marshall, H.J. Weston and Martin Bodian. Archives of Disease in Childhood, 1964, 39, 18. |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45829 |
| Study title: Pneumocystis carinii pneumonia associated with hypogammaglobulinaemia responding to pentamidine. Rodgers T.S., Haggie M.H.K. The Lancet, May 9, 1964, p.1042Pneumocystis carinii pneumonia associated with hypogammaglobulinaemia responding to pentamidine. Rodgers T.S., Haggie M.H.K. The Lancet, May 9, 1964, p.1042 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45830 |
| Study title: Pneumocystis carinii pneumonia in an adopted vietnamese infant. Redman, J.C. (1974) Journal of the American Medical association 230 : 1561-1563Pneumocystis carinii pneumonia in an adopted vietnamese infant. Redman, J.C. (1974) Journal of the American Medical association 230 : 1561-1563 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45831 |
| Study title: Pneumocystis carinii pneumonia in children with cancer. Diagnosis and treatment. Johnson, H.D. and Johnson, W.W. (1970). Journal of the American Medical Association 214 : 1067-1073Pneumocystis carinii pneumonia in children with cancer. Diagnosis and treatment. Johnson, H.D. and Johnson, W.W. (1970). Journal of the American Medical Association 214 : 1067-1073 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45832 |
| Study title: Rapport d'expert sur la documentation pharmacologie humaine et clinique : Dr. F. Pichon - Juin 1989Rapport d'expert sur la documentation pharmacologie humaine et clinique : Dr. F. Pichon - Juin 1989 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45833 |
| Study title: Successful treatment of Pneumocystis carinii pneumonitis in a patient with congenital hypogammaglobulinaemia. Robbins, J.B., Miller, R.H.; Arean, V.M. and Pearson , H.A. (1965). New England Journal of Medicine 272:708-713Successful treatment of Pneumocystis carinii pneumonitis in a patient with congenital hypogammaglobulinaemia. Robbins, J.B., Miller, R.H.; Arean, V.M. and Pearson , H.A. (1965). New England Journal of Medicine 272:708-713 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45834 |
| Study title: Treatment of Pneumocystis carinii in children. Lipson, A., Marshall, W.C., and Hayward, A.R. (1977) Archives of disease in childhood 52 : 314-319Treatment of Pneumocystis carinii in children. Lipson, A., Marshall, W.C., and Hayward, A.R. (1977) Archives of disease in childhood 52 : 314-319 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45835 |
| Study title: Treatment of Pneumocystis carinii pneumonia in infancy Ivady, G. and Paldy, L. (1976). National Cancer Institute Monograph 43:201-208Treatment of Pneumocystis carinii pneumonia in infancy Ivady, G. and Paldy, L. (1976). National Cancer Institute Monograph 43:201-208 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45836 |
| Study title: 23.) Use of Woben- zym for pseudo- tuberculosis and yersiniosis of children |
| Active substance: Pancreatin Papain (HERB) Rutosid • 3 H2O Bromelain (HERB) Trypsin Chymotrypsin Amylase Lipase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40111 |
| Study title: Antibiotherapie prophylactique de l'enfant - Herrault A. - 1966 (Ann. Pédiatr., 13 (5) 368 - 371)Antibiotherapie prophylactique de l'enfant - Herrault A. - 1966 (Ann. Pédiatr., 13 (5) 368 - 371) |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45873 |
| Study title: Comment je traite un R.A.A. de l'enfant - 1973 (Gaz. Méd., 80, (3), 345 - 352)Comment je traite un R.A.A. de l'enfant - 1973 (Gaz. Méd., 80, (3), 345 - 352) |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45874 |
| Study title: En présence des angines de l'enfant - Carrier A. - 1976 (Méd. Gén. 2 (4) 33-36)En présence des angines de l'enfant - Carrier A. - 1976 (Méd. Gén. 2 (4) 33-36) |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45875 |
| Study title: Essai clinique en pédiatrie d'une forme sirop de pénicilline: l'Oracilline sirop - Verger P. & Guillard J. M. - 1967 (J. Méd. Bordeaux, (12) 1903 - 1908)Essai clinique en pédiatrie d'une forme sirop de pénicilline: l'Oracilline sirop - Verger P. & Guillard J. M. - 1967 (J. Méd. Bordeaux, (12) 1903 - 1908) |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45876 |
| Study title: Evaluer l'acceptabilité et la tolérance clinique de la nouvelle formule d'Oracilline suspension buvable, dosée à 250.000 Unités par cuillère-doseuse de 5 ml, auprès d'une population de nourrissons et de jeunes enfants - Pr Y. Castel, Dr Y. Fryda - 1985 à 1986 (résumé du compte-rendu d'essai clinique)Evaluer l'acceptabilité et la tolérance clinique de la nouvelle formule d'Oracilline suspension buvable, dosée à 250.000 Unités par cuillère-doseuse de 5 ml, auprès d'une population de nourrissons et de jeunes enfants - Pr Y. Castel, Dr Y. Fryda - 1985 à 1986 (résumé du compte-rendu d'essai clinique) |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45877 |
| Study title: Evaluer l'acceptabilité et la tolérance clinique de la nouvelle formule d'Oracilline suspension buvable, dosée à 250.000 Unités par cuillère-doseuse de 5 ml, auprès d'une population de nourrissons et de jeunes enfants - Pr Y. Castel, Dr Y. Fryda - 1985 à 1986 (résumé du compte-rendu d'essai clinique)Evaluer l'acceptabilité et la tolérance clinique de la nouvelle formule d'Oracilline suspension buvable, dosée à 250.000 Unités par cuillère-doseuse de 5 ml, auprès d'une population de nourrissons et de jeunes enfants - Pr Y. Castel, Dr Y. Fryda - 1985 à 1986 (résumé du compte-rendu d'essai clinique) |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45889 |
| Study title: [A multicenter randomized study of fusidic acid ophthalmic gel and rifamycine eyedrops in acute conjunctivitis]. [Article in French]. Adenis J P, Arrata M, Gastaud P, Limon S, Massin M. J. Fr Ophtalmol 1989; 12(4): 317-322 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48449 |
| Study title: A multicentre, randomised, investigator-blind, parallel group study to compare efficacy and safety of Fucithalmic® with chloramphenicol. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48445 |
| Study title: A multicentre, randomised, investigator-blind, parallel group study to compare efficacy and safety of Fucithalmic® with chloramphenicol. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48446 |
| Study title: A multicentre, randomised, investigator-blind, parallel group study to compare Efficacy and safety of Fucithalmic® with norfloxacin 0.3% |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48447 |
| Study title: A multicentre, randomised, investigator-blind, parallel group study to compare efficacy and safety of Fucithalmic® with rifamycin 1%Arrata et al |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48453 |
| Study title: A multicentre, randomised, open, parallel group study to compare clinical and bacteriological effect as well as safety and acceptability of Fucithalmic® with Minims® eye drops in neonates with a clinical diagnosis of acute conjonctivitis. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48442 |
| Study title: A multicentre,randomised, controlled, parallel group study to compare efficacy and safety of Fucithalmic® with ofloxacin 0.3%. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48444 |
| Study title: A multicentre,randomised, open-label, parallel group study to compare efficacy and safety of Fucithalmic® with tobramycin 0.3%. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48443 |
| Study title: A single centre, randomised, single-blind, parallel group study to compare efficacy and safety of Fucithalmic® compared with chloramphenicol |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48448 |
| Study title: An open label study to compare efficacy and safety of Fucithalmic® with chloramphenicol. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48455 |
| Study title: An open label study to compare efficacy and safety of Fucithalmic® with Fucidin® eye drop.J. Hvidberg |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48451 |
| Study title: An open label, randomised study to compare efficacy and safety of Fucithalmic® with neosporin.Yacinto U Dy, Llacco, Int. J. of clinical practices, Vol 7., No. 3., 1991 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48450 |
| Study title: An open randomised study to compare efficacy and safety of Fucithalmic® with chloramphenicolPetounis AD. 4th Mediterranean congress of chemotherapy 1984 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48458 |
| Study title: An open randomised study to compare efficacy and safety of Fucithalmic® with neosporin.Yacinto U Dy, Llacco Int. J. of clinical practices, Vol 7., No. 3., 1991 82 pts (4-75) |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48461 |
| Study title: Effects of fusidic acid on staphylococcal keratitis. Tabbara. British jounal Ophthalmology, Vol 73, issue 2 1989 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48462 |
| Study title: Efficacy and safety of Fucithalmic® compared with chloramphenicolHørven I |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48460 |
| Study title: Efficacy and tolerability of Fucidin® eye dropThanpaichitra |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48454 |
| Study title: Efficacy and tolerability of Fucithalmic®P. M. Møller |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48452 |
| Study title: 8.) An open pilot clinical trial Woben- zym for imporvement of treatment results in resistant and complicated case of pulmonary tuberculo- sis |
| Active substance: Pancreatin Papain (HERB) Rutosid • 3 H2O Bromelain (HERB) Trypsin Chymotrypsin Amylase Lipase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40100 |
| Study title: L'angine aiguë de l'enfant. Son traitement curatif et préventif. Boissiere H. - 1976 (Concours méd., 98 (46) 7437 - 7441)L'angine aiguë de l'enfant. Son traitement curatif et préventif. Boissiere H. - 1976 (Concours méd., 98 (46) 7437 - 7441) |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45879 |
| Study title: L'antibiotherapie dans le rhumatisme de l'enfant. 4ème Conférence internationale des maladies rhumatismales - Mozziconacci P. & Gautier M. - 1964 (Les Thérapeutiques médicales des affections rhumatismales. Grenoble, Edit. Imprimerie générale pp. 157 - 176)L'antibiotherapie dans le rhumatisme de l'enfant. 4ème Conférence internationale des maladies rhumatismales - Mozziconacci P. & Gautier M. - 1964 (Les Thérapeutiques médicales des affections rhumatismales. Grenoble, Edit. Imprimerie générale pp. 157 - 176) |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45880 |
| Study title: Fucithalmic in acute conjunctivitis. Open, randomized comparison of fusidic acid, chloramphenicol and framycetin eye drops.Dirdal M. Acta Ophthalmol 1987; 65: 129-133. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48456 |
| Study title: Fusidic acid in infections of the external eye.Bijsterveld O.P. van 1987, Infection, 15: 16-19 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48457 |
| Study title: The document describes a West German trial. 337 patients . 90 patients were under the age of 10, 63 patients aged 11-20. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28676 |
| Study title: Levron JC, Chwetzoff E, Stephan P, Gluckman DR. Etude des concentrations plasmatiques de L'itraconazole en traitement prophylactique des greffes de moelle, pendant 5 semaines.Rapport de recherche clinique, May 1986. (12-42 years, LMD51161)Levron JC, Chwetzoff E, Stephan P, Gluckman DR. Etude des concentrations plasmatiques de L'itraconazole en traitement prophylactique des greffes de moelle, pendant 5 semaines.Rapport de recherche clinique, May 1986. (12-42 years, LMD51161) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30810 |
| Study title: Effectiveness of Mass Oral Cholera Vaccination in Beira, Mozambique, published in New England Journal Med in Feb 2005 |
| Active substance: oral cholera vaccine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41502 |
| Study title: Comparison of cefuroxime axetil and phenoxymethyl penicillin for the treatment of children with solitary erythema migrans. Arnez M, Radsel-Medvescek A, Pleterski-Rigler D, Fuzic-Sablijic E, Strle F.Wien Klin Wochenschr (1999) 111/22-23: 916-922.Comparison of cefuroxime axetil and phenoxymethyl penicillin for the treatment of children with solitary erythema migrans. Arnez M, Radsel-Medvescek A, Pleterski-Rigler D, Fuzic-Sablijic E, Strle F.Wien Klin Wochenschr (1999) 111/22-23: 916-922. |
| Active substance: PENICILLAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33841 |
| Study title: L'antibiotherapie dans le rhumatisme de l'enfant. 4ème Conférence internationale des maladies rhumatismales - Mozziconacci P. & Gautier M. - 1964 (Les Thérapeutiques médicales des affections rhumatismales. Grenoble, Edit. Imprimerie générale pp. 157 - 176)L'antibiotherapie dans le rhumatisme de l'enfant. 4ème Conférence internationale des maladies rhumatismales - Mozziconacci P. & Gautier M. - 1964 (Les Thérapeutiques médicales des affections rhumatismales. Grenoble, Edit. Imprimerie générale pp. 157 - 176) |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45890 |
| Study title: La scarlatine - Bastin R. & Pechere J. C. - 1966 (Presse méd., 74 (34) 1773.La scarlatine - Bastin R. & Pechere J. C. - 1966 (Presse méd., 74 (34) 1773. |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45878 |
| Study title: Pharmacologic evaluation of orally administered antibiotics in infants and children: effect of feeding on bioavailability - Mc Cracken G. H, Jr, Ginsburb Ch. M., Clahsen J.C. & Thomas M. L. - 1978 (Pediatrics, 62 (5) 738 - 743, 10 réf.)Pharmacologic evaluation of orally administered antibiotics in infants and children: effect of feeding on bioavailability - Mc Cracken G. H, Jr, Ginsburb Ch. M., Clahsen J.C. & Thomas M. L. - 1978 (Pediatrics, 62 (5) 738 - 743, 10 réf.) |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45881 |
| Study title: Prophylaxie de la scarlatine dans les collectivités - Vilde J. C. - 1978 (Gaz. Méd. Fr., 85 (35) 4103)Prophylaxie de la scarlatine dans les collectivités - Vilde J. C. - 1978 (Gaz. Méd. Fr., 85 (35) 4103) |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45882 |
| Study title: Randomized, multicenter open study comparing the efficacy of potassium-phenoxymethylpenicillin V three times daily for 10 days versus benzathine penicillin V twice daily for 5 days in the treatment of acute group A ß-hemolytic streptococcal tonsillopharyngitis in children |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45891 |
| Study title: Randomized, multicenter pilot study comparing the efficacy of potassium-phenoxymethylpenicillin granules for oral suspension 100.000 IU /kg/day tid for 10 days versus benzathine-phenoxymethylpenicillin suspension 100.000 IU /kg/day bid for 7 days versus benzathine-phenoxymethylpenicillin suspension 100.000 IU /kg/day bid for 5 days in the treatment of acute group A ß-hemolytic streptococcal tonsillopharyngitis in children |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45872 |
| Study title: Résultats et accidents de la prophylaxie par la pénicilline - Dagonet (Y.) & Gautier (M.) - 1969 (Journées parisiennes de Pédiatrie, 1 volume, Editions médicales Flammarion, p. 417 - 434)Résultats et accidents de la prophylaxie par la pénicilline - Dagonet (Y.) & Gautier (M.) - 1969 (Journées parisiennes de Pédiatrie, 1 volume, Editions médicales Flammarion, p. 417 - 434) |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45883 |
| Study title: Streptococcal infection in pediatric patients. Comparison of dicloxacillin with phenoxymethyl penicillin - Aronovitz (G. H.), Morgan (D. L.) & Spitzer (T. Q.) - 1968 (Amer. J. Dis. Child., 116, 66-69, July).Streptococcal infection in pediatric patients. Comparison of dicloxacillin with phenoxymethyl penicillin - Aronovitz (G. H.), Morgan (D. L.) & Spitzer (T. Q.) - 1968 (Amer. J. Dis. Child., 116, 66-69, July). |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45884 |
| Study title: Table ronde sur l'infection streptococcique - Mozziconacci (P.) - 1969 (Journées parisiennes de Pédiatrie, 1 volume, Editions médicales Flammarion, p. 381 - 388)Table ronde sur l'infection streptococcique - Mozziconacci (P.) - 1969 (Journées parisiennes de Pédiatrie, 1 volume, Editions médicales Flammarion, p. 381 - 388) |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45885 |
| Study title: Traitement des angines aiguës de l'enfant - De Paillerets F., Rivron M. & Boussangant Y. - 1977 (Rev. Prat., 27 (59) 4129 - 4132)Traitement des angines aiguës de l'enfant - De Paillerets F., Rivron M. & Boussangant Y. - 1977 (Rev. Prat., 27 (59) 4129 - 4132) |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45886 |
| Study title: Un R.A.A. de l'enfant. Hambourg M. - 1973 (Gaz. Méd. France, 80 (3) 345 - 352)Un R.A.A. de l'enfant. Hambourg M. - 1973 (Gaz. Méd. France, 80 (3) 345 - 352) |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45887 |
| Study title: Utilisation de l'Oricilline en pédiatrie - Pennaforte F. & Pennaforte M. - 1970 (Ann. Méd. Reims, 159 - 165)Utilisation de l'Oricilline en pédiatrie - Pennaforte F. & Pennaforte M. - 1970 (Ann. Méd. Reims, 159 - 165) |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45888 |
| Study title: Oberbaum, M et al.: A Randomized, Controlled Clinical Trial of the Homeopathic Medication Traumeel S in the Treatment of Chemotherapy-Induced Stomatitis in Children Undergoing Stem Cell Transplantation. Cancer 2001;92(3):684-690 [IIT-publication] |
| Active substance: Traumeel - Ampullen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40281 |
| Study title: |
| Active substance: TIAGABINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 38491 |
| Study title: |
| Active substance: TIAGABINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 38492 |
| Study title: |
| Active substance: TIAGABINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 38496 |
| Study title: A Multicentre Open Randomised Parallel-Group Trial of Meropenem versus Ceftoxamine plus Metronidazole in the Treatment of Abdominal Infections |
| Active substance: MEROPENEM TRIHYDRATE |
| Study summary document link (including results): 3591IL0027.xls |
| View full study record |
| Document reference: 31623 |
| Study title: A Single-Blind Randomised Comparative Study of MERREM (Meropenem) Versus Cefotaxime in the Treatment of Acute Bacterial Meningitis in Hospitalised Infants and Children. |
| Active substance: MEROPENEM TRIHYDRATE |
| Study summary document link (including results): 3591IL0065.xls |
| View full study record |
| Document reference: 31621 |
| Study title: Efficacy and tolerability of Meropenem 20 mg/kg tid in infants (3-12 months old) vs meropenem tid in children (1-14 years old) for the initial treatment of severe infections in hospitalised children. |
| Active substance: MEROPENEM TRIHYDRATE |
| Study summary document link (including results): 3591IL9003.xls |
| View full study record |
| Document reference: 31622 |
| Study title: Meropenem versus Ceftazidime plus Amikacin as Empirical Therapy for Fever in Cancer Patients with Granulocytopenia; A Prospective, Randomised, Multicentre Study. |
| Active substance: MEROPENEM TRIHYDRATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31620 |
| Study title: Support for recruitment to Turkish study comparing Merrem with Ceftazidime + Amikacin in the empirical treatment of febrile infective episodes in neutropenic padiatric patients in Latin America. |
| Active substance: MEROPENEM TRIHYDRATE |
| Study summary document link (including results): 3591IL9006.xls |
| View full study record |
| Document reference: 31624 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IV AND/OR PO O.S. FLUCONAZOLE IN THE TREATMENT OF PEDIATRIC PATIENTS WITH SYSTEMIC CANDIDIASIS. THIS IS A COMPASSIONATE TREATMENT. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27374 |
| Study title: A pharmacokinetic study |
| Active substance: TICARCILLIN |
| Study summary document link (including results): Study HP-83-14 Ticarcillin (Timentin).xls |
| View full study record |
| Document reference: 47676 |
| Study title: A Single Dose Study to Define Pharmacokinetic Parameters of Tiagabine HCl in Pediatric Patients with Complex Partial SeizuresEfficiency of pulmonary administration of tobramycin solution for inhalation in cystic fibrosis using an improved drug delivery system. (Chest. 2003 Jan;123(1):28-36) |
| Active substance: TIAGABINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 38533 |
| Study title: A single-blind, tolerability and preliminary efficacy study of tiagabine in children with epilepsyPhase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitis. Protzko E, Bowman L, Abelson M, Shapiro A; AzaSite Clinical Study Group. Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3425-9. |
| Active substance: TIAGABINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 38527 |
| Study title: An open label extension study of safety and efficacy of tiagabine in children with epilepsy |
| Active substance: TIAGABINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 38531 |
| Study title: An Open-Label Extension Study of Tiagabine HCl in the Treatment of Patients with Partial Seizures |
| Active substance: TIAGABINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 38522 |
| Study title: An Open-Label Extension Study of Tiagabine HCl in the Treatment of Pediatric Patients with Partial Seizures |
| Active substance: TIAGABINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 38535 |
| Study title: An open-label study of the safety and efficacy of long-term tiagabine administration in patients with epilepsy3-day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children. Cochereau I, Meddeb-Ouertani A, Khairallah M, Amraoui A, Zaghloul K, Pop M, Delval L, Pouliquen P, Tandon R, Garg P, Goldschmidt P, Bourcier T. Br J Ophthalmol. 2007 Apr;91(4):465-9;Epub 2006 Oct 18. |
| Active substance: TIAGABINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 38528 |
| Study title: Meenan FO. A clinical trial of Tolnaftate in fungus infection of the skin. J Ir Med Assoc. 1967 Dec;60(366):450-2. Meenan FO. A clinical trial of Tolnaftate in fungus infection of the skin. J Ir Med Assoc. 1967 Dec;60(366):450-2. |
| Active substance: TOLNAFTATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44825 |
| Study title: O'Brien JM. Common skin problems of infancy, childhood, and adolescence. Prim Care. 1995 Mar;22(1):99-115. O'Brien JM. Common skin problems of infancy, childhood, and adolescence. Prim Care. 1995 Mar;22(1):99-115. |
| Active substance: TOLNAFTATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44830 |
| Study title: Schwartz RA, Janniger CK. Tinea capitis. Cutis. 1995 Jan;55(1):29-33. Schwartz RA, Janniger CK. Tinea capitis. Cutis. 1995 Jan;55(1):29-33. |
| Active substance: TOLNAFTATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44832 |
| Study title: Theos A. Diagnosis and management of superficial cutaneous fungal infections in children. Pediatr Ann. 2007 Jan;36(1):46-54. Theos A. Diagnosis and management of superficial cutaneous fungal infections in children. Pediatr Ann. 2007 Jan;36(1):46-54. |
| Active substance: TOLNAFTATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44833 |
| Study title: Tong MM, Altman PM, Barnetson RS. Tea tree oil in the treatment of tinea pedis. Friedlander SF, Suarez S. Pediatric antifungal therapy. Dermatol Clin. 1998 Jul;16(3):527-37. Tong MM, Altman PM, Barnetson RS. Tea tree oil in the treatment of tinea pedis. Friedlander SF, Suarez S. Pediatric antifungal therapy. Dermatol Clin. 1998 Jul;16(3):527-37. |
| Active substance: TOLNAFTATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44828 |
| Study title: An open-label study of the safety and efficacy of long-term tiagabine administration in patients with epilepsy unsatisfactorily controlled with other antiepileptic medicationTreatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops. Jackson WB, Low DE, Dattani D, Whitsitt PF, Leeder RG, MacDougall R. Can J Ophthalmol. 2002 Jun;37(4):228-37; discussion 237. |
| Active substance: TIAGABINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 38529 |
| Study title: An Open-Label Study of the Safety of Long-Term Tiagabine HCl Administration in Patients with Epilepsy |
| Active substance: TIAGABINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 38526 |
| Study title: A compassionate Program of Tiagabine HCl in Treatment of Pediatric Patients with Partial Seizures |
| Active substance: TIAGABINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 38536 |
| Study title: Compassionate Use of Tiagabine HCl in Patients with Refractory Epilepsy |
| Active substance: TIAGABINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 38524 |
| Study title: MULTICENTRIC NON-COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF FCA FOR THE TREATMENT OF SEVERE SYSTEMIC CANDIDIASIS AND CRYPTOCOCCAL MENINGITIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28035 |
| Study title: A PROSPECTIVE RANDOMIZED TRIAL OF FCA VS. AMPHOTERICIN B FOR EMPERIC ANTI-FUNGAL THERAPY OF THE NEUTROPENIC FEBRILE PATIENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27986 |
| Study title: A CLINICAL STUDY ENTITLED TIOCONAZOL 6,5% SINGLE DOSE VAGINAL OINTMENT IN THE TREATMENT OF VAGINAL CANDIDASIS (DR. GRIGORIU ET ALL) (MULTICENTER STUDY) |
| Active substance: TIOCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44807 |
| Study title: Randomised, double-blind placebo controlled cross-over study of efficacy and safety of tiagabine as adjunctive treatment of partial seizures in children with epilepsyTreatment with tobramycin solution for inhalation reduces hospitalizations in young CF subjects with mild lung disease. (Pediatr Pulmonol. 2004 Oct; 38(4):314-20) |
| Active substance: TIAGABINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 38532 |
| Study title: Randomised, Double-blind, Placebo-controlled, Parallel-group Study of the Safety and Efficacy of Tiagabine Administered TID as Adjunctive Treatment for Partial Seizures |
| Active substance: TIAGABINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 38525 |
| Study title: Safety and Efficacy of BID and QID Dosing with Tiagabine HCl versus Placebo as Adjunctive Treatment for Partial Seizures |
| Active substance: TIAGABINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 38523 |
| Study title: A Multicentre Study for the Evaluation of the Clinical Efficacy and of Local and General Safety of Tioconazole in the Gynaecological Use |
| Active substance: TIOCONAZOLE |
| Study summary document link (including results): TCN-I-88-004 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 48033 |
| Study title: A Multicentre Study on the Efficacy and Tolerability of 1% Tioconazole Cream in Dermatomycoses |
| Active substance: TIOCONAZOLE |
| Study summary document link (including results): TCN-I-88-004 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 48034 |
| Study title: A NON COMPARATIVE MULTICENTER STUDY OF TIOCONAZOLE 300MG VAGINAL OVULES FO THE SINGLE DOSE TREATMENT OF VAGINAL YEAST INFECTIONS |
| Active substance: TIOCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44806 |
| Study title: A NON-COMPARATIVE MULTICENTER STUDY OF TIOCONAZOLE 100MG VAGINAL OVULES FOR THE TREATMENT OF VAGINAL CANDIDIASIS WITH A 3 DAY COURSE OF THERAPY |
| Active substance: TIOCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44809 |
| Study title: An Open, Non-comparative Study of the Efficacy and Safety of Tioconazole in Neonates and Infants with Candidal Diaper Rash |
| Active substance: TIOCONAZOLE |
| Study summary document link (including results): TCN-TR-94-001A EMA Pediatric Web Synopsis.pdf |
| View full study record |
| Document reference: 48036 |
| Study title: Double-Blind Comparison of the Efficacy, Toleration, and Safety of Tioconazole Base 1% and Tioconazole Base 2% w/w Creams in the Treatment of Patients with Fungal Infection of the Skin |
| Active substance: TIOCONAZOLE |
| Study summary document link (including results): EMEA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 48031 |
| Study title: Double-blind Comparison of the Efficacy, Toleration, and Safety of Tioconazole Hydrochloride 2% w/w and Econazole Nitrate 1% Creams in the Treatment of Patients with Fungal Infection of the Skin or with Erythrasma |
| Active substance: TIOCONAZOLE |
| Study summary document link (including results): 13-1 EMA Pediatric Web Synopsis.pdf |
| View full study record |
| Document reference: 44810 |
| Study title: Efficacy and Safety of Tioconazole in the Treatment of Candidal Diaper Rash |
| Active substance: TIOCONAZOLE |
| Study summary document link (including results): TCN-TR-94-001B EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 48037 |
| Study title: A CLINICAL STUDY ENTITLED TROSID (TIOCONAZOL) SOLUTION. A EFFICACY OPEN LABEL STUDY IN THE TREATMENT OF ONYCHOMYCOSIS (ST. JOHAN´S HOSPITAL FOR DISEASE OF SKIN (LONDON) AND DEPARTMENT OF DERMATOLOGY-UNIVERSITY OF GRALGOW. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 10, 11-115, 1985) |
| Active substance: TIOCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44808 |
| Study title: Efficacy and Tolerability of Dermatologic Tioconazole 1% Cream and Lotion vs Bifonazole 1% Cream and Lotion in the Treatment of Superficial Cutaneous Mycoses |
| Active substance: TIOCONAZOLE |
| Study summary document link (including results): TCN-I-86-004 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 48032 |
| Study title: Efficacy, Safety, and Toleration of a 28% Tioconazole Solution Compared with a 2% Miconazole Tincture in Treatment of Fungal Nail Infection |
| Active substance: TIOCONAZOLE |
| Study summary document link (including results): EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 48030 |
| Study title: OPEN STUDY OF THE EFFICACY AND TOLERATION OF TIOCONAZOLE SINGLE DOSE OINTMENT IN THE TREATMENT OF PATIENTS WITH VAGINAL CANDIDOSIS (PEIOS SWITZERLAND) |
| Active substance: TIOCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44811 |
| Study title: OPEN STUDY OF THE EFFICACY AND TOLERATION OF TIOCONAZOLE SINGLE DOSE OINTMENT IN THE TREATMENT OF PATIENTS WITH VAGINAL CANDIDOSIS (ARTNER AUSTRIA) |
| Active substance: TIOCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44812 |
| Study title: OPEN STUDY OF THE EFFICACY AND TOLERATION OF TIOCONAZOLE SINGLE DOSE OINTMENT IN THE TREATMENT OF PATIENTS WITH VAGINAL CANDIDOSIS (GRANETZNY WEST GERMANY) |
| Active substance: TIOCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44813 |
| Study title: OPEN STUDY OF THE EFFICACY AND TOLERATION OF TIOCONAZOLE SINGLE DOSE OINTMENT IN THE TREATMENT OF PATIENTS WITH VAGINAL CANDIOSIS (DR PEIOS SWITZERLAND) |
| Active substance: TIOCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44814 |
| Study title: Treatment of Dermatomycosis with Tioconazole 2% Dermal Cream |
| Active substance: TIOCONAZOLE |
| Study summary document link (including results): TCN-MEX-87-001 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 48035 |
| Study title: Efficacy of Thiobactin in the treatment of acute non tuberculosis lower respiratory tract infections in children |
| Active substance: THIAMPHENICOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44737 |
| Study title: Safety and Efficacy of Tiagabine HCl Monotherapy in the Treatment for Partial Seizures: High Dose versus Low Dose |
| Active substance: TIAGABINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 38530 |
| Study title: CLINICAL EVALUATION OF DIFLUCAN ON SEVERE CANDIDEMIA |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27536 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS IN HOSPITALIZED PATIENTS IN ICU. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27877 |
| Study title: Safety and Efficacy of Three Dose Levels of Tiagabine HCl versus Placebo as Adjunctive Treatment for Complex Partial Seizures |
| Active substance: TIAGABINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 38521 |
| Study title: Safety and efficacy of Tiagabine HCl in the treatment of Pediatric Patients with Partial Seizures |
| Active substance: TIAGABINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 38534 |
| Study title: EFFICACY AND SAFETY OF FLUCONAZOLE IN PATIENTS WITH OROPHARINGEAL CANDIDIASIS WITHOUT AIDS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27404 |
| Study title: Blood pressure results on patients treated with intravenous Metronidazole (FLAGYL). Study Blood Pressure |
| Active substance: METRONIDAZOLE |
| Study summary document link (including results): Metronidazole STUDY Blood Pressure.xls |
| View full study record |
| Document reference: 47999 |
| Study title: Disposition kinetics of metronidazole in children - AmonI; et al. - 1983 - Publication in Human pharmacological and clinical documentation in support for a change of dosage for prophylaxis and treatment of anaerobic infections. Dose recommendation for use in children also included - 12/1985Disposition kinetics of metronidazole in children - AmonI; et al. - 1983 - Publication in Human pharmacological and clinical documentation in support for a change of dosage for prophylaxis and treatment of anaerobic infections. Dose recommendation for use in children also included - 12/1985 |
| Active substance: METRONIDAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31967 |
| Study title: Metronidazole and anaerobic sepsis. |
| Active substance: METRONIDAZOLE |
| Study summary document link (including results): Metronidazole STUDY Anaerobic sepsis.xls |
| View full study record |
| Document reference: 48002 |
| Study title: Metronidazole FLAGYL injection 0.5% v/v. Adverse reactions. |
| Active substance: METRONIDAZOLE |
| Study summary document link (including results): Metronidazole STUDY Safety Review.xls |
| View full study record |
| Document reference: 48000 |
| Study title: Metronidazole in surgical infections. |
| Active substance: METRONIDAZOLE |
| Study summary document link (including results): Metronidazole STUDY Surgery.xls |
| View full study record |
| Document reference: 47998 |
| Study title: A double-blind comparison study of pivampicillin suspension and cefaclor suspension in the treatment of acute otitis media |
| Active substance: PIVAMPICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46047 |
| Study title: Absorption in children and Infants following oral administration of Pivampicillin; Part of SE/DK expert report. Prof. C simon (Kiel) |
| Active substance: PIVAMPICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46048 |
| Study title: Antibiotics in the treatment of gastroenteritis caused by enteropathgenic E. coliAntibiotics in the treatment of gastroenteritis caused by enteropathgenic E. coli |
| Active substance: PIVAMPICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46050 |
| Study title: Comparative efficacy of mecillinam, mecillinam/ amoxicillin and trimethoprim/ sulfamethazole for treatment of typhoid fever in childrenComparative efficacy of mecillinam, mecillinam/ amoxicillin and trimethoprim/ sulfamethazole for treatment of typhoid fever in children |
| Active substance: PIVAMPICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46051 |
| Study title: Comparative efficacy of pivmecillinam and cotrimoxazole in acute shigellosis in childrenComparative efficacy of pivmecillinam and cotrimoxazole in acute shigellosis in children |
| Active substance: PIVAMPICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46052 |
| Study title: Comparison of long-term, low dose pivmecillinam and nitrofurantoin in the control of recurrent urinary tract infection in childrenComparison of long-term, low dose pivmecillinam and nitrofurantoin in the control of recurrent urinary tract infection in children |
| Active substance: PIVAMPICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46063 |
| Study title: Comparison of pivmecillinam and nalidixic acid in the treatment of acute shigellosis in childrenComparison of pivmecillinam and nalidixic acid in the treatment of acute shigellosis in children |
| Active substance: PIVAMPICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46062 |
| Study title: Efficacy, pharmacology, and safety of amdinocillin in treatment of neonatesEfficacy, pharmacology, and safety of amdinocillin in treatment of neonates |
| Active substance: PIVAMPICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46056 |
| Study title: Long term, low dose treatment with pivmecillinam alone and in combination with pivampicillin in patients prone to recurrent bacteriuria; Barclay R.P.C. et al. 1982, Current medical research and opinion, 8: 82-88 LEO sponsored |
| Active substance: PIVAMPICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46049 |
| Study title: Loracarbef in acute maxiliary sinusitis |
| Active substance: LORACARBEF |
| Study summary document link (including results): Loracarbef - B9U-US-AZDE Synopsis with AE table.pdf |
| View full study record |
| Document reference: 31452 |
| Study title: Loracarbef in pediatric patients with skeletal infections |
| Active substance: LORACARBEF |
| Study summary document link (including results): Loracarbef - B9U-US-AZDD Synopsis with AE table.pdf |
| View full study record |
| Document reference: 31451 |
| Study title: Loracarbef: Multiple dose pharmacokinetics in paediatric patients |
| Active substance: LORACARBEF |
| Study summary document link (including results): Loracarbef - B9U-MC-AZAC Synopsis.pdf |
| View full study record |
| Document reference: 31456 |
| Study title: LY163892 vs Augmentin in otitis media - South Africa |
| Active substance: LORACARBEF |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31457 |
| Study title: LY163892 vs V-Cillin-K in streptococcal pharyngitis/tonsillitis |
| Active substance: LORACARBEF |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31458 |
| Study title: Pharmacokinetics and tissue distribution of metronidazole in the newborn infant - Jager.Roman, E. et al. - 1982 - Publication in Human pharmacological and clinical documentation in support for a change of dosage for prophylaxis and treatment of anaerobic infections. Dose recommandation for use in children also included - 12/1985Pharmacokinetics and tissue distribution of metronidazole in the newborn infant - Jager.Roman, E. et al. - 1982 - Publication in Human pharmacological and clinical documentation in support for a change of dosage for prophylaxis and treatment of anaerobic infections. Dose recommandation for use in children also included - 12/1985 |
| Active substance: METRONIDAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31968 |
| Study title: Publication 12 dans Rapport d'expertise clinique - Rôle thérapeutique du metronidazole dans les infections à bactéries anaérobies (A. Bertrand - 24 mars 1978): Treatment of a brain abscess due to Bacteroides fragilis with metronidazole - George R.H., Bint - 1976Publication 12 dans Rapport d'expertise clinique - Rôle thérapeutique du metronidazole dans les infections à bactéries anaérobies (A. Bertrand - 24 mars 1978): Treatment of a brain abscess due to Bacteroides fragilis with metronidazole - George R.H., Bint - 1976 |
| Active substance: METRONIDAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31969 |
| Study title: Publication: Giardiasis in infant and chidhood - Siavash Kavousi - 1979Publication: Giardiasis in infant and chidhood - Siavash Kavousi - 1979 |
| Active substance: METRONIDAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31970 |
| Study title: Publication: Single-dose treatment of giardiasis in children: a comparison of tinidazole and metronidazole - A.J. Gazder & coll. - 1977Publication: Single-dose treatment of giardiasis in children: a comparison of tinidazole and metronidazole - A.J. Gazder & coll. - 1977 |
| Active substance: METRONIDAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31971 |
| Study title: Schmör 1967 |
| Active substance: METRONIDAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47562 |
| Study title: Single day prophylaxis with metronidazole in infants during abdominal surgery: a pharmacokinetic surgery - Rubenson A., Rosetzsky A. - No date - Publication in Human pharmacological and clinical documentation in support for a change of dosage for prophylaxis and treatment of anaerobic infections. Dose recommandation for use in children also included - 12/1985Single day prophylaxis with metronidazole in infants during abdominal surgery: a pharmacokinetic surgery - Rubenson A., Rosetzsky A. - No date - Publication in Human pharmacological and clinical documentation in support for a change of dosage for prophylaxis and treatment of anaerobic infections. Dose recommandation for use in children also included - 12/1985 |
| Active substance: METRONIDAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31972 |
| Study title: The bacteriology and chemotherapy of otogenic cerebral abscesses. |
| Active substance: METRONIDAZOLE |
| Study summary document link (including results): Metronidazole STUDY Otogenic Cerebral Abcesses.xls |
| View full study record |
| Document reference: 48001 |
| Study title: Rapport d'expertise clinique - Professeur Pierre Benoît - 20/06/1969 |
| Active substance: METRONIDAZOLE AND SPIRAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31973 |
| Study title: Long term, low dose treatment with pivmecillinam alone and in combination with pivampicillin in patients prone to recurrent bacteriuriaLong term, low dose treatment with pivmecillinam alone and in combination with pivampicillin in patients prone to recurrent bacteriuria |
| Active substance: PIVAMPICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46061 |
| Study title: Mecillinam in cerebrospinal fluid in childrenMecillinam in cerebrospinal fluid in children |
| Active substance: PIVAMPICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46057 |
| Study title: Mecillinam in enteric feverMecillinam in enteric fever |
| Active substance: PIVAMPICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46054 |
| Study title: Pharmacokinetics of loracarbef in infants and children |
| Active substance: LORACARBEF |
| Study summary document link (including results): Loracarbef - B9U-MC-AZAN Summary.PDF |
| View full study record |
| Document reference: 31455 |
| Study title: Control of epidemic meningococcal meningitis by mass vaccination. |
| Active substance: Meningococcal polysaccharide vaccine (strains A+C) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47477 |
| Study title: Langer DH, Rapoport JL, Ebert MH, Lake CR, Nee LE. In: Greenhill, LL; Shopsin, B (Eds). The psychobiology of childhood; A Profile of current issues. Lancaster, MTP, 1984. P.197-210.Langer DH, Rapoport JL, Ebert MH, Lake CR, Nee LE. In: Greenhill, LL; Shopsin, B (Eds). The psychobiology of childhood; A Profile of current issues. Lancaster, MTP, 1984. P.197-210. |
| Active substance: MIANSERIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31989 |
| Study title: Prospektiver vergleich von miconazol-gel und nystatin-suspension in der therapie des mundsoorsProspektiver vergleich von miconazol-gel und nystatin-suspension in der therapie des mundsoors |
| Active substance: MICONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31995 |
| Study title: Antibiotics in the treatment of gastroenteritis caused by enteropathgenic E. coli |
| Active substance: MECILLINAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31562 |
| Study title: Comparative study of an acellular (P.M.sv.) and a whole cell (Wellcome) Pertussis vaccines com bined with Diphtheria and Tetanus vaccines in healthy infants according to 2 schedules in the U.K. |
| Active substance: Diphtheria, Tetanus, Acellular Pertussis and inactivated Poliomyelitis Vaccine, adsorbed. |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41410 |
| Study title: Prevention of secondary cases of meningococcal disease in household contacts by vaccination. |
| Active substance: Meningococcal polysaccharide vaccine (strains A+C) |
| Study summary document link (including results): link to document |
| View full study record |
| Document reference: 41274 |
| Study title: Uchida Y. Clinical efficacy of topical lomefloxacin (NY-198) in bacterial infections of the external eye – A multicenter double-blind phase III study. No report date.Uchida Y. Clinical efficacy of topical lomefloxacin (NY-198) in bacterial infections of the external eye – A multicenter double-blind phase III study. No report date. |
| Active substance: LOMEFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31382 |
| Study title: Susceptibility to antifungal agents of Candida species isolated from paediatric and adult patients with haematological diseases; U. Nawrot, J. Nowicka, K. Juszczak and B. Gusin; 2005 Mycoses, 48, 385–390Susceptibility to antifungal agents of Candida species isolated from paediatric and adult patients with haematological diseases; U. Nawrot, J. Nowicka, K. Juszczak and B. Gusin; 2005 Mycoses, 48, 385–390 |
| Active substance: MICONAZOLE |
| Study summary document link (including results): nawrot_miconazole.pdf |
| View full study record |
| Document reference: 47618 |
| Study title: Treatment of oropharyngeal candidiasis and candidal diaper dermatitis in neonates and infants: review and reappraisalTreatment of oropharyngeal candidiasis and candidal diaper dermatitis in neonates and infants: review and reappraisal |
| Active substance: MICONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31997 |
| Study title: Phase I trial of the effectiveness and safety of loperamide oxide in the treatment of diarrhoea resulting from different pathophysiological mechanisms (12-75 yrs) |
| Active substance: LOPERAMIDE AND SIMETICONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31448 |
| Study title: |
| Active substance: MEROPENEM TRIHYDRATE |
| Study summary document link (including results): 3591IL0020 21 22.xls |
| View full study record |
| Document reference: 31625 |
| Study title: |
| Active substance: MEROPENEM TRIHYDRATE |
| Study summary document link (including results): 3591IL0045.xls |
| View full study record |
| Document reference: 45255 |
| Study title: |
| Active substance: MEROPENEM TRIHYDRATE |
| Study summary document link (including results): 3591US0001.xls |
| View full study record |
| Document reference: 45256 |
| Study title: |
| Active substance: MEROPENEM TRIHYDRATE |
| Study summary document link (including results): 3591IL0062.xls |
| View full study record |
| Document reference: 45257 |
| Study title: |
| Active substance: MEROPENEM TRIHYDRATE |
| Study summary document link (including results): 3591US0013.xls |
| View full study record |
| Document reference: 45258 |
| Study title: |
| Active substance: MEROPENEM TRIHYDRATE |
| Study summary document link (including results): 1946600600.xls |
| View full study record |
| Document reference: 45259 |
| Study title: A survey of the side effects of midecamycin acetate (Miocamycin) dry syrup after marketing - T. Mayama, K. Maruyama, T. Nakazawa and M. Iida - International journal of clinical Pharmacology, therapy and toxicology, vol.28 nr6 - 1990 (245-250) |
| Active substance: MIDECAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32012 |
| Study title: Comparison of Miocamycin versus Amoxicillin in lower respiratory tract infections in children. Clinical response and effect on natural killer activity - C. Agostini et al. - Journal Internat. Medical Research 1988, 16; 305-311 |
| Active substance: MIDECAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32016 |
| Study title: Effect of Miocamycin on theophylline kinetics in children - N. Principi, J. Onorato, M.G. Guiliani, and A. Vigano - Eur. J. Clin Pharmacol (1987)31:701-704 |
| Active substance: MIDECAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32010 |
| Study title: La miocamicina nel tratamento di infezione delle vie aeree in pazienti di età pediatrica - N. Principi, P. Marchisio, J. Onorato - G. Ital. Chemioter., 33, 129-134, 1986 |
| Active substance: MIDECAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32015 |
| Study title: Studio comparativo tra miocamicina ed eritromicina nell'erradicazione di streptococco B-emolitico di Gruppo a ed influenza di miocamicina sulla fagocitosi dei polimorfonucleati verso streptococco autologo - M. Borzani, F. Varotto, L.Garlaschi, et al. - Riv. Inf. Ped. 1989, 1, 29-35 |
| Active substance: MIDECAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32014 |
| Study title: Studio multicentrico sulla faringotonsillite in età pediatrica - P. Marchisio, A. Calanchi, J. Onorato, A. Plebani, E. Reali, L. Rancilio, E. Grasso, L. Magni, G. Caramia, et al. - Riv. Inf. Ped. (1989), 4, 239-249 |
| Active substance: MIDECAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32011 |
| Study title: Studio preliminare sulla Farmacocinetica della miocamicina nell'età pediatrica - L. Tarani, A. Teggi, L. Bruni, et al Riv. Inf. Ped. 1989, 4, 251-255 |
| Active substance: MIDECAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32013 |
| Study title: Upper respiratory tract infections in children: Antibiotic treatment - Marchisio P., Principi, N. - Drugs Exptl. Clin. Res. XIII(9) 585-588 (1987) |
| Active substance: MIDECAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32017 |
| Study title: A Comparative Trial of a Loperamide and Simethicone Combination Product vs Loperamide Alone, Simethicone Alone and Placebo in the Treatment of Acute Diarrhea With Gas-Related Abdominal Discomfort |
| Active substance: LORACARBEF |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31459 |
| Study title: Lorabid in acute otitis media: 10-day vs 5-day therapy |
| Active substance: LORACARBEF |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31453 |
| Study title: Lorabid in acute otitis media: 10-day vs 5-day therapy |
| Active substance: LORACARBEF |
| Study summary document link (including results): Loracarbef - B9U-MC-AZAZ aCSR redacted.PDF |
| View full study record |
| Document reference: 31454 |
| Study title: Loracarbef concentration in sinus secretions/mucosa in children |
| Active substance: LORACARBEF |
| Study summary document link (including results): Loracarbef - B9U-MC-AZCX Synopsis.pdf |
| View full study record |
| Document reference: 31450 |
| Study title: COMPARISON OF PIROXICAM VS PARACETAMOL IN PATIENTS WITH DENTAL SURGERY |
| Active substance: PIROXICAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34433 |
| Study title: Observational use study of the tolerability of Octenisept in premature infants in the neonatal intensive care unit of Innsbruck University Hospital. University clinic for paediatric and juvenile medicine. 2000. |
| Active substance: OCTENIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32739 |
| Study title: Extension of Study LUI-01-00 in Austria: LUIVAC treatment under daily life conditions in patients with recurrent respiratory tract infections including obstructive pulmonary diseases |
| Active substance: Bacterial lysate |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41833 |
| Study title: Expertise clinique Claforan 1g I.M. préparation injectable solvant: Lidocaine - Pr J. Kermarec - 1979Expertise clinique Claforan 1g I.M. préparation injectable solvant: Lidocaine - Pr J. Kermarec - 1979 |
| Active substance: CEFOTAXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23479 |
| Study title: Short term treatment of acute urinary tract infection in girlsShort term treatment of acute urinary tract infection in girls |
| Active substance: PIVAMPICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46053 |
| Study title: Short term treatment with pivmecillinam in uncomplicated urinary tract infections in childrenShort term treatment with pivmecillinam in uncomplicated urinary tract infections in children |
| Active substance: PIVAMPICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46059 |
| Study title: A comparison of Pivmecillinam and Co-trimoxazole in the treatment of simple cystitis in general practice; D. Guttmann, J of antimicrobial chemotherapy 1977, 3 suppl. B 137-140 A comparison of Pivmecillinam and Co-trimoxazole in the treatment of simple cystitis in general practice; D. Guttmann, J of antimicrobial chemotherapy 1977, 3 suppl. B 137-140 |
| Active substance: PIVMECILLINAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34528 |
| Study title: Antibiotics in the treatment of gastroenteritis caused by enteropathgenic E. coli; Thoren A. et al Journal of Infectious Diseases, 1980, 141: 27-31 Antibiotics in the treatment of gastroenteritis caused by enteropathgenic E. coli; Thoren A. et al Journal of Infectious Diseases, 1980, 141: 27-31 |
| Active substance: PIVMECILLINAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34530 |
| Study title: Comparison of pivmecillinam and nalidixic acid in the treatment of acute shigellosis in children; Alam A.N. et al, 1994, Scand J Gastroenterol, 29: 313-317 Comparison of pivmecillinam and nalidixic acid in the treatment of acute shigellosis in children; Alam A.N. et al, 1994, Scand J Gastroenterol, 29: 313-317 |
| Active substance: PIVMECILLINAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34537 |
| Study title: Efficacy, pharmacology, and safety of amdinocillin in treatment of neonates; de Louvois et al, 1983, American Journal of medicine, 29 August, 119-124 Efficacy, pharmacology, and safety of amdinocillin in treatment of neonates; de Louvois et al, 1983, American Journal of medicine, 29 August, 119-124 |
| Active substance: PIVMECILLINAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34533 |
| Study title: FL 1039, a new Semisynthetic Penicillin, Preliminary Report on Its Use in Enteric Fever ; B. Limson FL 1039, a new Semisynthetic Penicillin, Preliminary Report on Its Use in Enteric Fever ; B. Limson |
| Active substance: PIVMECILLINAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34527 |
| Study title: Long term, low dose treatment with pivmecillinam alone and in combination with pivampicillin in patients prone to recurrent bacteriuria; Barclay R.P.C. et al. 1982, Current medical research and opinion, 8: 82-88 Long term, low dose treatment with pivmecillinam alone and in combination with pivampicillin in patients prone to recurrent bacteriuria; Barclay R.P.C. et al. 1982, Current medical research and opinion, 8: 82-88 |
| Active substance: PIVMECILLINAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34536 |
| Study title: Mecillinam in cerebrospinal fluid in children; Garborg O. 1981, Clinical Pharmacokinetics, 6:475-479 Mecillinam in cerebrospinal fluid in children; Garborg O. 1981, Clinical Pharmacokinetics, 6:475-479 |
| Active substance: PIVMECILLINAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34534 |
| Study title: Trimethoprim-polymyxin B ophthalmic solution in treatment of surface ocular bacterial infections.Nozik RA, Smolin G, Knowlton G, Austin R. Ann Ophthalmol. 1985 Dec;17(12):746-8.Trimethoprim-polymyxin B ophthalmic solution in treatment of surface ocular bacterial infections.Nozik RA, Smolin G, Knowlton G, Austin R. Ann Ophthalmol. 1985 Dec;17(12):746-8. |
| Active substance: POLYMYXIN B AND TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34585 |
| Study title: Mecillinam in enteric fever; Mandal BK et al, BMJ, 1979, 1:586-587 Mecillinam in enteric fever; Mandal BK et al, BMJ, 1979, 1:586-587 |
| Active substance: PIVMECILLINAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34531 |
| Study title: Mecillinam in the treatment of neonates; de Louvois J et al, 1981, J. Pernat. Med. 9: 87-95 Mecillinam in the treatment of neonates; de Louvois J et al, 1981, J. Pernat. Med. 9: 87-95 |
| Active substance: PIVMECILLINAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34532 |
| Study title: Pivmecillinam cotrimoxazole and oral mecillinam in gastro enteritis due to vibrio spp; Uylangco C. et al, 1984, JAC, 13: 171-175 Pivmecillinam cotrimoxazole and oral mecillinam in gastro enteritis due to vibrio spp; Uylangco C. et al, 1984, JAC, 13: 171-175 |
| Active substance: PIVMECILLINAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34538 |
| Study title: Pivmecillinam in the treatment of recurrent urinary infection in girls; (Deasy P.F: and Lynch K., 1980, Irish Medical Journal, 73: 388-389 Pivmecillinam in the treatment of recurrent urinary infection in girls; (Deasy P.F: and Lynch K., 1980, Irish Medical Journal, 73: 388-389 |
| Active substance: PIVMECILLINAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34535 |
| Study title: Randomised trial of pivampicillin plus pivmecillinam vs pivampicillin in children and young adults with chronic obstructive pulmonary disease and infection with Haemophilus influenzae; Johansen HK et al 1999 Curr Med Res Opin, 15: 300-309 Randomised trial of pivampicillin plus pivmecillinam vs pivampicillin in children and young adults with chronic obstructive pulmonary disease and infection with Haemophilus influenzae; Johansen HK et al 1999 Curr Med Res Opin, 15: 300-309 |
| Active substance: PIVMECILLINAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34539 |
| Study title: Slow replenishment of carnitine deficiency after cessation of longterm treatment with pivaloyl-containing antibiotics; Diep, Pharmacy World Sci Vol. 15(5), 1993. 225-229 Slow replenishment of carnitine deficiency after cessation of longterm treatment with pivaloyl-containing antibiotics; Diep, Pharmacy World Sci Vol. 15(5), 1993. 225-229 |
| Active substance: PIVMECILLINAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34529 |
| Study title: Bibliography - Pyostacine and Cutaneous infections in children - Larregue et al. - 1982 - Revue Int. Pediatric (122:1-4)Bibliography - Pyostacine and Cutaneous infections in children - Larregue et al. - 1982 - Revue Int. Pediatric (122:1-4) |
| Active substance: PRISTINAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46114 |
| Study title: Bibliography - Resistant pneumococci in paediatrics : therapeutic indications - E. Bingen and A. Bourrillon - January 4th, 1995 - La Presse Médicale (24:N°2)Bibliography - Resistant pneumococci in paediatrics : therapeutic indications - E. Bingen and A. Bourrillon - January 4th, 1995 - La Presse Médicale (24:N°2) |
| Active substance: PRISTINAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46115 |
| Study title: Bibliography - Treatment with pristinamycin of acute dermohypodermitis. Open study in 42 patients - P. Bernard et al. - 1996 - Ann Dermatol. Venereol. (123: 16-20) English VersionBibliography - Treatment with pristinamycin of acute dermohypodermitis. Open study in 42 patients - P. Bernard et al. - 1996 - Ann Dermatol. Venereol. (123: 16-20) English Version |
| Active substance: PRISTINAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46116 |
| Study title: Bibliography - Treatment with pristinamycin of bone and joint infections in children - P. Beauvais et al. - 1981 - Arch. Fr. Pediatr. (38:489-493)Bibliography - Treatment with pristinamycin of bone and joint infections in children - P. Beauvais et al. - 1981 - Arch. Fr. Pediatr. (38:489-493) |
| Active substance: PRISTINAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46117 |
| Study title: Phase IV, double- blind, double-dummy, multicenter clinical study randomized in two parallel groups comparing the efficacy and safety of pristinamycin (PYOSTACINE) at an oral dose of 1 gram twice a day for ten days versus oxacillin (BRISTOPEN) at an oral dose of 1 gram twice a day for 10 days in the treatment of superficial bacterial skin infections in 250 outpatients. Study report PY 403 - Phase IV, double blind, double-dummy, multicenter clinical study, randomised, in two parallel groups, comparing the efficacy and safety of pristinamycin (Pyostacine®) at the posology of 1 gramm orally twice a day for 10 days, versus oxacilline (Bristopen®) at the posology of 1 gramm orally twice a day for 10 days, in the treatment of superficial cutaneous bacterial infections in 250 out-patient. -... |
| Active substance: PRISTINAMYCIN |
| Study summary document link (including results): Pristinamycin STUDY SPECIA PY 403.xls |
| View full study record |
| Document reference: 46118 |
| Study title: Clinical report on the efficacy and tolerability of miocamycin (HM/MIO) in paediatric patients with respiratory tract infections |
| Active substance: MIOCAMYCIN |
| Study summary document link (including results): Miocamycin_Synopses.doc |
| View full study record |
| Document reference: 47538 |
| Study title: Clinical trial of the pneumococcal 23-valent vaccine in children with sickle cell disease or splenectomy (> 6 months-15 years old) |
| Active substance: PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENCES) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41324 |
| Study title: Safety and immunogenicity of the 23-valent pneumococcal vaccine after storage at 4°C for one year. (age 10-52 years old) |
| Active substance: PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENCES) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41325 |
| Study title: Safety and immunogenicity of the 23-valent vaccine in healthy children at increased risk of pneumococcal infection. (2-18 years old) |
| Active substance: PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENCES) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41323 |
| Study title: A Pilot Study of the Safety, Tolerability and Immunogenicity of Monovalent Pneumococcal Type 6B Conjugate Vaccine in Adults, Children and Infants |
| Active substance: Pneumococcal polysaccharides (serotypes 1,2,3,4,5,6B,7F,8,9N,9V,10A,11A,12F,14,15B,17F,18C, 19F,20,22F,23F,33F) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47769 |
| Study title: A Multicenter, Open-Label Study of Safety and Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Healthy Infants |
| Active substance: Pneumococcal saccharide conjugated vaccine, absorbed |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41586 |
| Study title: A Phase II Randomized, Controlled Study to Determine the Safety and Immunogenicity of Two Combination Vaccines Containing Meningococcal C and Pneumococcal Capsular Polysaccharide-CRM197 Conjugates with or without PRP-CRM197 (HibTITER) in Healthy Infants |
| Active substance: Pneumococcal saccharide conjugated vaccine, absorbed |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41587 |
| Study title: A Phase III Randomized Single-Blind Study to Evaluate the Safety of the 9-Valent Pneumococcal, Meningococcal Group C Saccharide-CRM197 Conjugate Combination Vaccine Compared to Licensed 7-Valent Pneumococcal Conjugate Vaccine (Prevnar®) Administered to Healthy Infants |
| Active substance: Pneumococcal saccharide conjugated vaccine, absorbed |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41588 |
| Study title: A Phase III Randomized, Controlled Study to Compare the Safety and Immunogenicity of Two Different Formulations of a 9-Valent Pneumococcal, Meningococcal Group C Saccharide Conjugate Combination Vaccine Concurrently Administered at Two Different Sites With DTaP-IPV- HepB/Hib in Healthy Infants at 3, 4 and 5 Months of Age |
| Active substance: Pneumococcal saccharide conjugated vaccine, absorbed |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41589 |
| Study title: DTPa-HBV-IPV-103 |
| Active substance: diphtheria, tetanus, acellular pertussis, hepatitis b recombinant (adsorbed), inactivated poliovirus, adsorbed conjugated haemophilus influenzae type b vaccine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41516 |
| Study title: Guarnieri J.,Ciliberto R. Osservazioni cliniche sull’impiego di una nuova associazione antibiotica Aggior.Pediat.,23(1-2-3)1-10,1972Guarnieri J.,Ciliberto R. Osservazioni cliniche sull’impiego di una nuova associazione antibiotica Aggior.Pediat.,23(1-2-3)1-10,1972 |
| Active substance: AMPICILLIN AND CLOXACILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46653 |
| Study title: A Phase III Randomized, Double-Blind Trial to Compare the Immunogenicity of Three Unique Lots of 9-Valent Pneumococcal, Meningococcal Group C Saccharide Conjugate Combination Vaccine in Infants. Amendment to Evaluate the Responses to a Fourth Dose of DTaP Vaccine Given Concurrently with 9-Valent Pneumococcal, Meningococcal Group C Saccharide Conjugate Combination Vaccine |
| Active substance: Pneumococcal saccharide conjugated vaccine, absorbed |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41590 |
| Study title: A Randomized, Controlled, Single-Blinded Study to Determine Equivalence of Immunogenicity Between a 7-Valent Pneumococcal Conjugate Vaccine and a 9-Valent Pneumococcal Conjugate Vaccine Administered Concurrently at Separate Sites with a DTPa/IPV+Hib Vaccine in Healthy Infants |
| Active substance: Pneumococcal saccharide conjugated vaccine, absorbed |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41591 |
| Study title: A Randomized, Double Blind, Study of the Safety and Immunogenicity of Nine Valent (1, 4, 5, 6B, 9V, 14, 18C, 19F, 23F) Pneumococcal Conjugate Vaccine in Healthy Infants at 2, 4, and 6 Months of Age. Amendment # 1: Safety and Immunogenicity of a Booster Dose of Nine Valent (1, 4, 5, 6B, 9V, 14, 18C, 19F, 23F) Pneumococcal Conjugate Vaccine Administered Concurrently with MMR in Toddlers 12-15 Months of Age. |
| Active substance: Pneumococcal saccharide conjugated vaccine, absorbed |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41592 |
| Study title: An Open Label Phase I/III Study to Evaluate the Safety and Immunogenicity of Pneumococcal 7-Valent Conjugate Vaccine (DIPHTHERIA CRM197 PROTEIN) (PREVNARTM) in Healthy Infants Phase III |
| Active substance: Pneumococcal saccharide conjugated vaccine, absorbed |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41593 |
| Study title: An Open Label Phase I/III Study to Evaluate the Safety and Immunogenicity of Pneumococcal 7-Valent Conjugate Vaccine (DIPHTHERIA CRM197 PROTEIN) (PREVNARTM) in Healthy Infants Phase III |
| Active substance: Pneumococcal saccharide conjugated vaccine, absorbed |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41594 |
| Study title: An Open-Label Pilot Study to Evaluate the Safety Of Pneumococcal 7-Valent Conjugate Vaccine [Diphtheria Crm197 Protein] (Prevenar) in Healthy Adults and Children at 3 to 5 Years Old. |
| Active substance: Pneumococcal saccharide conjugated vaccine, absorbed |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41595 |
| Study title: An Open-Label Trial of the Immunogenicity and Safety of Prevenar in Healthy Infants at 2, 4 and 6 months of age. |
| Active substance: Pneumococcal saccharide conjugated vaccine, absorbed |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41597 |
| Study title: Randomized Controlled Comparison of PREVEsNAR booster Dose Administration at 15 or 18 Months of Age. |
| Active substance: Pneumococcal saccharide conjugated vaccine, absorbed |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41598 |
| Study title: AN OPEN COMPARATIVE STUDY TO COMPARE THE EFFICACY, TOLERATION AND SAFETY OF IV AND ORAL FLUCONAZOLE WITH ORAL KETOCONAZOLE IN THE PROPHYLAXIS OF FUNGAL COLONIZATION AND INFECTION IN PATIENTS WITH ALLOGENEIC BONE MARROW TRANSPLANT. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27361 |
| Study title: COMPASSIONATE USE PROTOCOL FOR THE TREATMENT OF A THREE-YEAR OLD CHILD WITH SCEDOSPORIUM INFECTION |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27341 |
| Study title: TO COMPARE THE EFFICACY OF FLUCONAZOLE VS. ORAL KETOCONAZOLE IN THE PREVENTION OF FUNGAL INFECTION IN PATIENTS RECEIVING CHEMOTHERAPY FOR HEMATOLOGICAL DISEASE. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28028 |
| Study title: AN OPEN NONCOMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE PREVENTION OF SYSTEMIC FUNGAL INFECTIONS IN PATIENTS RECEIVING CHEMOTHERAPY FOR HAEMOTOLOGICAL DISEASE |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27847 |
| Study title: EFFICACY, SAFETY AND PRACTICABILITY OF FLUCONAZOLE VS. LOCAL CLOTRIMAZOLE THERAPY IN PATIENTS WITH VAGINAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27788 |
| Study title: Hiddemann W et al. Antifungal treatment by amphotericin B and 5-fluorocytosine delays the recovery of normal hematopoietic cells after intensive cytostatic therapy for acute myeloid leukemia. Cancer. 1991 Jul 1;68(1):9-14 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27303 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSES ASSOCIATED WITH DIGESTIVE MALIGNANCY |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27925 |
| Study title: OPEN, NON-COMPARATIVE STUDY OF FLUCONAZOLE IN PATIENTS WITH COCCIDIOIDAL MENINGITIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28052 |
| Study title: Antibiotics in Acute Osteomyelitis in Children;Blockey N J, McAllister T A J Bone Jt Surg Ser B 1972; 54(2): 299-309 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28707 |
| Study title: |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41160 |
| Study title: Mecillinam in the treatment of neonatesMecillinam in the treatment of neonates |
| Active substance: PIVAMPICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46055 |
| Study title: Pivmecillinam cotrimoxazole and oral mecillinam in gastro enteritis due to vibrio sppPivmecillinam cotrimoxazole and oral mecillinam in gastro enteritis due to vibrio spp |
| Active substance: PIVAMPICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46064 |
| Study title: Pivmecillinam in the treatment of childhood pyelonephritisPivmecillinam in the treatment of childhood pyelonephritis |
| Active substance: PIVAMPICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46058 |
| Study title: Pivmecillinam in the treatment of recurrent urinary infection in girlsPivmecillinam in the treatment of recurrent urinary infection in girls |
| Active substance: PIVAMPICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46060 |
| Study title: Randomised trial of pivampicillin plus pivmecillinam vs pivampicillin in children and young adults with chronic obstructive pulmonary disease and infection with Haemophilus influenzaeRandomised trial of pivampicillin plus pivmecillinam vs pivampicillin in children and young adults with chronic obstructive pulmonary disease and infection with Haemophilus influenzae |
| Active substance: PIVAMPICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46067 |
| Study title: Randomized trial of cefamandole plus amdinocillin versus cefamandole in serious pediatric infectionsRandomized trial of cefamandole plus amdinocillin versus cefamandole in serious pediatric infections |
| Active substance: PIVAMPICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46066 |
| Study title: Randomized, double blinded comparison of ciprofloxacin brasionc and pivamdinocillin tablets in the treatment of shigellosis in childrenRandomized, double blinded comparison of ciprofloxacin brasionc and pivamdinocillin tablets in the treatment of shigellosis in children |
| Active substance: PIVAMPICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46065 |
| Study title: TO STUDY THE EFFICACY AND INCIDENCE IN THE SEVERITY OF LOCAL AND SYSTEMIC ADVERSE REACTIONS OF INTRAMUSCULAR PIROXICAM ADMINISTRATION IN ACUTE MUSCULOSKELETAL DISORDERS. |
| Active substance: PIROXICAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34429 |
| Study title: TO STUDY THE EFFICACY AND TOLERATION OF PIROXICAM GEL 0.5% IN THE TREATMENT OF SELECTED MUSCULOSKELETAL DISORDERS. |
| Active substance: PIROXICAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34434 |
| Study title: A comparison of Pondocillin® and Calcipen® in children with acute otitis media |
| Active substance: PIVAMPICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46046 |
| Study title: A Controlled Trial of Povidone–Iodine to Treat Infectious Conjunctivitis in ChildrenA Controlled Trial of Povidone–Iodine to Treat Infectious Conjunctivitis in Children |
| Active substance: POVIDONE IODINE |
| Study summary document link (including results): A controlled trial of povidone-iodine.pdf |
| View full study record |
| Document reference: 34611 |
| Study title: AWB-Rei/100797 2 March 1999: Post marketing surveillance for Betaisodona ointment in paediatrics |
| Active substance: POVIDONE IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34612 |
| Study title: AWB-TDG/BETA-LSG/220193, 07-Apr-1994, Anwendungsbeobachtung 1992/1993 Betaisodona. (Post marketing surveillance study 1992/1993 Betaisodona.) (Germany) |
| Active substance: POVIDONE IODINE |
| Study summary document link (including results): Povidone iodine - Option 1 Mundipharma IACs.xls |
| View full study record |
| Document reference: 45115 |
| Study title: A PARALLEL DOUBLE BLIND STUDY OF THE EFFECT OF FELDENE AS ADJUNCT THERAPY TO PREVENT LUNG DAMAGE IN CYSTIC FIBROSIS PATIENTS WITH PSEUDOMONAS AERUGINOSA LUNG INFECTION. |
| Active substance: PIROXICAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34435 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE EFFICACY AND TOLERATION OF A PRX FDDF TAB IN THE TREATMENT OF ACUTE LOW BACK PAIN. |
| Active substance: PIROXICAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34439 |
| Study title: NA |
| Active substance: PIROXICAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34440 |
| Study title: OPEN, NON-COMPARATIVE STUDY WITH FELDENE 20 MG CAPSULES IN PRIMARY DYSMENORRHEA. |
| Active substance: PIROXICAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34443 |
| Study title: PIROXICAM IN THE TREATMENT OF ACUTE LUMBAGO. |
| Active substance: PIROXICAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34426 |
| Study title: TO ASSESS THE EFFICACY AND SAFETY OF PIROXICAM COMPARED TO PARACETAMOL WHEN TAKEN AT THE ONSET OF PAIN DUE TO 1 DEGREE DYSMENORRHEA. |
| Active substance: PIROXICAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34427 |
| Study title: TO EVALUATE CLINICAL EFFICACY AND SAFETY OF PIROXICAM IN THE TREATMENT OF PRIMARY DYSMENORRHEA. |
| Active substance: PIROXICAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34444 |
| Study title: EFFICACY OF PIROXICAM IN COMPARISON WITH NAPROXEN OR PLACEBO IN LARGE PATIENT POPULATION WITH ACUTE M.D. |
| Active substance: PIROXICAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34428 |
| Study title: EFFICACY OF PIROXICAM VS. NAPROXEN IN PATIENTS WITH RHEUMATIOD ARTHRITIS. |
| Active substance: PIROXICAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34441 |
| Study title: INVESTIGATE WHETHER PIROXICAM CREAM AND GEL 1% OR CREAM AND GEL CONTAINING THE SAM EXCIPIENT EXCEPT PIROXICAM INDUCE ANY UNWANTED LOCAL SIDE EFFECTS AS ASSESSED BY A PATCH TEST. |
| Active substance: PIROXICAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34430 |
| Study title: A single blind study of the efficacy and tolerance of roxithromycin (25mg bid) and erythromycin ethylsuccinate (1OOmg bid) in children with chlamydia! conjunctivitis |
| Active substance: ROXYTHROMYCIN |
| Study summary document link (including results): Roxithromycin STUDY S8796508a.xls |
| View full study record |
| Document reference: 48008 |
| Study title: A randomized, open label, comparative multicenter study of voriconazole versus conventional amphotericin B → fluconazole in the treatment of candidemia in non neutropenic subjects |
| Active substance: VORICONAZOLE |
| Study summary document link (including results): 150-608 PhRMA Web Synopsis.pdf |
| View full study record |
| Document reference: 48051 |
| Study title: A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole vs. AmBisome for Empirical Antifungal Therapy in Immunocompromised Patients with Persistent Fever and Neutropenia |
| Active substance: VORICONAZOLE |
| Study summary document link (including results): A1500603 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 48053 |
| Study title: An Historical Control Study of the Efficacy of Standard Therapy in Acute Aspergillosis to Allow Comparison with the Efficacy of Voriconazole in Protocol 150-304 |
| Active substance: VORICONAZOLE |
| Study summary document link (including results): A1501003 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 48054 |
| Study title: A double-Blind, Randomized, Placebo-Controled, Multicenter, Parallel Group Evaluation of the efficacy and Safety of Sertaconazole 2% Cream in Patients with interdigital Tinea Pedis. October 7, 1999 |
| Active substance: SERTACONAZOLE |
| Study summary document link (including results): Ferrer_ Spain_ Ser-960603.pdf |
| View full study record |
| Document reference: 42125 |
| Study title: A double-Blind, Randomized, Placebo-Controled, Multicenter, Parallel Group Evaluation of the efficacy and Safety of Sertaconazole 2% Cream in Patients with interdigital Tinea Pedis. January 29, 1999 |
| Active substance: SERTACONAZOLE |
| Study summary document link (including results): Ferrer_ Spain_ Ser-960602.pdf |
| View full study record |
| Document reference: 48114 |
| Study title: Van Esso D.; Fajo G.; Losada I., Vilallonga M, Casanovas JM; Clanxet J.; Aliaga A. Clinical Therapeutics 1995; 17:264-269 Sertaconazole in the treatment of paediatric patients with cutaneous dermatophyte infections PMID: 7614526 http://www.ncbi.nlm.nih.gov/pubmed?term=7614526 Van Esso D.; Fajo G.; Losada I., Vilallonga M, Casanovas JM; Clanxet J.; Aliaga A. Clinical Therapeutics 1995; 17:264-269 Sertaconazole in the treatment of paediatric patients with cutaneous dermatophyte infections PMID: 7614526 http://www.ncbi.nlm.nih.gov/pubmed?term=7614526 |
| Active substance: SERTACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45241 |
| Study title: An Open Label, Non-Comparative Protocol for the Emergency Use of Voriconazole in Patients with Life-threatening, Invasive Mycoses who are failing on currently available antifungal Agents |
| Active substance: VORICONAZOLE |
| Study summary document link (including results): A1501050 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 48057 |
| Study title: An Open Label, Non-comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections |
| Active substance: VORICONAZOLE |
| Study summary document link (including results): 150-309 and 150-604 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 48050 |
| Study title: Trial to explore efficacy, kinetics and safetyKosmidis et al |
| Active substance: AMOXICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Amoxillin_7.xlsx |
| View full study record |
| Document reference: 42447 |
| Study title: An Open Label, Non-comparative, Multicentre, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections |
| Active substance: VORICONAZOLE |
| Study summary document link (including results): 150-309 and 150-604 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 48049 |
| Study title: An Open Multicentre Study of the Efficacy, Safety and Toleration of UK-109,496 (Voriconazole) in the Treatment of Chronic Invasive Aspergillosis and Candidiasis |
| Active substance: VORICONAZOLE |
| Study summary document link (including results): A150-303 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 48052 |
| Study title: An Open-Label, Intravenous to Oral Switch, Multiple Dose, Multi- Centre Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Hospitalized Children Aged 2 to < 12 Years Who Require Treatment for the Prevention of Systemic Fungal Infection |
| Active substance: VORICONAZOLE |
| Study summary document link (including results): A1501037 PhRMA Web Synopsis.pdf |
| View full study record |
| Document reference: 48056 |
| Study title: An Open, Intravenous Multiple Dose, Multi-Centre Study to Investigate the Pharmacokinetics, Safety and Toleration of Voriconazole in Children Aged 2-12 Years Who Require Treatment for the Prevention of Systemic Fungal Infection |
| Active substance: VORICONAZOLE |
| Study summary document link (including results): A1501007 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 48055 |
| Study title: An Open, Multicentre, Dose Escalating Study of the Efficacy, Safety and Toleration of UK-109,496 (Voriconazole) in the Treatment of Acute Invasive Aspergillosis |
| Active substance: VORICONAZOLE |
| Study summary document link (including results): 150-304 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 48048 |
| Study title: An Open, Single Intravenous Dose, Multicentre Study to Investigate the Pharmacokinetics, Safety and Toleration of Voriconazole in Immunocompromised Children Aged 211 Years |
| Active substance: VORICONAZOLE |
| Study summary document link (including results): 150-249 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 48047 |
| Study title: An international, multi - center, randomised, open - label, parallel group, observer - blind study of the efficacy and tolerance of roxithromycin 5 - 8mg/Kg/day, administered bid and amoxicillin / clavulanic acid 40/10mg/Kg/day administered tid in the treatment of lower respiratory tract infections in children - Rostand A. - 11/86 |
| Active substance: ROXYTHROMYCIN |
| Study summary document link (including results): FF9296530.pdf |
| View full study record |
| Document reference: 35458 |
| Study title: Evaluation of the efficacy and tolerance of roxithromycin 5-8 mg/kg/day taken B.I.D. and clarithromycin 11-21 mg/kg/day taken B.I.D. in a 5 to 10 days treatment of lower respiratory tract infections in children. |
| Active substance: ROXYTHROMYCIN |
| Study summary document link (including results): FF9496564.pdf |
| View full study record |
| Document reference: 45229 |
| Study title: Roxithromycin 1OOmg paediatric tablet - Multicenter clinical trial |
| Active substance: ROXYTHROMYCIN |
| Study summary document link (including results): Roxithromycin STUDY FFR8796523.xls |
| View full study record |
| Document reference: 48007 |
| Study title: Roxithromycin 50 mg paediatric tablet - Multicenter clinical trial. |
| Active substance: ROXYTHROMYCIN |
| Study summary document link (including results): Roxithromycin STUDY FFR 87 965 19.xls |
| View full study record |
| Document reference: 48006 |
| Study title: Study in children and young adults of the diffusion of roxithromycin (RU 28965) into tonsillar tissue following administration of 2 or 3 doses. |
| Active substance: ROXYTHROMYCIN |
| Study summary document link (including results): Roxithromycin STUDY Begue &Cotin.xls |
| View full study record |
| Document reference: 48009 |
| Study title: Study of the diffusion of Roxithromycin (RU 28 965) in the middle ear secretions of children after repeated oral administration |
| Active substance: ROXYTHROMYCIN |
| Study summary document link (including results): Roxithromycin STUDY FFR869652.xls |
| View full study record |
| Document reference: 48005 |
| Study title: The use of macrolides in the treatment of Paediatric infections - Kafetzis - 14th International Congress of Chemotherapy - 1985, Kyoto The use of macrolides in the treatment of Paediatric infections - Kafetzis - 14th International Congress of Chemotherapy - 1985, Kyoto |
| Active substance: ROXYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35459 |
| Study title: A small risk canot be excluded, but a high risk of congenital anomalies in the children of women who are treated with spiramycin during pregnancy is unlikely (article retrieved from Micromedx online database) |
| Active substance: SPIRAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42585 |
| Study title: Clinical Expert Report - Rovamycin syrup - J. Paupe - May 22nd, 1980Clinical Expert Report - Rovamycin syrup - J. Paupe - May 22nd, 1980 |
| Active substance: SPIRAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42576 |
| Study title: Compared Biodisponibility in human - Rovamycin Syrup 0,375 MUI - J. Gaillot - August 26, 1976Compared Biodisponibility in human - Rovamycin Syrup 0,375 MUI - J. Gaillot - August 26, 1976 |
| Active substance: SPIRAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42577 |
| Study title: Etude Clinique Nationale de la Rovamycin Sirop - J.R. Paupe - 1980 - RPR FileEtude Clinique Nationale de la Rovamycin Sirop - J.R. Paupe - 1980 - RPR File |
| Active substance: SPIRAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42578 |
| Study title: Expert Clinical Assessment - Rovamycine 1.5 M.I.U. - Freeze-dried preparation and solution for slow intravenous injection - F. Vachon - March 1985Expert Clinical Assessment - Rovamycine 1.5 M.I.U. - Freeze-dried preparation and solution for slow intravenous injection - F. Vachon - March 1985 |
| Active substance: SPIRAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42579 |
| Study title: Intérêt de la Rovamycine Sirop en pédiatrie - H. Batellier, PS Jouk - 1982 (Tome XIII N° 1) |
| Active substance: SPIRAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42580 |
| Study title: 10 day oral toxicity study in the young dog - Thien - Aubert and al. - 31/12/95 |
| Active substance: ROXYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35461 |
| Study title: 28 day oral toxicity study and recovery study of RU 28 965 in infant beagle dogs - Moriya A. And al. - 31/07/90 |
| Active substance: ROXYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35463 |
| Study title: Spiramycin and erythromycin in the treatment of acute tonsillopharyngitis : a comparative study. - I. Soekrawinata et al. - 1984 - Curr Med Res Opin (9 (5):296-300) Spiramycin and erythromycin in the treatment of acute tonsillopharyngitis : a comparative study. - I. Soekrawinata et al. - 1984 - Curr Med Res Opin (9 (5):296-300) |
| Active substance: SPIRAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42581 |
| Study title: Spiramycin and erythromycin in the treatment of acute tonsillopharyngitis in children - D. Soebardja et al. - 1987 - Paediatrica Indonesiana (27: 223-230)Spiramycin and erythromycin in the treatment of acute tonsillopharyngitis in children - D. Soebardja et al. - 1987 - Paediatrica Indonesiana (27: 223-230) |
| Active substance: SPIRAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42582 |
| Study title: Spiramycin versus penicillin V in the empiric treatment of bacterial tonsillitis - L Manolopoulos et al. - 1989 - BJCP (43 (3): 94-96)Spiramycin versus penicillin V in the empiric treatment of bacterial tonsillitis - L Manolopoulos et al. - 1989 - BJCP (43 (3): 94-96) |
| Active substance: SPIRAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42583 |
| Study title: Traitement presomptif de première intention des infections cutanées par la spiramycine - H. Meilo - 1993 - Médecine d'Afrique Noire (40(3): 213-215)Traitement presomptif de première intention des infections cutanées par la spiramycine - H. Meilo - 1993 - Médecine d'Afrique Noire (40(3): 213-215) |
| Active substance: SPIRAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42584 |
| Study title: Risperidone in the traztment of behavioural disturbances in mentally retarded children and adolescents: a double-blind placebo-controlled pilot trial. |
| Active substance: RISPERIDONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35429 |
